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ABSTRACT 
The role of the periaqueductal grey (PAG) in the central control of micturition was 
investigated in urethane-anaesthetised rats, with the aims of furthering understanding of 
the central control of micturition and identifying novel therapeutic targets for urinary 
incontinence. Experiments using microinjection of GABAA agonists and antagonists into 
the midbrain showed that transmission through a localised region of the caudal 
ventrolateral PAG (cvlatPAG) is critical for reflex voiding and the micturition pathway is 
normally subject to tonic inhibitory GABAergic control. Experiments to determine the role 
of dopamine in controlling micturition by selectively lesioning dopamine-containing 
neurons in the cvlatPAG and microinjection of dopamine agonists and antagonists were 
inconclusive and require further work. Micturition could however be suppressed 
completely by trains of electrical stimulation applied throughout the midbrain. 
Microinjection of an excitatory amino acid over the same area reduced the frequency of 
micturition without disrupting the pattern of voiding. Though further work is required to 
determine the mechanism by which electrical stimulation inhibits reflex micturition, 
collaboration with clinical colleagues has indicated the exciting translational potential of 
electrical stimulation of the midbrain in human patients to treat urinary disturbances that 
have proven refractory to pharmacotherapy. 
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CHAPTER 1: GENERAL INTRODUCTION 
2 
 
Medical advances, improved sanitation and increased quality of life have led to an 
increased life expectancy and an aging population. United Kingdom (UK) Government 
statistics suggest that for the first time in England and Wales since records began, the 
percentage of the population made up by people above 65 years old exceeds that made 
up by under 16 year olds. Between 1981 and 2007 the growth in the population above 
retirement age was around 1%, however between 2006 and 2007 this growth doubled to 
2% (UK National statistics, 2008). The increase in life expectancy inevitably means an 
increase in diseases associated with aging. One such disease with high prevalence 
amongst the elderly, though certainly not exclusively associated with age, is urinary 
incontinence.  
 
1.1 URINARY INCONTINENCE 
The term ‘urinary incontinence’ (UI) refers to the inability to control voiding adequately, 
or a leaking of urine in-between voiding. There are numerous types of incontinence 
covered by the term: stress urinary incontinence (urine loss associated with coughing, 
laughing etc.); urge urinary incontinence (where the urge to void comes on suddenly and 
cannot always be suppressed until an appropriate time); mixed urinary incontinence 
(combined symptoms of stress and urge incontinence); and enuresis (the involuntary 
loss of urine, which can occur in the daytime or at night). Accurate assessment of the 
prevalence of urinary incontinence throughout the community and institutional settings is 
often complicated by sample bias, a reliance on self-reporting of past events and 
3 
 
inconsistencies in the definition of incontinence between different studies (Lagace et al., 
1993; Cheater & Castleden, 2000).  
 
O’Brien et al. (1991) estimate incontinence prevalence at 1 million women and 100,000 
men in the UK suffering from regular incontinent episodes. Their prediction is based on 
an initial postal questionnaire, followed up with interviews of those who replied. In their 
initial survey, they found that 16.1% of women (aged 35 and above) and 7.4% of men 
(of the same age category) regularly suffer from incontinence (‘regular’ is defined as two 
or more episodes a month) (O'Brien et al., 1991). More recently, Milsom (2009) 
suggests that 10% of women of all ages suffer from incontinence, and this value 
increases to 20% of women over the age of 70, though he points out that this may be a 
modest prediction as not all sufferers will approach the medical profession. A review of 
studies which estimate the prevalence of urinary incontinence in the community and 
institutions has been undertaken by Cheater and Castleden (2000), who summarise 
studies which estimate a range from 3 – 58% prevalence in the community and 6 – 72% 
prevalence in institutional settings. 
 
The cost of UI to the UK National Health Service is substantial, with estimates of up to 
£536 million per year, and on top of this there is substantial monetary cost for the 
individual in terms of prescription charges, over-the-counter drugs, pads and travel 
expenses for medical appointments (Turner et al., 2004). As well as the financial 
demands, there are significant social costs associated with UI. Some of these include 
social isolation (for fear of embarrassment with uncontrollable bladder emptying), 
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depression and a decreased quality of life (Temml et al., 2000; Margalith et al., 2004; Ko 
et al., 2005).  
 
1.2 THEORIES OF INCONTINENCE 
Incontinence occurs where there is a failure to store or release urine adequately. The 
pathologies underlying incontinence are varied. The slightly higher prevalence in 
females may be explained by incontinence as a result of the trauma of giving birth, but 
the inequality in incidence becomes less significant after menopause and is equal 
between men and women in age groups of 75 years and above (McGrother et al., 1987).  
 
There are a number of theories that explain incontinence where an obvious nerve or 
tissue injury is absent, which focus on neurological changes and physiological 
alterations in the bladder wall and external urethral sphincter.  
 
1.2.1 Non-neurologic causes 
A common cause for incontinence in males presenting with an inability to empty the 
bladder is benign prostatic hyperplasia. This can be treated effectively with surgery in 
66% of cases. There is a similar prognosis for females suffering urinary retention as a 
result of a prolapsed vagina which causes bending and consequent blockade of the 
urethra (Keane & O'Sullivan, 2000). Obstruction of the urethra in guinea pigs caused a 
decrease in the passage of electrical signals between neighbouring myocytes of the 
detrusor, which did not fully recover after the obstruction was removed (Seki et al., 
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1992a, b). This could explain why success rate in humans suffering benign prostatic 
hyperplasia, treated with surgery lies at 66%, not 100%, as one would expect if the 
problem was a simple obstruction.  
 
Another theory of incontinence suggests that bladder over-activity leading to urge 
incontinence has a myogenic basis. Brading  (1997) suggests that increased activity of 
the detrusor muscle could be explained by increased tonic activity in myocytes within the 
detrusor, and a lower threshold for the spread of excitability between neighbouring cells 
(Brading, 1997), which could lead to the urgency that so many sufferers report. Other 
research has proposed that the disease could have a neural basis. 
 
1.2.2 Neurologic causes 
In a comprehensive review of literature on the neural control of micturition, de Groat 
(1997) puts forward the argument that changes in both peripheral and central neural 
pathways can lead to bladder over-activity. He suggests that neuronal changes could 
mean a reduction in central inhibition of the micturition pathway, a reduction in sensitivity 
of the bladder and EUS to descending inhibition, an increase in excitatory input to the 
micturition reflex pathway, or an increase in afferent activity from the bladder in to the 
micturition circuitry (de Groat, 1997). The suggestion of a neural origin for incontinence 
is supported by neuro-imaging studies in humans which have shown decreased activity 
(measured by functional magnetic resonance imaging) in the orbitofrontal cortex in 
incontinent compared to continent subjects (Griffiths et al., 2005), and the high incidence 
of urge incontinence in patients with Parkinson’s disease – a disorder known to be 
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caused by a loss of central dopaminergic neurons (Singer, 1998; Sakakibara et al., 
2010).  
 
As Brading and de Groat show in their 1997 reviews, there are likely to be a number of 
underlying pathologies that result in incontinence. To be able to treat the problem 
pharmacologically, it is important to be able to understand the underlying cause, 
otherwise treatments simply mask the symptoms, as opposed to targeting the cause of 
the disorder. This is likely to lead to less efficacious results. However, in reality, often the 
cause of incontinence is unknown and available treatments ineffective. 
 
1.3 THERAPIES FOR INCONTINENCE 
Current treatments for urinary incontinence include both behavioural and 
pharmacological approaches. Behavioural methods include monitoring of fluid intake 
and avoidance of drinks in the evening with the aim of reducing nocturnal enuresis. 
Pharmacological approaches primarily target the bladder, and often aim to reduce the 
activity of the detrusor muscle. 
 
No existing therapeutic approach is completely successful in ‘curing’ incontinence, which 
is most likely a combination of mixed underlying pathologies and also as a result of 
targeting the symptoms as opposed to the cause of the problem. Most success is 
achieved in treating urge incontinence (Andersson, 2000). Some of the available 
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therapies have been included in this introduction, but for a more comprehensive review 
see Andersson (2000).  
 
1.3.1 Antimuscarinic drugs 
The first line of treatment in those who present themselves to a medical professional 
with an over-active bladder is likely to be antimuscarinic drugs. These act via 
antagonism of M-type muscarinic receptors in the bladder wall to prevent over-activity 
(Andersson, 2000). These systemic drugs have undesirable side effects such as 
xerostomia, constipation, blurred vision, dyspepsia and nausea (Lazzeri & Spinelli, 
2006). However the benefits of reduced urinary frequency, reduced sensation of 
urgency, increased voiding volume and an increase in quality of life are presumed 
sufficient to out-weigh the potential side effects (Chapple et al., 2008). 
 
1.3.2 Botulinum toxin 
It was initially hypothesised that injection of botulinum toxin A into the detrusor could 
prevent detrusor activity solely through preventing pre-synaptic acetylcholine release, 
thus reducing the power of the parasympathetically-mediated detrusor contraction 
(Schurch et al., 2000). It has since been realised that the effects of botulinum A are 
more complex. A review by Apostolidis et al. (2006) proposes that the effects of 
botulinum toxin A (increasing bladder capacity, compliance and increasing the volume 
voided at the first reflex detrusor void) are brought about via inhibition of vesicular 
release of adenosine triphosphate (ATP) and substance P as well as acetylcholine. 
They also suggest that the botulinum toxin A has direct effects on myofibroblasts within 
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the lamina propria causing changes in the expression of receptors within the plasma 
membrane (Apostolidis et al., 2006).  
 
1.3.3 Antidepressants 
Imipramine is an agent used to treat depression, and has a spectrum of effects via 
action on a number of neurotransmitter systems, including systemic antimuscarinic 
action and serotonin and noradrenaline re-uptake inhibition (Andersson, 2000). It has 
shown some success in treating incontinence as a result of bladder instability, though it 
is suggested that these success rates with imipramine may be more attributable to the 
change in habits alongside the administration of the drug, as opposed to an actual effect 
of the drug itself. There are also undesirable side effects such as xerostomia and 
constipation (Castleden et al., 1986) 
 
1.3.4 Sacral nerve modulation 
Electrical stimulation of the sacral spinal cord via electrodes connected to an implanted 
pulse generator, (sacral nerve modulation (SNM)) has proven effective in reducing 
urinary disturbance caused by urge urinary incontinence and non-obstructive urinary 
retention that is refractory to other therapies (Tanagho et al., 1989; Van Kerrebroeck & 
Marcelissen, 2011; Monga et al., 2012). The mechanism of action of SNM is unclear, but 
clinical studies suggest that this treatment is effective in up to 70% of patients (Monga et 
al., 2012). Implantation of the neuromodulatory system is considered to be minimally 
invasive, however some patients report pain and discomfort during stimulation, but this 
can be limited by the patient since the implantable pulse generator can be switched off 
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when not required, and in serious cases the electrodes can be repositioned (Van 
Kerrebroeck & Marcelissen, 2011).  
 
The available therapies have limited efficacy amongst incontinence sufferers, which is 
likely to be explained by a varied spectrum of the pathology of incontinence. To be able 
to tackle incontinence more successfully, it is essential to further the understanding of 
the normal control of continence, to be able to target areas of the control system that 
may be inactive or damaged in incontinent subjects. 
 
1.4 CURRENT UNDERSTANDING OF CONTINENCE 
The bladder acts a reservoir, and collects urine until a socially acceptable time for 
emptying. The organ consists of a smooth muscle wall (the detrusor), which is lined with 
transitional epithelium. This specialised epithelium can accommodate a large degree of 
stretch as the bladder fills with urine. The bladder receives urine, containing waste 
products and metabolites from the kidneys via the ureters, receiving between 0.5 and 5 
ml per minute in the human (Keane & O'Sullivan, 2000). Because of the distensible 
properties of the detrusor and the transitional epithelium, the pressure rise in response 
to filling is minimal, allowing the storage of large volumes of urine. The external urethral 
sphincter (EUS) is a striated muscle structure, which surrounds the urethra and is 
responsible for preventing bladder emptying until it is safe and socially acceptable to do 
so. During micturition, coordinated contraction of the detrusor and relaxation of the 
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external urethral sphincter allow the bladder to empty. This coordination is mediated 
both spinally and supra-spinally. 
 
Figure 1.1 shows a basic schematic of the micturition pathway linking the bladder and 
EUS, the spinal cord and the brain. Sensory information from the bladder and proximal 
urethra is conveyed to higher centres within the midbrain and pons via the spinal cord, 
which integrate this information and if deemed socially acceptable, signal to the bladder 
and EUS and allow bladder emptying. The following section will describe the current 
understanding of the role of each level (the bladder, spinal cord, and brain stem), paying 
attention to the tissue types and structures, innervation, and neurotransmitters involved 
in maintaining continence.  
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Figure 1.1. Schematic diagram of the micturition pathway. Intravesicular volume is 
detected by stretch receptors in the bladder wall, which signal to the sacral spinal cord. 
Projections from the sacral cord reach the periaqueductal grey (PAG), which also 
receives projections from the frontal cortex that may be involved in the conscious control 
of the micturition reflex. The PAG sends projections to the pontine micturition centre 
(PMC), which is essential for the coordination of the detrusor muscle and external 
urethral sphincter (EUS). The PMC signals via the sacral spinal cord and causes 
contraction of the detrusor in synchrony with relaxation of the EUS, allowing the bladder 
to empty. 
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1.4.1 Bladder and external urethral sphincter 
The bladder and external urethral sphincter (EUS) act in concert to maintain continence. 
In humans and some other species, as the bladder fills, the activity of the EUS increases 
to counteract the pressure build-up of the fluid accumulating in the bladder. This is 
known as the guarding reflex, and is a spinal mechanism that helps to maintain 
continence (Garry et al., 1959). The guarding reflex can be seen experimentally in both 
humans and some animals through measurement of intravesicular pressure and 
electromyography (EMG) of the EUS. Since there is little increase in the level of the 
EMG activity in the EUS during the period between voids when the bladder is being filled 
(Conte et al., 1991; Streng et al., 2004; D'Amico et al., 2011), it is generally suggested 
that rats do not show a guarding reflex (McMurray et al., 2006), and the pattern of EMG 
activity during voiding shows significant difference from that seen in humans. The EUS 
of the rat contracts intermittently during flow through the urethra, with EMG bursts 
interspersed between EMG silences (Conte et al., 1991; Streng et al., 2002; Streng et 
al., 2004; Peng et al., 2006; Sadananda et al., 2011), whereas EMG of the EUS is silent 
during flow in humans (de Groat, 2011). It is thought that these phasic contractions of 
the EUS in rats facilitate the flow of urine and are important in scent marking behaviours 
(Van Asselt et al., 1995; Park et al., 1997). 
 
1.4.2 Neuronal control of the bladder and EUS 
In neonates and also following spinal injury above the lumbosacral level, the control of 
bladder emptying is a spinal reflex. As the intravesicular pressure builds up with the 
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inflow of urine from the ureters, there is an increase in firing in afferent fibres which 
project to the lumbosacral spinal cord. This activity is conveyed via spinal interneurons 
to efferent fibres projecting to the EUS. The immediate response to this increased 
efferent firing is an increase in the tone of the EUS, to prevent the bladder from 
emptying. Eventually the pressure inside the bladder overcomes the internal urethral 
sphincter (IUS), and there is flow of urine into the urethra. This is detected by flow 
receptors in the urethral wall, and their activation results in the relaxation of the EUS, 
allowing urine to empty from the bladder (de Groat, 2006). Without the control of supra-
spinal mechanisms, this cycle could happen at any time. The input of higher centres 
allows bladder emptying to be deferred until an individual is in a safe and socially 
acceptable environment, even when the bladder is at near full capacity (Janig & 
Morrison, 1986; Fowler et al., 2008).  
 
1.4.2.1 Sympathetic control 
During bladder filling, the detrusor is relaxed and the smooth muscle IUS is contracted. 
This is mediated by tonic activity in the sympathetic nervous system. Postganglionic 
sympathetic fibres originate in the thoracolumbar portion of the spinal cord and reach 
the bladder and EUS via the hypogastric and pelvic nerves (Fowler et al., 2008). Their 
effect is to relax the detrusor (via action of noradrenaline on β-adrenoceptors) and cause 
contraction of the IUS (via action of noradrenaline on α-adrenoceptors), (de Groat, 2006; 
Michel & Vrydag, 2006). 
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1.4.2.2 Parasympathetic control 
During voiding, the detrusor contracts and the EUS relaxes, allowing urine to be 
expelled. This is mediated by parasympathetic projections from the sacral spinal cord 
(Fowler et al., 2008) and also the lower lumbar cord in rats (Morrison 1997). These 
parasympathetic fibres reach the bladder in the pelvic nerves, and cause contraction of 
the detrusor in response to the release of acetylcholine (ACh), which acts principally on 
M3 receptors in the detrusor, and also via M2 receptors (Hegde, 2006). ACh also 
facilitates contraction via action on presynaptic M1 receptors, causing the release of 
more ACh during activity, and can also inhibit neurotransmitter release via M4 receptors 
(Somogyi et al., 1998; Fowler et al., 2008). As well as ACh, adenosine triphosphate 
(ATP) and nitric oxide (NO) released from nerve terminals contribute to the 
parasympathetic control of the bladder. ATP elicits contractile activity, predominantly via 
the P2X1 receptor in humans, and it has been shown that expression of other subtypes 
of the P2X receptors are up-regulated in some pathological conditions (O'Reilly et al., 
2001). The role of nitric oxide in the expulsion phase is contentious, with some 
suggesting it functions only under pathological conditions (Andersson & Arner, 2004). 
However, it has also been suggested that NO released from parasympathetic nerve 
terminals relaxes the smooth muscle of the internal urethral sphincter to allow flow 
through (Bennett et al., 1995; Fowler et al., 2008). 
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1.4.2.3 Somatic efferent control  
Somatic cholinergic fibres originate in Onuf’s nucleus within the sacral spinal cord and 
project to the EUS via the pudendal nerve (Morrison 1997). These fibres play an 
important role in maintaining continence when it is not socially inappropriate to void by 
increasing activity of the external urethral sphincter, preventing urine outflow. It is 
suggested that Onuf’s nucleus receives projections from a lateral region of the pons, 
which promotes continence. This is discussed in more detail below. 
 
1.4.2.4 Sensory afferents of the bladder and EUS 
As well as carrying efferent signals to the bladder, Aδ and C fibres in the hypogastric, 
pelvic and pudendal nerves transmit sensory information from the bladder and EUS. In 
the cat myelinated Aδ fibres are activated by both bladder distension and contraction 
(Janig & Morrison, 1986; Habler et al., 1993). The unmyelinated C-fibres are not 
activated in response to bladder filling, or in response to isovolumetric contractions of 
the bladder (Bahns et al., 1987), but they do respond under conditions such as 
inflammation and mechanical stimulation, suggesting a role in transmitting sensory 
information on painful and pathological bladder conditions (Habler et al., 1990). In the 
rat, the electrophysiological activity in the Aδ fibres is indistinguishable from that in the C 
fibre afferents (Sengupta & Gebhart, 1994).  
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1.4.3 Central control of micturition 
Transneuronal retrograde tracing techniques have identified areas of the brain likely to 
be involved in the central control of micturition. Immunotracing studies using the 
pseudorabies virus, have shown immunoreactivity in the sacral parasympathetic 
nucleus, other areas of the spinal cord, the PMC and also the periaqueductal grey, locus 
coeruleus, the subcoeruleus alpha and the red nucleus following microinjection of the 
virus in to the detrusor and external urethral sphincter (Nadelhaft et al., 1992; Vizzard et 
al., 1995; Sugaya et al., 1997; Grill et al., 1999). Marson’s (1997) work supported these 
findings, and also found pseudorabies immunoreactivity in forebrain regions when the 
survival times were longer. These areas were the lateral hypothalamus, the 
parvocellular region of the paraventricular nucleus and the medial preoptic area 
(Marson, 1997). These regions may play a part in the conscious control of micturition, in 
which decisions are made as to whether voiding is safe and socially acceptable. 
 
1.4.3.1 The periaqueductal grey 
The periaqueductal grey (PAG) is well known for its functions in pain and analgesia, the 
fight-fright-flight response (also known as the defence response), anxiety, 
cardiovascular control and lordosis behaviour (for a review see (Behbehani, 1995). 
However, there are indications that the PAG also plays an important role in the control of 
micturition. In an interesting case study by Yaguchi et al. (2004), a 31 year old male 
presented with acute urinary retention. Upon examination and after extensive tests, the 
only abnormality was shown up by an MRI scan: a lesion in the PAG. Treatment with 
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steroid therapy reduced the size of the lesion, and the patient’s continence returned 
(Yaguchi et al., 2004). This case provides a small but valuable insight into the critical 
involvement of the PAG in the control of micturition in humans and shows how an 
underlying pathology in the structure can have profound effects on continence. Other 
studies in humans using a number of neuroimaging techniques have suggested a role 
for the PAG in the control of micturition (Blok et al., 1997a; Blok et al., 1997b; Blok et al., 
1998; Griffiths & Tadic, 2008; Fowler & Griffiths, 2010). 
 
Transneuronal retrograde tracing techniques in animals have highlighted the PAG as an 
area which has neural connections with the bladder and EUS (Nadelhaft et al., 1992; 
Vizzard et al., 1995; Marson, 1997). An increase in neuronal activity in the PAG evoked 
by an intravesicular infusion of saline has also been shown in the urethane 
anaesthetised rat by functional magnetic resonance imaging (fMRI) (Tai et al., 2009).  
Micturition-related neuronal firing has also been recorded in the PAG under 
isovolumetric bladder conditions in decerebrate cats (Liu, Sakakibara et al. 2004). The 
responsive cells were located predominantly in the ventrolateral PAG. Interestingly, 
when Matsuura et al (2000) inhibited synaptic transmission in the ventrolateral PAG of 
the rat with cobalt chloride, they found that this blocked reflex micturition evoked by 
continuous infusion of saline into the bladder. They also found that under isovolumetric 
conditions, microinjection of the excitatory amino acid L-glutamate at the same sites at 
which cobalt chloride blocked neurotransmission, caused contraction of the bladder (as 
reflected by an increase in intravesicular pressure) and evoked corresponding activity in 
the EUS. Taniguchi et al. followed this work in 2002, and showed in cats that electrical 
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stimulation or microinjection of the excitatory amino acid D,L-homocysteic acid (DLH) 
into a similar region of PAG could initiate bladder contraction (coupled with appropriate 
activation of the EUS). These studies suggest that the ventrolateral part of the PAG 
contains synaptic relays that are important for normal micturition.  
 
The descending pathway from the PAG relays in the pontine micturition centre (PMC). 
With the use of neuronal tracers, the ventrolateral PAG has been shown to send 
projections to the PMC in the cat and the PMC receives a projection from the 
dorsomedial region of the PAG too (Blok & Holstege, 1994; Ding et al., 1998). The 
projection from the PAG to the PMC is bilateral since unilateral microinjection of the 
retrograde neuronal tracer fluorogold into the PMC, resulted in labelling on both the right 
and left hand side of the PAG (Taniguchi et al., 2002). Matsuura (2000) showed that the 
excitatory effects of L-glutamate in the PAG could be blocked with cobalt chloride 
microinjected into the PMC (Matsuura et al., 2000) thus providing unequivocal evidence 
that the micturition reflex pathway relays via the PMC. 
 
1.4.3.2 The pontine micturition centre (PMC) and storage centre (L-
region) 
The importance of the pontine micturition centre (PMC), in the control of micturition has 
been recognised for over 80 years. Barrington was the first to investigate the effects of 
lesioning the brainstem on micturition in cats (Barrington, 1925). He found that pontine 
lesions either caused an increase in residual volume (despite maintenance of the desire 
to void as judged by persistence of the behavioural traits normally preceding voiding in 
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the cat), loss of consciousness of the desire to void without any increase in residual 
volume, or a combination of the above. Post-mortem histological analysis of the brains 
of the cats identified a common region in the pons, which is now known as ‘pontine 
micturition centre' or ‘Barrington’s nucleus’. 
As Barrington concluded, the integrity of the PMC is essential for normal micturition to 
take place, and it is now known that projections from the PMC, via the sacral spinal cord 
(Holstege et al., 1979) are responsible for activating the synchronous contraction of the 
smooth muscle of the detrusor and relaxation of the striated EUS that allows bladder 
emptying to take place (Holstege et al., 1979; Holstege et al., 1986; Blok et al., 1995; 
Sasaki, 2005).  
 
As well as a pontine micturition centre, which allows the coordinated contraction of the 
bladder detrusor and relaxation of the EUS, it has been suggested that more laterally in 
the pons, a ‘pontine storage centre’ or ‘lateral region’ (L-region), becomes active during 
the storage phase. This region was identified following the discovery of projections from 
the region to Onuf’s nucleus in the lumbosacral spinal cord in the cat (Holstege et al., 
1979). Electrical stimulation in this region led to contraction of the musculature of the 
pelvic floor and the external urethral sphincter (and anal sphincter) (Holstege et al., 
1986). It was later found that bilateral lesion of the region caused a decrease in bladder 
capacity and an increase in detrusor activity, which resulted in incontinence in cats 
(Griffiths, Holstege et al. 1990). Neuroimaging in humans has also suggested that there 
may be an equivalent region in the pons, which is active during the withholding of urine 
against a ‘full’ bladder (Blok et al., 1997b). Though this evidence strongly suggests a 
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role for the L-region in the control of continence in some species (no such equivalent 
region has been identified in the rat (Morrison et al., 2005)), no direct neural projections 
between the L-region and the PMC can be identified (Blok & Holstege, 1999). This 
suggests that unless they are linked indirectly, rather than there being some reciprocal 
coordination between the areas, they appear to act independently in controlling the 
storage and voiding phases. It is more likely that activation of the L-region continuously 
during bladder filling plays a role in initiating contraction of the EUS, and then during 
micturition, this excitatory control over the EUS is overcome by activation of the 
pathways via the PMC, which allow the bladder to empty. 
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1.5 AIMS AND HYPOTHESIS 
The primary aim of the present experiments was to seek further understanding of the 
control of the micturition reflex at the level of the PAG using a rat model, with a 
secondary, more long-term aim of identifying new targets for therapeutic intervention in 
the treatment of urinary incontinence in human patients. Though it is suggested that the 
PAG may play a role in integrating and processing afferent input from the distended 
bladder, the specific role of this midbrain structure in the control of micturition is not fully 
understood. The fact that micturition can be suppressed in humans and socialised 
animals until an appropriate time infers that there is a higher level of control over the 
micturition reflex circuitry. We hypothesised that the PAG is involved in the inhibitory 
control over the micturition reflex that allows voiding to be deferred at will, and 
modulation of neuronal activity in this region might be a useful clinical tool for the 
treatment of urinary disturbances in human patients in the future. 
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CHAPTER 2: GENERAL METHODS 
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2.1 ANIMALS 
Male Sprague Dawley rats (Charles River, Kent, UK) weighing between 206 and 410 g 
were housed under a 12 hour light/dark cycle, with lights  on at 7 am and off at 7 pm. 
Temperature was maintained at 21°C with 50% humidity, and food and water were 
available in home cages ad libitum. All procedures were in accordance with agreed local 
ethical guidelines of the University of Birmingham and complied with the UK Animals 
(Scientific Procedures) Act 1986. Every care was taken to minimise suffering of subjects 
and to reduce the number of animals used.  
2.2 ACUTE SURGICAL PREPARATION 
2.2.1 Anaesthesia 
For terminal procedures, animals were anaesthetised with 1.4 g kg-1 urethane 
intraperitoneally (20% weight/volume (W/V) solution, 0.7 ml 100g-1 administered. 
Vehicle: dH2O. Sigma, Poole, Dorset). Depth of anaesthesia was assessed as sufficient 
when the lower limb flexor reflex was absent. Experiments were terminated with an 
intravenous overdose of pentobarbitone (Sigma, Poole, Dorset), followed by cervical 
dislocation to confirm death.  
 
2.2.2 Tracheal cannulation 
A tracheal cannula was inserted to allow recording of respiratory flow via a spirometer 
and to maintain a clear airway throughout the procedure. A 15 to 20 mm longitudinal 
midline incision of the skin over the trachea was made to expose the underlying salivary 
gland tissue, which was then separated from the underlying longus colli muscle. The 
24 
 
vertebral portion of the sternohyoid was blunt dissected longitudinally to expose the 
underlying trachea. The trachea was separated from the surrounding connective tissue 
and a loose ligature placed around it distally. Curved forceps were placed under the 
trachea to raise it clear from the surrounding tissue and a small transverse cut was 
made between two cartilaginous rings using a scalpel. The first 2 to 3 mm of a bevelled 
30 mm polythene cannula (1.67 mm inner diameter (ID), 2.42 mm outer diameter (OD) 
Portex tubing, SIMS Portex Ltd, Kent, UK) was inserted pointing towards the lungs and 
secured with the previously placed suture. 
 
2.2.3 Cannulation of femoral artery and vein 
Cannulation of the femoral artery and vein allowed monitoring of blood pressure and 
provided a route for administering fluids and drugs respectively. A longitudinal incision of 
the skin of the inner right thigh was made to expose the underlying inguinal fat pad, 
which was ligated, divided and reflected with clamps to allow access to the underlying 
vessels. Blunt dissection was used to separate the femoral artery and the femoral vein 
from surrounding tissue and from each other, and obvious side branches from the 
vessels were tied to prevent blood loss during the cannula insertion. The artery was tied 
off peripherally and a loose ligature placed centrally and a small artery clip was used to 
temporarily occlude the vessel while the cannula was inserted. A small incision was 
made in the vessel between the clip and the tight ligature and a polythene cannula (1.14 
mm ID, 1.57 mm OD Portex tubing, SIMS Portex Ltd, Kent, UK) filled with heparinised 
saline (10 units ml-1 Multiparin™ CP Pharmaceuticals Ltd, Wrexham, UK) was advanced 
25 
 
into the vessel in a retrograde direction, and secured in place with ligatures on either 
side of the site of entry into the vessel, and the clamp removed. A second cannula (1.14 
mm ID, 1.57 mm OD Portex tubing, SIMS Portex Ltd, Kent, UK) containing 0.9% 
physiological saline was inserted into the femoral vein in an identical fashion, but in an 
orthograde direction for administration of fluids (Gelofusine Ecobag, plasma substitute, 
B Braun Medical Ltd., Sheffield, UK) and supplementary anaesthesia if necessary. 
 
2.2.4 Laparotomy and cannulation of the bladder 
Rats were placed prone in a stereotaxic instrument (Kopf Instruments, California, USA) 
in the attitude described by Paxinos and Watson (1986). A temperature sensing probe 
attached to a homeothermic blanket system (Harvard Apparatus, Kent, UK) was inserted 
into the rectum and secured in place by taping to the tail. The lower body was twisted 
and the left leg was raised to give access to the lower abdomen. Rat tooth forceps were 
used to lift the abdominal skin away from the underlying abdominal muscle. A midline 
abdominal incision extending 20 mm from the point at which the penis folds allowed 
exposure of the underlying linea alba muscle. This muscle was lifted with rat tooth 
forceps to separate it from the abdominal contents, and gently cut until perforated. This 
hole was extended 20 mm along the midline from the fold of the penis, taking care not to 
puncture the abdominal contents. The laparotomy was extended 10 mm bilaterally at the 
distal end so that the muscle and skin could be reflected.  
 
A cotton bud was used to gently reflect the abdominal contents and locate the bladder 
with minimal tissue damage. Where the bladder contained residual urine, the bladder 
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pressure and hence the tension in the wall was increased by gently squeezing the 
bladder between the index and middle finger, placed close to the bladder neck. For 
cannulating the bladder, a 23 gauge hypodermic needle was cut 10 mm from the tip and 
the blunt end inserted into a length of polythene tubing (0.58 mm ID 0.96 mm OD Portex 
Tubing, SIMS Portex Ltd, Kent, UK). The assembly was filled with saline and connected 
to a T-piece with one arm connected to a pressure transducer (AD Instruments, 
Oxfordshire, UK) and the other to an infusion pump (Harvard Apparatus, Kent, UK). 
Cannulation was achieved by piercing the bladder through the dome. Insertion into an 
empty bladder meant the bladder dome was grasped gently with blunt forceps so that 
sufficient tension could be applied to the wall to allow insertion of the needle. Once the 
cannulation had been performed the tubing was secured to a supportive bar with Blu-
tack®, and was not moved for the remainder of the experiment. Cling film was placed 
over the wound to prevent drying.  
 
2.2.5 Electromyographic recordings from the external urethral 
sphincter (EUS) 
A cotton bud was used to gently reflect the bladder and forceps were used to separate 
connective tissue overlying the urethra. Excess abdominal fluid was absorbed with 
cotton wool. Two stainless steel needle electrodes fashioned by soldering the 10 mm 
ends from 26G hypodermic needles (insulated except for the tips) to a length of 
insulated flexible wire were inserted bilaterally into the external urethral sphincter 
proximal to the symphysis pubis which remained intact (Fig. 2.1). For connections see 
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Fig. 2.2. Correct placement of the electrodes in the EUS was verified by the appearance 
of EMG activity in response to gentle application of pressure on to the bladder. 
 
2.2.6 Craniotomy 
A longitudinal midline incision was made to expose the dorsal surface of the skull. Skin 
was reflected using clamps, and the periosteum was scraped back. Areas of the skull 
seeping blood were sealed by “spot” drilling the bone over the area with a dental drill 
(W&H, Austria). A limited craniotomy 3 mm caudal to lambda (approximately 5 mm x 5 
mm) was made to expose the cortex overlying the midbrain. The skull was thinned using 
the drill until the remaining bone could be removed with fine forceps. The tip of a 
hypodermic needle was used to pierce the dura and this hole was extended using 
Vannas microscissors.  
 
2.2.7 Electrode placement 
An injection cannula, made from either stainless steel or glass, depending on the 
experiment (see individual chapter methods for details) was inserted into the midbrain 
using a microdrive (Harvard Apparatus, Kent, UK) attached to a stereotaxic frame (Kopf 
Instruments, California, USA). Stereotaxic placement of the microcannula into the PAG 
was originally guided by coordinates from the Paxinos and Watson Rat Brain Atlas 
(1986). Often the optimal coordinates lay directly below the confluence of the sagittal 
and transverse sinuses so the cannula was inclined caudally at a 10° angle to be able to 
reach the more caudal regions of the PAG. With experience, cannula placement was 
guided by the location of cerebral vessels, in particular the sagittal and transverse 
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sinuses. The pattern of smaller surface vessels varied between experiments, and these 
vessels were carefully avoided to prevent blood loss. Depth measurements were also 
guided by the atlas of Paxinos and Watson (1986) and ranged from -4.0 mm to -10.00 
mm below the surface of the cortex, in order to reach the most dorsal and most ventral 
midbrain respectively (Paxinos & Watson, 1986).  
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Figure 2.1. Labelled photograph showing location of electrodes placed to record 
EMG activity of the external urethral sphincter (EUS). Two electrodes, insulated 
except for the tip were inserted into the EUS on either side of the urethra and proximal 
to the pubic symphysis to record bipolar EMG activity of the skeletal musculature.  
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2.2.8 Cystometry  
In the majority of acute experiments, saline was infused continuously into the bladder at 
a rate of 6ml h-1 via polyethylene tubing connected to an infusion pump (Harvard 
Apparatus Syringe Pump 11, Model: 555-1111, Kent, UK). Intravesicular pressure was 
recorded via a pressure transducer connected to a t-arm from the infusion tubing. The 
urethral outlet remained open in all experiments. Drop output during cystometry was 
recorded by an automatic infra-red drop counter (AD Instruments, Oxford, UK), which 
was positioned below the channel that drops naturally exited the urethral opening. A 
manual counter was always available and was used in the initial stages of setting up the 
drop counter in the correct position, and also at times when the trajectory of the drop 
channel changed and the automatic counter did not detect all drops.  
2.3 DATA COLLECTION 
All data inputs in acute experiments fed into a PowerLab data acquisition system 
running Chart 4.2.3 software module. Signals from the pressure transducers (AD 
Instruments, Oxford, UK), the spirometer, and infra-red drop counter all fed in via bridge 
amplifiers (AD Instruments, Oxford, UK). EMG electrodes were connected to a 
headstage, and the signal was amplified (x 5000) and filtered (low freq. 15 – 500 Hz, 
high freq. 50 – 5000 Hz) using NeuroLog apparatus (Digitimer, Welwyn Garden City, 
UK), before feeding into the PowerLab. The manual drop counter connected directly into 
PowerLab that sampled at 100 Hz (AD Instruments, Oxford, UK). The thermostatic heat 
blanket displayed the temperature of the preparation; this was monitored regularly to 
ensure it remained within a physiological range.
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Figure 2.2. Diagram representing inputs and outputs to NeuroLog and PowerLab 
apparatus that allowed recording of intravesicular pressure, blood pressure, heart rate, 
respiratory flow, urine output, EMG of the external urethral sphincter (EUS) during 
cystometry in the urethane anaesthetised rat. 
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2.4 PREPARATION OF TISSUE FOR HISTOLOGICAL ANALYSIS 
In terminal experiments that involved the microinjection of drugs and electrical 
stimulation of the midbrain, rats were killed by an overdose of pentobarbitone whilst 
under urethane anaesthesia and cervically dislocated (see Section 2.2.1: Anaesthesia). 
The whole brain was then removed and placed into 10% formol saline solution for 
fixation. Once fixed, the midbrain was blocked for sectioning (see Section 2.5: 
Sectioning brain tissue for histology). In terminal experiments that required 
immunohistochemical analysis of the midbrain, rats were terminally anaesthetised and 
perfused with fixative retrogradely via the descending aorta with the jugular veins cut 
bilaterally to allow the perfusate to drain from the circulation (see Chapter 5, Section 
5.3.4). Brains were removed and stored in paraformaldehyde before being transferred to 
30% sucrose in phosphate buffer (0.1M, pH 7.4) to afford cryoprotection (see Chapter 5, 
Section 5.3.5 for immunohistochemistry protocol). 
 
2.5 SECTIONING BRAIN TISSUE FOR HISTOLOGY 
Blocks of brain containing the PAG were frozen on a microtome (Measuring and 
Scientific Equipment Ltd., London, UK) and cut in coronal sections either 40 or 60µm 
thick. Sections that were required for locating microinjection tracks only were cut to a 
60µm thickness and were mounted on to gelatinised slides, dried at 37°C and then 
stained as outlined in the individual chapter methods. Where fluorescent dyes were 
used for identification of microinjection sites, alternate sections were nissl stained to 
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identify brain structures, and the remaining sections were left unstained and viewed 
under the fluorescence microscope. 
2.6 ANALYSIS 
All data are represented as mean ± standard error of the mean (SEM) unless stated 
otherwise. Normality of the distributions was assessed with a D’Agostino-Pearson 
Omnibus test in Prism 4 (Omnibus K2 version, GraphPad Software, Inc, California, 
USA). Paired data sets displaying a normal distribution were compared with a Student’s 
Paired t test unless otherwise stated. Data failing to follow the normal distribution were 
analysed with the Mann-Whitney U Test. Data from 3 or more groups, were compared 
using a one-way ANOVA with Bonferroni post-hoc analysis. Significance was assumed 
when P ≤ 0.05. Where administration of a drug or stimulation produced a response, the 
maximal effect during the response was compared to the mean response before 
administration. 
2.6.1 Definition of parameters of a contraction 
 
Figure 2.3. Sample contraction. Broken lines define parameters measured for analysis 
of the periodic increases in bladder pressure associated with voiding during continuous 
infusion of saline into the bladder of the urethane anaesthetised rat.
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CHAPTER 3: THE EFFECTS OF GABAA AGONISM AND ANTAGONISM IN THE 
PERIAQUEDUCTAL GREY ON THE MICTURITION REFLEX EVOKED BY 
CONTINUOUS INTRAVESICULAR INFUSION OF SALINE IN THE URETHANE 
ANAESTHETISED MALE RAT. 
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3.1 INTRODUCTION 
Micturition is a spino-midbrain-spinal event that requires coordinated contraction of the 
detrusor and relaxation of the external urethral sphincter (EUS) to allow the bladder to 
empty. Humans and socialised animals are able to defer bladder emptying until a 
socially appropriate moment, which suggests that there is inhibitory control over the 
micturition reflex. However, the level of the micturition circuitry at which this inhibitory 
control is imposed is presently unknown.  
 
As the bladder fills with urine, afferent signals from stretch receptors in the bladder wall 
are transmitted to the sacral spinal cord. After synapsing in the sacral spinal cord, these 
fibres project to the periaqueductal grey (PAG) (Vizzard et al., 1995; Marson, 1997). The 
ventral PAG sends dense bilateral projections to the pontine micturition centre (Blok & 
Holstege, 1994; Ding et al., 1998) which is known to be integral to the coordination of 
contraction of the bladder and relaxation of the EUS that allows voiding, via projections 
to the sacral spinal cord (Barrington, 1925; Holstege, 2005; Fowler et al., 2008; Drake et 
al., 2010; Holstege, 2010).  
 
Recent evidence suggests that inhibitory control of the micturition reflex may be exerted 
at the level of the PAG. The PAG contains a dense population of inhibitory ɣ-
aminobutyric acid-containing (GABAergic) interneurons (Reichling & Basbaum, 1990; 
Lovick & Paul, 1999; Griffiths & Lovick, 2005) which exert tonic inhibitory control over 
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output neurons that coordinate behavioural responses such as flight and anti-
nociception (Bandler et al., 1985; Carrive et al., 1986; Morgan & Clayton, 2005). 
Furthermore, there is evidence that the extracellular levels of GABA in the ventrolateral 
PAG are reduced during periods of intravesical distension (Kitta et al., 2008), suggesting 
that GABAergic inhibition of the micturition circuitry is withdrawn to permit voiding to 
occur.  
 
3.2 AIMS AND HYPOTHESIS 
We hypothesised that GABAergic neurotransmission is involved in the inhibitory control 
of the micturition circuitry as it passes though the periaqueductal grey. Our initial 
objective was to determine the location at which the micturition reflex pathway passes 
through the PAG using microinjection of the GABAA agonist, muscimol to inhibit local 
neurotransmission at the site of injection in the urethane-anaesthetised rat during 
continuous cystometry. We then investigated whether GABA tonically inhibits the 
micturition reflex at the level of the PAG by microinjecting the GABAA antagonist, 
bicuculline into the region. 
 
37 
 
 
3.3 METHODS 
Male Sprague Dawley rats (n = 79, 197 – 410 g, Charles River, Kent, UK) were 
anaesthetised with urethane (20% W/V, 0.7 ml 100g-1) and prepared for cystometry 
along with recording of cardiovascular and respiratory parameters as described in 
Chapter 2: General methods, Section 2.2). A dorsal craniotomy exposed the surface of 
the brain, which allowed insertion of a stainless steel cannula (500 µm diameter) into the 
periaqueductal grey (PAG) and surrounding midbrain for the administration of drugs.  
 
3.3.1 Microinjection of drugs 
The effects of microinjection of the GABAA agonist, muscimol (5 x 10-3 M, pH adjusted to 
7.4 using NaOH, vehicle: 0.9% saline, Sigma-Aldrich, Gillingham, UK), GABAA 
antagonist, bicuculline methiodide (2 x 10-2 M, pH 6.8, vehicle: dH2O, Sigma-Aldrich, 
Gillingham UK) and saline (0.9%, pH 7.4) into the PAG on the micturition reflex evoked 
by continuous infusion of saline into the bladder (6 ml h-1) were investigated in the 
majority of experiments (n = 73). Doses were based on those reported to have been 
used in the literature and in preliminary experiments, and were administered in 50 nl 
volumes. To allow post mortem histological location of microinjection sites, 
approximately 2 mg ml-1 of pontamine sky blue (PSB, Searle Diagnostics, High 
Wycombe, UK) was added to the muscimol and saline solutions. The bicuculline solution 
contained 0.2% yellow-green fluorescent microbeads (FluoSphere, Invitrogen Molecular 
Probes, USA) since PSB caused precipitation of bicuculline from solution. 
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3.3.2 Stepped volume infusion experiments 
In 6 experiments, the bladder was emptied manually using a 1 ml syringe connected via 
a 3-way tap to the infusion tubing. Saline was then introduced into the bladder in 
stepped increases in volume and the effects on EMG activity of the EUS were recorded. 
This protocol was repeated following microinjection of bicuculline into the PAG in order 
to determine whether the changes in EUS activity seen following microinjection 
represented a primary response or a secondary effect related to changes in 
intravesicular pressure. 
 
3.3.3 Histology 
Experiments were terminated by an intravenous overdose of pentobarbitone anaesthetic 
followed by cervical dislocation. Brains were removed, stored in 10% formol saline and 
sectioned (60 µm, see Chapter 2: General methods, sections 2.4 and 2.5 for details). 
Sections from experiments in which pontamine sky blue dye was used to mark injection 
sites were all stained with Neutral Red (1% in water, Sigma-Aldrich, Gillingham, UK). 
Only alternate sections were stained with Neutral Red where fluorescent beads were 
used for identification of brain structures, and unstained sections were viewed under a 
fluorescence microscope exciting at 450 – 500 nm and detecting at 475 – 700 nm 
(Olympus BH-2 Microscope, filtered with Omega Optical XF100-2, Olympus, Southend-
on-Sea, UK). Images of whole sections were enlarged x17.5 using a Carl Zeiss 
documenter (Carl Zeiss, Welwyn Garden City, UK). The location of the centre of the 
microinjection site as judged by the most densely stained region with PSB dye or 
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fluospheres, was marked on to a map of four representative levels of the PAG (P -5.6, P 
-6.2, P -8.0 and P -8.8) taken from the stereotaxic atlas of Paxinos and Watson (1986). 
 
3.3.4 Analysis 
All values are represented as mean ± SEM, and unless otherwise stated, paired data 
sets have been compared with a Student’s paired t test, with significance assumed 
where P ≤ 0.05. See Chapter 2: General methods, section 2.6 for details). 
 
3.3.4.1 Bladder and EMG of the EUS 
A bladder ‘contraction' was defined as a change in the intravesicular pressure of more 
than 7 mmHg, and the parameters of contractions measured have been defined in 
Chapter 2: General methods, Section 2.6.1). For analysis of the frequency of 
contractions, voiding and non-voiding contractions were grouped together. A text file 
from a 60 s period of raw EMG signal from the EUS in between bladder contractions 
recorded in LabChart (AD Instruments, Oxford, UK) was exported in to Microsoft Excel 
(Microsoft, Reading, UK), where values were rectified. The area under the curve was 
calculated by summing the amplitude of the rectified activity in individual bins in 
Microsoft Excel (Microsoft, Reading, UK), see appendix A for detailed instructions. 
 
3.3.4.2 Cardiorespiratory parameters 
Mean values for arterial blood pressure, heart rate and respiratory rate over 1 min during 
the pre-drug control period were compared to the maximum values reached in the post-
drug response period.
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3.4 Results 
3.4.1 Response to infusion of saline into the bladder 
Continuous infusion of saline (room temperature, 0.9%, 6 ml h-1) into the bladder of the 
urethane anaesthetised male rat elicited a micturition reflex that was characterised by 
(1) a sharp rise in intravesicular pressure of 7 mmHg or greater, (2) an increase in the 
level of tonic EMG activity in the EUS, which adopted a bursting pattern with EMG bursts 
followed by EMG silence and (3) drop output from the urethral meatus (Fig. 3.1). 
 
The micturition reflex occurred at a frequency of 0.7 ± 0.04 contractions min-1 (n = 68), 
though there was a considerable degree of inter-rat variability, with frequencies ranging 
from 0.1 to 1.9 contractions min-1. The amplitude of the periodic increase in 
intravesicular pressure was 21.5 ± 0.6 mmHg (range 10.7 to 35.1) and lasted for 32.3 ± 
2.4 s (range from 14 to 124 s). The number of drops per void was also highly variable, 
with a mean of 5.6 ± 0.4 drops void-1, and range of 1 to 35 drops void-1. With the 
exception of frequency, the mean values were the same in all treatment groups (Table 
3.1). Despite this, there was no relationship between the control voiding frequency and 
the effect of microinjection of the GABA agonist and antagonist on the voiding 
frequency. In 25 rats that had EMG electrodes in the EUS, there was an increase in the 
level of tonic EMG activity as the pressure in the bladder increased at the onset of a 
contraction. At the peak of the contraction, this EMG activity adopted a bursting pattern 
(6.8 ± 0.1 Hz), with EMG silences interspersed between bursts. During this time, drop 
output from the urethra occurred. This rhythmic bursting was reflected as small 
oscillations in the intravesicular pressure (Fig. 3.1 A ii). Following voiding, EMG of the 
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EUS returned to a sustained tonic activity and the levels gradually decreased to 
baseline. This reflex remained stable for up to 9 hours or until the experiment was 
terminated. 
 
In 11 rats (13.9%), this reflex failed to develop and as saline was infused into the 
bladder, the intravesicular pressure rose to 31.0 ± 1.2 mmHg. As the infusion continued, 
fluid began to exit the urethral meatus in a dropwise fashion (2.2 ± 0.1 drops min-1) as 
opposed to in clusters of drops as was normally seen during micturition. There was no 
coordinated bursting activity in the EMG recorded from the EUS, and periodic increases 
in intravesicular pressure were absent. These experiments were terminated after a 
minimum of 2 hours and no data was obtained.  
 
Table 3.1. Mean frequency of contractions for each group before microinjection of 
drug or control solutions into the PAG. 
 
 Muscimol Bicuculline Control 
Mean frequency ± SEM 
(contractions min-1)  
0.8                ± 
0.04 
0.7               
± 0.04 
0.8             
± 0.04 
Minimum frequency (contractions 
min-1) 
0.3 0.1 0.6 
Maximum frequency 
(contractions min-1) 
1.9 1.7 1.1 
Although there was a significantly lower frequency of contractions in rats that went on to 
receive microinjections of bicuculline (F (2, 142) = 5.2, P = 0.007), there was no 
relationship between the control voiding frequency and the effect of microinjection of the 
GABA agonist, antagonist or saline on the voiding frequency. 
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Figure 3.1. Sample sequence of voiding evoked by continuous infusion of saline 
into the bladder of the urethane anaesthetized rat. (A) Periodic increases in 
intravesicular pressure were accompanied by an increase in EMG activity and drop 
output from the urethral meatus. Rectangle highlights void shown on a faster time base 
in Ai. Ai, EMG activity of the EUS initially showed a tonic increase, and adopted a 
bursting pattern which was associated with drop output via the urethra. Bursting stopped 
shortly before the last drop was expelled and EUS EMG activity gradually declined after 
the void. Aii, EMG bursts were followed by EMG silence and occurred at a frequency of 
approximately 7Hz. 
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3.4.2 Effect of microinjection of a GABAA agonist into the PAG on 
reflex contractions of the bladder 
 
Microinjections of the GABAA agonist, muscimol (250 pmol, 50 nl) were made at 61 sites 
distributed over a wide area of the PAG and adjacent tegmentum, on either side of the 
midline. At most injection sites (n = 50) there was no change in the micturition reflex 
evoked by continuous infusion of saline into the bladder (Fig. 3.2 A, open circles). There 
was no change in the frequency (0.9 ± 0.1 v. 0.8 ± 0.1 contractions min-1), amplitude 
(19.4 ± 0.4 v. 19.6 ± 0.4 mmHg) or duration of contractions (22 ± 1 v. 26 ± 2 s before 
and after microinjection of muscimol respectively). There was also no significant change 
in the number of drops of fluid expelled per void (7.2 ± 0.6 v. 7.2 ± 0.6 drops per void). 
 
At 11 sites (Fig. 3.2 A, filled circles, 7 on the left hand side and 4 on the right hand side), 
microinjection of muscimol evoked an inhibitory effect on the micturition reflex induced 
by continuous infusion of saline into the bladder. At these inhibitory sites, the effects of 
microinjection of muscimol into the left hand side of the PAG were indistinguishable from 
those evoked by microinjection on the right hand side (Table 3.2). Therefore data from 
both sides of the PAG have been pooled.  
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Table 3.2. Comparison of left and right PAG microinjections of muscimol on the 
frequency of voiding evoked by continuous cystometry. 
 
 Left hand 
side of PAG 
Right hand 
side of PAG 
P = 
n = 7 4  
Pre-muscimol frequency 
(contractions min-1) 
 
0.9  
± 0.1  
1.2 
± 0.1 
0.79 
Post-muscimol frequency 
(contractions min-1) 
 
0.3 
± 0.1 
0.2 
± 0.1 
0.23 
The inhibitory effects of microinjection of muscimol into the left hand side of the PAG 
were indistinguishable from those evoked by microinjection on the right hand side of the 
PAG. Therefore data from the left and right hand side have been pooled. Analysed with 
non-parametric Mann Whitney U test.  
 
 
At 7 of the inhibitory sites, the frequency of voids was reduced from 0.9 ± 0.1 to 0.4 ± 0.1 
contractions min-1 (Fig. 3.3 A i, P < 0.001). There was no change in the amplitude of the 
pressure rise (23.0 ± 1.7 v. 21.0 ± 1.7 mmHg, P = 0.22), duration of contraction (27.0 ± 
2.9 v. 39.3 ± 9.6 s, P = 0.21), or number of drops per void (5.5 ± 0.9 v. 6.5 ± 0.7 drops 
void-1 P = 0.2) at these sites (Fig. 3.3 B, C, D consecutively). The inhibitory effect on the 
frequency of contractions lasted for 49.0 ± 26.2 min (range 3.3 to 236.9 min). At the 
other 4 sites, the micturition reflex was completely abolished (Fig. 3.4 B). Within 14.8 
min (mean: 7.1 ± 3.9 min) of microinjection of muscimol into the midbrain, cyclic voiding 
ceased. As the infusion of saline continued, the intravesicular pressure began to rise 
until reaching a plateau at 20.3 ± 5.0 mmHg. Urine output resumed, but it was not in 
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association with any sharp rise in intravesicular pressure, or the development of bursting 
activity in the EUS which was normally associated with a void. Indeed, rather than the 
clusters of drops normally seen during a void, drops of fluid were expelled from the 
penis in a regular fashion at a rate of 2.7 ± 0.3 min-1. In 6 of the experiments the EMG 
from the EUS was also recorded alongside the intravesicular pressure. Following 
microinjection of muscimol, there was a significant decrease in the amplitude of tonic 
EMG activity present in between voids in comparison to control values (Fig. 3.4 C, 0.3 ± 
0.1 v. 0.2 ± 0.1 µV.s, P = 0.03, n = 6). At sites where there was a reduction in the 
frequency of the micturition reflex, the relationship between the intravesicular pressure, 
bursting activity in the EMG of the EUS and the drop output was maintained despite the 
reduction in the tonic EMG of the EUS during the inter-void period (Fig. 3.4 A).  
 
Sites at which muscimol produced inhibitory effects were clustered together in the 
caudal ventrolateral (cvlat) region of the PAG at P levels -8.0 and -8.8mm (Paxinos and 
Watson, 1986) (Fig. 3.2 A). Within this region, injection sites at which muscimol evoked 
the two types of inhibitory effect (‘partial’: grey circles and ‘complete’: black circles) were 
intermingled. 
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Figure 3.2. Location of sites where muscimol was microinjected in and around the 
PAG plotted on to outlines of the PAG taken from the Atlas of Paxinos and 
Watson (1986). A, Black filled circles represent the centre of sites at which 
microinjection of muscimol completely inhibited the micturition reflex in response to 
continuous intravesicular filling (6 ml h-1). Grey filled circles represent the centre of sites 
at which microinjection of muscimol reduced the frequency of the micturition reflex in 
response to continuous infusion of saline into the bladder. Open circles represent the 
centre of sites at which microinjection of muscimol produced no change in the frequency 
of the micturition reflex. B, open triangles represent the centre of sites where saline was 
microinjected into the PAG. Numbers indicate distance (mm) caudal to Bregma. 
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Figure 3.3. Quantification of the effect of microinjection of muscimol into and 
around the PAG on the micturition reflex evoked by continuous cystometry. A i, At 
11 sites located in the caudal ventrolateral PAG, microinjection of muscimol significantly 
reduced the frequency of contractions. These sites are marked on fig. 3.2 A as grey and 
black filled circles. A ii, At the remaining 50 sites microinjection of muscimol did not 
affect the frequency of contractions (marked as open circles in the map of microinjection 
sites, fig. 3.2 A). Microinjection of muscimol did not affect B i and ii, the amplitude of the 
pressure rise associated with a void, C i and ii, the number of drops per void, or D i and 
ii, the duration of contraction at any sites in the midbrain during continuous cystometry. < 
0.001.
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Figure 3.4. Effect of microinjection of muscimol (250 pmol in 50 nl) into the caudal 
ventrolateral PAG on the micturition reflex evoked by intravesicular filling: Sample 
traces. A, At most effective sites (n = 7), microinjection of muscimol reduced the 
frequency of reflex voiding which was accompanied by a decrease in the level of EMG 
activity in the EUS in the inter-void period (asterisk). B, at 4 sites, muscimol completely 
suppressed the micturition reflex. As the infusion of saline continued, drop output 
returned but was not in association with the sharp change in the intravesicular pressure 
that normally indicates a void. C, at the 6 inhibitory sites where EMG of the EUS was 
recorded, microinjection of muscimol produced a significant decrease in the EUS EMG 
activity during the inter-void period. *P ≤ 0.05. 
C 
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3.4.3 Effect of microinjection of muscimol into the PAG on 
cardiorespiratory function 
Microinjection of muscimol at sites in and around the PAG did not produce changes in 
any of the cardiovascular and respiratory parameters recorded. This was true both at 
sites where muscimol reduced the frequency or abolished cyclic voiding in response to 
infusion of saline into the bladder (Fig. 3.5 A) and at sites where muscimol evoked no 
effect on micturition (Fig. 3.5 B).  
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Figure 3.5. Microinjection of muscimol (250 pmol in 50 nl) evoked no changes in 
the cardiovascular and respiratory parameters recorded at both inhibitory (A) and 
‘no effect’ (B) sites. Abbreviations: BP: Blood pressure, HR: heart rate, BPM: beats 
min-1, RF: respiratory flow, Arb: arbitrary units, RR: respiratory rate, Br.PM: breaths min-
1, MABP: mean arterial blood pressure. 
51 
 
3.4.4 Control experiments 
Microinjection of saline at 19 sites throughout the midbrain and PAG (Fig. 3.2 B) did not 
affect the micturition reflex evoked by continuous infusion of saline into the bladder (Fig. 
3.6 A). There was no significant change in the frequency of contractions (Fig. 3.6 B. 0.8 
± 0.04 v. 0.8 ± 0.03 contractions min-1) or any other parameters recorded. There was 
also no change in the mean arterial blood pressure (Fig. 3.6 C, 77.6 ± 4.3 v. 84.9 ± 5.7 
mmHg), heart rate (Fig. 3.6 D, 481.1 ± 20.6 v. 492.7 ± 20.6 beats min-1) or respiratory 
rate (Fig. 3.6 E, 164.9 ± 9.5 v.189.4 ± 13.6). 
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Figure 3.6. Effect of microinjection of saline (0.9%, 50 nl) into the PAG on the 
micturition reflex induced by continuous infusion of saline into the bladder and on 
the cardiorespiratory system. A, sample trace demonstrating that microinjection of 
saline into the PAG (between horizontal broken lines) evoked no change in the 
micturition reflex or cardiovascular and respiratory parameters recorded. B, 
microinjection of saline evoked no change in the frequency of the micturition reflex 
during continuous cystometry (n = 11). C, D, E, microinjection of saline into the PAG did 
not affect MABP (mmHg), HR (BPM) or RR (Br.PM) respectively. Abbreviations: BP: 
Blood pressure, HR: heart rate, BPM: beats min-1, RF: respiratory flow, Arb. U: arbitrary 
units, RR: respiratory rate, Br.PM: breaths min-1, MABP: mean arterial blood pressure. 
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3.4.5 Effect of microinjection of a GABAA antagonist into the PAG on 
reflex contractions of the bladder 
 
3.4.5.1 Microinjection of bicuculline in the ventral PAG 
The inhibitory effects evoked by microinjection of muscimol into the cvlat PAG on the 
micturition reflex induced by continuous cystometry suggested that synapses in this part 
of the PAG could be subject to tonic GABAergic inhibition. To investigate this further, the 
GABAA antagonist, bicuculline was microinjected into the region in the cvlat PAG where 
microinjection of muscimol inhibited micturition. 
 
Microinjection of bicuculline (1 nmol in 50 nl) into the cvlat PAG facilitated the micturition 
reflex evoked by continuous infusion of saline into the bladder (Fig. 3.7, black filled 
circles and Fig. 3.8). At 16/26 sites, this effect was characterised by an increase in the 
frequency of the micturition reflex (from 0.6 ± 0.1 to 3.5 ± 0.5 contractions min-1, P < 
0.0001, Fig. 3.9 A). In contrast to the control period, when each contraction of the 
detrusor was associated with a void, following microinjection of bicuculline, non-voiding 
contractions developed. These were classified as periodic increases in intravesicular 
pressure of 7 mmHg or greater without associated expulsion of drops from the urethra 
(Fig. 3.8, Ai). There was also a significant reduction in the amplitude of contractions 
(pressure change from baseline to maximum) from 23.2 ± 1.1 to 16.3 ± 2.4 mmHg, (Fig. 
3.9 B, P = 0.02). Following microinjection of bicuculline there was a significant increase 
in the amplitude of tonic EMG activity of the EUS (Fig. 3.8 A ii, from 0.2 ± 0.1 to 0.4 ± 0.1 
µV. s, P = 0.02, n = 7) along with a disruption of the bursting activity normally seen in the 
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EMG of the EUS during voiding. Although some bursts were evident these were 
superimposed on a tonic level of EMG activity rather than being interspersed with 
silences in the EMG as seen in the control period (Fig. 3.8 A i). Normal voiding returned 
within 21.4 ± 5.5 min of the initial microinjection of bicuculline (range 6.1 to 70.2 min).  
 
At the remaining 10 sites, microinjection of bicuculline into the cvlat PAG during 
continuous cystometry inhibited the cyclic pattern of voiding completely (Fig. 3.8 B). In 
6/10 cases this followed a short period (9.4 ± 2.2 min) of contractions of increased 
frequency (from 0.7 ± 0.2 to 1.7 ± 0.4 contractions min-1). Intravesicular pressure rose 
and was maintained at 27.6 ± 1.1 mmHg. Low amplitude oscillations in bladder pressure 
were superimposed on top of the raised baseline (Fig. 3.8 B). In 3 cases where EMG 
activity of the EUS was also recorded there was an increase in the level of tonic EMG 
activity (Fig. 3.8 Bi, from 0.1 ± 0.02 to 0.3 ± 0.1 µV.s). As the infusion of saline into the 
bladder continued, drops of fluid were expelled from the penis in an irregular manner, 
rather than in clusters of drops that characterised a void during the control period. 
Moreover, drops were not associated with the sharp rise in bladder pressure that was 
normally associated with a void.  
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Figure 3.7. Location of sites where bicuculline was microinjected into the PAG 
plotted onto outlines of the PAG taken from the atlas of Paxinos and Watson 
(1986). Black circles represent the centre of sites at which microinjection of bicuculline 
facilitated micturition evoked by continuous cystometry, accompanied by only moderate 
cardiorespiratory changes. Grey circles represent the centre of sites where 
microinjection of bicuculline facilitated micturition evoked by continuous cystometry, and 
this was accompanied by intense autonomic activation. Open circles represent the 
centre of sites at which microinjection of bicuculline evoked no effect on the micturition 
reflex. Numbers indicate distance (mm) caudal to Bregma. 
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Figure 3.8. Effect of microinjection of bicuculline (BIC, 1 nmol in 50 nl) into the 
caudal ventrolateral PAG on the micturition reflex evoked by continuous infusion 
of saline into the bladder. A, at most sites (n = 16), microinjection of bicuculline 
caused an increase in the frequency of the micturition reflex, the appearance of non-
voiding contractions (A.i), and a significant increase in the level of tonic EMG activity in 
the external urethral sphincter (EUS, A.ii) paired with desynchronisation of the EMG 
bursting activity (A.i). B, at 10 sites, following microinjection of bicuculline, micturition 
ceased. Despite an increase in EMG activity of the EUS (B.i), overflow incontinence 
developed as the infusion of saline into the bladder continued. *P < 0.05.
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Figure 3.9. Quantification of the effect of microinjection of bicuculline (1 pmol in 
50 nl) into the caudal ventrolateral PAG on the micturition reflex evoked by 
continuous infusion of saline into the bladder at sites where the micturition reflex 
persisted (16/26 sites). A, microinjection of bicuculline caused a significant increase in 
the frequency of the cyclic voids induced by continuous cystometry. B, in these cases 
there was also a significant decrease in the amplitude of the pressure rise normally 
associated with a void. C, there was no change in the duration of each contraction 
following microinjection of bicuculline (BIC) into the PAG. *P < 0.05, **P < 0.001. 
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We were concerned that the increase in the level of tonic EMG activity following 
microinjection of bicuculline into the PAG was secondary to increased bladder pressure, 
rather than due to direct activation of afferent pathways projecting through the PAG. In 
six experiments, the bladder was emptied by withdrawing fluid through the injection port 
and the relationship between the intravesicular volume and level of tonic EMG activity in 
the EUS was investigated. There was a direct relationship between the level of tonic 
EMG activity and bladder volume when increasing volumes of saline were injected into 
the bladder (Fig. 3.10 A). Microinjection of bicuculline into the PAG when the bladder 
was empty caused an increase in the tonic EMG activity of the EUS (from 0.1 ± 0.00 to 
0.3 ± 0.1 µV s, n = 4, P < 0.05, Mann Whitney U test). This was accompanied by a 
small, transient rise in intravesicular pressure (Fig. 3.10 B, +8.7 ± 2.6 mmHg). When 
incremental volumes of saline were infused into the bladder following microinjection of 
bicuculline into the PAG, this relationship was maintained but the curve was shifted 
upwards, reaching significance at 0.4 ml intravesicular volume (Fig. 3.10 A).  
 
At 7 other sites (Fig. 3.10 C, open circles), at which microinjection of bicuculline did not 
produce a change the level of tonic EMG activity, there was no shift in the curve when 
saline was infused into the bladder in incrementally increasing volumes (Fig. 3.10 C, 
open circles).  
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Figure 3.10. Effect of microinjection of bicuculline into the caudal ventrolateral 
PAG on the response of the external urethral sphincter (EUS) to stepped infusion 
of saline into the bladder. A, effect of microinjection of bicuculline (BIC) into the caudal 
ventrolateral PAG on the response of the EUS to stepped infusion of saline into the 
bladder before (open triangles) and after (filled circles) the microinjection (n = 8 in 
control group and n = 4 in BIC group). Note that due to the necessity of limiting the 
experiment to within the period that BIC was active after microinjection, it was not 
possible to test the response of the EUS to the complete range of intravesicular volumes 
tried in the control experiments. *P < 0.05 significant increase in the tonic EMG activity 
following microinjection of BIC into the PAG without distension of the bladder (Multiple 
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Mann Whitney U tests. Given the problems with multiple measurements, in future a 
greater n and more sophisticated statistical analysis may be warranted). B, example of 
EUS EMG activity and increase in intravesicular pressure evoked after microinjection of 
BIC into the cvlat PAG in a rat in which the bladder had previously been emptied. C, 
location of microinjection sites in the PAG mapped on to two representative levels taken 
from the atlas of Paxinos and Watson (1986). Black circles represent the centre of sites 
at which microinjection of BIC increased the level of tonic EMG activity in the EUS whilst 
the bladder was empty. Open circles show centre of sites where microinjection of BIC 
had no effect on tonic EMG activity of the EUS.  
 
 
Alongside the changes in the micturition reflex in response to infusion of saline into the 
bladder, microinjection of bicuculline into the cvlat PAG produced a pressor effect (+32.7 
± 4.9 mmHg), tachycardia (+59.9 ± 9.6 beats min-1) and tachypnoea (+124.8 ± 16.1 
breaths min-1) (Fig. 3.11 A, B, C ventral PAG graphs). This finding was unexpected 
since previous studies have reported depressor effects upon activation of the cvlat PAG 
(Lovick, 1992; Behbehani, 1995). To determine whether the preparatory surgery or 
distension of the bladder contributed to these cardiovascular effects, a series of 
experiments was carried out in which bicuculline was microinjected into the midbrain 
when the bladder was cannulated but not distended (n = 4). Microinjection of bicuculline 
into the cvlat PAG when the intravesicular pressure was low, evoked a transient 
depressor response (Fig. 3.12 A, C, -22.1 ± 5.9 mmHg). The microinjection of bicuculline 
was then repeated at the same site after distension of the bladder by infusion of saline. 
Under these conditions, as well as a facilitation of the micturition reflex in response to 
infusion of saline into the bladder (see above), microinjection of bicuculline evoked a 
pressor effect (+27.0 ± 12.2 mmHg), tachycardia (+74.8 ± 42.5 beats min-1) and 
tachypnoea (+83.7 ± 26.2 breaths min-1) (Fig. 3.12 B, C). 
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Figure 3.11. Quantification of the effect of microinjection of bicuculline into the 
ventral PAG (left column, n = 26) and dorsal PAG (right column, n = 34) on 
cardiorespiratory parameters. A, effect on mean arterial blood pressure (MABP, 
mmHg), B, heart rate (HR, BPM: beats min-1). C, respiratory rate (RR, Br.PM: breaths 
min-1). All values show mean for the control period before microinjection compared to 
the maximum reached during the response. **P < 0.001.  
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Figure 3.12. Effect of microinjection of bicuculline into the caudal ventrolateral (cvlat) 
PAG on the cardiorespiratory system before and after distension of the bladder. A, 
sample trace: microinjection of bicuculline into the cvlat PAG with the bladder exposed 
and cannulated but before distension caused a marked depressor effect. B, 
microinjection of bicuculline at the same midbrain site when the bladder was distended 
caused a pressor response (n = 4). C, Change in mean arterial blood pressure (MABP, 
mmHg) with microinjection of bicuculline into the cvlat PAG before distension of the 
bladder and then ‘with distension’.
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3.4.5.2 Microinjection of bicuculline into the dorsal PAG 
In 18 experiments, microinjections of bicuculline were also made into the dorsal PAG (n 
= 34), an area in which microinjection of muscimol evoked no effect on the micturition 
reflex (Fig. 3.7, compare to Fig. 3.2 A). At most sites in this region (n = 21), bicuculline 
caused an increase in the frequency of the micturition reflex during continuous infusion 
of saline into the bladder, with the frequency of contractions increasing from 0.7 ± 0.1 to 
2.5 ± 0.4 min-1 (Fig. 3.13 A). There was no change in the amplitude of the pressure rise 
associated with a void (Fig. 3.13 B, 20.8 ± 1.1 v. 19.7 ± 1.2 mmHg, P = 0.41) or the 
duration of the contraction (Fig. 3.13 C, 30.2 ± 4.1 v. 25.2 ± 1.6 s, P = 0.26). At these 
dorsal sites bicuculline also evoked marked signs of sympatho-activation, including a 
pressor effect (Fig. 3.11 A dorsal PAG, +57.2 ± 5.6 mmHg), tachycardia (Fig. 3.11 B 
dorsal PAG, +122.6 ± 15.4 beats min-1), tachypnoea (Fig. 3.11 C, dorsal PAG, +152.3 ± 
15.7 breaths min-1), exophthalmos, pupillary dilatation and bilateral vibrissae twitching. 
At the remaining 13 sites, following an initial increase in the frequency of the micturition 
reflex, coordinated voiding ceased. As the infusion of saline into the bladder continued, 
the bladder pressure rose and urine output returned in an irregular dropwise manner 
rather than a clustering of drops seen during normal voiding. In addition, expulsion of 
drops of fluid from the penis was not associated with the sharp rise in bladder pressure 
normally associated with a void. Tonic EMG activity in the EUS was increased (from 0.1 
± 0.02 to 0.7 ±0.23 µV s, Fig. 3.13 D ii, n = 3). The coordinated micturition reflex showed 
no sign of recovery within 2 hours, when the experiment was terminated.  
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The dorsal PAG was exceptionally sensitive to the effects of bicuculline. At 23 sites, 
moving the cannula into the dorsal PAG was enough alone to evoke sympatho-
activation and facilitate the micturition reflex, presumably evoked by passive diffusion of 
bicuculline from the cannula tip. These effects could be reversed by withdrawing the 
cannula from the brain.  
 
Figure 3.13. Quantification of the effect of microinjection of bicuculline (BIC) into the 
dorsal PAG on the micturition reflex evoked by continuous infusion of saline into the 
bladder. Effect of microinjection of bicuculline into the dorsal PAG on A, frequency 
(contractions min-1), B, amplitude of the pressure rise associated with a void (mmHg), C, 
duration of contraction (s) and D, level of tonic EMG activity in the EUS. D, Right hand 
column shows increase in EMG activity at sites where coordinated micturition ceased. 
*P < 0.05, **P < 0.001.3.5  
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DISCUSSION  
Continuous infusion of saline into the bladder elicited periodic voids characterised by 
sharp increases in intravesicular pressure accompanied by bursting activity in the EMG 
recorded from the EUS. In between bursts EMG activity was silenced. This sequence of 
events was associated with expulsion of several drops of fluid from the urethral meatus. 
Similar responses have been reported previously using a comparable experimental 
protocol (Maggi et al., 1986; Kruse et al., 1993; Van Asselt et al., 1995; Matsuura et al., 
1998; Matsuura et al., 2000).  
 
3.5.1 Microinjection of muscimol into the PAG 
Microinjection of the GABA agonist, muscimol inhibited the micturition reflex. At effective 
sites, there was either a significant reduction in the frequency of phasic bladder 
contractions, accompanied by a reduction in the level of tonic EMG activity of the EUS 
during the lengthened inter-void interval. Alternatively, at some sites contractions 
ceased completely following microinjections of muscimol and as the saline infusion 
continued, a type of ‘overflow incontinence’ developed as fluid dripped regularly from the 
penis. These inhibitory effects were only seen when the microinjection of muscimol was 
made into the caudal ventrolateral periaqueductal grey (cvlat PAG), not in other areas of 
the PAG and midbrain. These negative sites were not due to insufficient dosing because 
two and three times the standard doses administered in the rostral and dorsal PAG in 
preliminary experiments also evoked no effect on the micturition reflex. Interestingly a 
similar reduction in voiding frequency has also been reported following microinjection of 
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the µ-opioid agonist DAMGO or the synaptic inhibitor CoCl2 into the ventrolateral PAG 
(Matsuura et al., 1998; Matsumoto et al., 2004) suggesting that the integrity of synaptic 
transmission through this region is essential for the development of reflex voiding 
patterns. Though muscimol is widely thought to primarily act as an agonist at GABAA 
receptors, there is also suggestion that the inhibitory effects may be mediated via 
activation of pre-synaptic GABAB receptors (Yamauchi et al., 2000). The concentration 
of muscimol microinjected in the present experiments (5 mM) would have been 
sufficient, according to Yamauchi and colleagues work in the calyx of Held, to activate 
any pre-synaptic GABAB receptors present as well as post-synaptic GABAA receptors, 
thus the inhibitory effects on micturition seen in the present experiments might have 
been evoked by both a pre- and post-synaptic effect on GABAA and GABAB receptors.  
 
Although microinjection of muscimol reduced the frequency of voiding, each void 
remained a co-ordinated event and there was no significant change in the threshold, 
amplitude, duration of contraction, in the number of drops of fluid expelled per void or in 
the pattern of bursting in the EMG activity of the EUS. This suggests that GABAergic 
neurotransmission in the region gates the circuitry in an on/off fashion, rather than being 
involved in the coordination of a void, which is likely to be integrated in the pontine 
micturition centre (Holstege et al., 1979; Holstege et al., 1986; Blok et al., 1995; Sasaki, 
2005). 
 
The cvlat PAG receives bilateral projections from the bladder and lumbosacral spinal 
cord (Blok & Holstege, 1994; Vizzard et al., 1995; Marson, 1997; Ding et al., 1998). 
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Interestingly, both the dorsal and the ventrolateral PAG project to the pontine micturition 
centre (PMC) (Blok & Holstege, 1994; Ding et al., 1998). Barrington showed in 1925 that 
the integrity of the PMC is essential for normal micturition to take place (Barrington, 
1925), and projections from the PMC, via the sacral spinal cord cause synchronous 
contraction of the detrusor and relaxation of the EUS (Holstege et al., 1979; Holstege et 
al., 1986; Blok et al., 1995; Sasaki, 2005). In the present study, microinjection of 
muscimol into the dorsolateral PAG evoked no effect on the micturition reflex induced by 
continuous infusion of saline into the bladder. Thus the pathway from the dorsal PAG to 
the PMC is unlikely to play a role in the reflexive control of micturition, at least during 
cystometry in the urethane-anaesthetised rat. It is likely that muscimol inhibited 
transmission in the reflex circuitry that controls micturition at the level of the cvlat PAG, 
and the functional inhibition was translated to the bladder and EUS via these projections 
from the cvlat PAG to the PMC.  
 
Projections from the bladder and urethra to the cvlat PAG and from the cvlat PAG to the 
PMC are bilateral (Blok & Holstege, 1994; Blok et al., 1995; Vizzard et al., 1995; 
Marson, 1997; Ding et al., 1998; Taniguchi et al., 2002). In the present study, all 
microinjections were made unilaterally thus it is possible that afferent signals from the 
bladder were still integrated on the contralateral side of the PAG. This explains the 
incomplete inhibition of the micturition reflex seen when microinjections of muscimol 
were made in the cvlat PAG. However, occasionally, microinjection of muscimol did 
produce a complete inhibition, as also reported by Matsuura (1998) following unilateral 
microinjection of CoCl2 in the ventrolateral PAG. Thus it is possible that in these cases 
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the GABA agonism was sufficient to inhibit activity in both the ipsi and contralateral PMC 
(Fig. 3.14). It seems possible that these complete inhibitory effects might have been 
evoked at sites that were in the centre of an ‘effective’ region. However, sites at which 
microinjection of muscimol produced transient and complete inhibitory effects on the 
micturition reflex were intermingled in the caudal ventrolateral PAG. Therefore it cannot 
be concluded from their anatomical location that the transient responses are simply 
weaker effects due to injection of muscimol at the periphery of the effective region. 
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Figure 3.14. Schematic diagram demonstrating how unilateral microinjection of 
muscimol might produce partial and complete inhibitory effects on the micturition 
reflex evoked by continuous infusion of saline into the bladder of the urethane 
anaesthetised rat. A, normally, bilateral projections from the PAG to the left and right 
PMC are active during micturition. B, Microinjection of muscimol into the left hand side of 
the PAG could prevent activity in projections from this area to both the left and right 
hand sides of the PMC. However the projections from the right hand side of the PAG to 
the PMC would still be active. Therefore the level of neuronal output from the PMC 
might be lower, but not completely inhibited, producing a reduction in the frequency of 
the micturition reflex, without complete prevention of voiding. C, in cases where the 
micturition reflex was completely inhibited by unilateral microinjection of muscimol, the 
drug could have been sufficient to block activity in both sides of the PMC, thus 
preventing the output of the micturition circuitry that would normally coordinate a void. 
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As well as the projections from the lumbosacral spinal cord to the PAG (Vizzard et al., 
1995; Marson, 1997; Peng et al., 2006; Peng et al., 2008), direct projections from the 
bladder and urethra to the PMC have been identified in the rat (Ding et al., 1998). The 
functional importance of these connections in the rat is unclear. It is unlikely in our 
experimental model, that these projections are functional and short-circuit the 
projections via the cvlat PAG; otherwise the micturition reflex evoked by continuous 
cystometry could not have been inhibited (both partially and completely) by 
microinjection of muscimol into the cvlat PAG, which lies more rostral in the micturition 
circuitry than the PMC.  
 
3.5.2 Microinjection of bicuculline into the caudal ventrolateral PAG 
Microinjection of the GABAA antagonist, bicuculline, into cvlat PAG increased the 
frequency of the micturition reflex evoked by continuous cystometry. This was 
associated with the appearance of non-voiding contractions and a centrally mediated 
increase in the level of tonic EMG activity in the EUS. The bursting activity in the EMG of 
the EUS normally seen during a void became dyssynergic and EMG bursts were not 
always followed by EMG silence. It is during this EMG silence that urine output normally 
occurs (Maggi et al., 1986; Peng et al., 2006; Peng et al., 2008) so this dyssynergia 
probably contributed to the appearance of non-voiding contractions (Matsuura & 
Downie, 2000) . 
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These findings indicate that micturition-related synapses in the cvlat PAG are normally 
subject to a tonic GABAergic influence, and the lifting of this tone may be a prerequisite 
for voiding to occur. In support of this theory, Kitta and colleagues (2008) found that 
extracellular levels of GABA in the cvlat PAG were reduced during periods of 
intravesicular distension in the conscious rat. The source of the inhibitory GABAergic 
tone is unknown; however a wealth of evidence suggests that it originates in frontal 
regions, and GABAergic interneurons seem strategically placed in the PAG to act as a 
local source of GABA (Reichling & Basbaum, 1990; An et al., 1998; Adolphs, 1999; 
Floyd et al., 2000; Fowler et al., 2008; Griffiths & Tadic, 2008; Fowler & Griffiths, 2010). 
In the urethane anaesthetised preparation it is likely that the activity in the frontal 
cortices is reduced, however there is suggestion that some activity in the motor cortex 
and higher centres may be preserved during urethane anaesthesia (Tai et al., 2009). 
 
Occasionally, following microinjection of bicuculline into the cvlat PAG the coordinated 
micturition reflex ceased despite continued infusion of saline into the bladder. In these 
cases small oscillations in intravesicular pressure were transposed on top of the tonically 
raised bladder pressure, urine drops were not uniformly expelled and tonic EMG activity 
in the EUS was increased. This suggested that the bladder was in an active ‘tonic 
contraction’ as opposed to the passive overflow seen when muscimol was microinjected 
at the same site. Recording the efferent activity in the pelvic nerve might resolve this 
question, though ideally, one would develop a reliable technique to record the EMG 
activity of the smooth muscle of the detrusor itself, which in the past, has proven difficult 
(Ballaro et al., 2001; Ballaro, 2008). 
72 
 
 
In the present study, microinjection of bicuculline into the cvlat PAG induced a pressor 
response. This is in contrast to a previous reports in which the drug evoked a fall in 
blood pressure in urethane anaesthetised rats (Lovick, 1991). However, Matsuura et al. 
(2000) also saw a pressor effect when they activated neurons in the ventrolateral PAG 
by microinjection of glutamate in a similar surgical preparation to the one used in the 
present study. Pressor responses were also evoked following microinjection into the 
dorsal PAG, raising the possibility that the pressor responses produced by bicuculline 
were a result of the drug leaking up the cannula track to act at more dorsal sites. 
However, this seems unlikely as there was no difference in the latency to onset of the 
responses evoked from the dorsal and ventral PAG. A major difference between the 
preparation used in the present studies compared to previous work that showed a 
depressor region in the ventrolateral PAG was the laparotomy carried out to gain access 
to the bladder for cannulation and also distension of the bladder. Interestingly, in the 
absence of intravesicular distension, microinjection of bicuculline into the cvlat PAG 
evoked depressor effects, in agreement with previous studies. Distension of the bladder 
has been shown to produce a sympathetically mediated redistribution of splanchnic 
blood flow (Guttmann & Whitteridge, 1947; Cunningham et al., 1953; Mukherjee, 1957; 
Weaver, 1985; Ward et al., 1995) which might have masked any depressor effect that 
would normally be produced by activation of neurons in the ventrolateral PAG. Also, a 
high level of visceral nociceptor activation of the ventrolateral PAG might be expected to 
be evoked by bladder pressures produced by the cystometry protocol (Su et al., 2008). 
Thus, it is possible that in the present study, the high level of visceral input to the 
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ventrolateral PAG, which could have been nociceptive (Keay & Bandler, 1993; Lumb, 
2002), may have caused some change in local neurotransmitter activity in the region. 
Therefore, the effects of antagonising GABA in the cvlat PAG were not the same as they 
may have been in the absence of this afferent input. This theory is in accord with that of 
Behbehani, who suggests in his 1995 review that the efferent output of the PAG is 
dependent on the level of afferent input. 
 
3.5.3 Microinjection of bicuculline in the dorsal PAG 
Though it is clear that the functional integrity of the cvlat PAG is essential for reflex 
micturition to occur, the role of the dorsal PAG is much less clear. Microinjection of 
muscimol into the dorsal PAG failed to affect reflex micturition, suggesting that the area 
is not integral to the micturition reflex in response to continuous cystometry. However, 
activation of the dorsal PAG is undoubtedly able to influence micturition because 
microinjection of bicuculline into the area in the present series of experiments increased 
the frequency of reflexive voiding. Also, electrical stimulation and microinjection of 
glutamate in the dorsal PAG can modulate micturition (Vargas et al., 2000; Bittencourt et 
al., 2004; Schenberg et al., 2005), and strategically placed projections from the dorsal 
PAG to the PMC have been shown (Blok & Holstege, 1994; Ding et al., 1998).  
 
The dorsal PAG is known to integrate and initiate the cardiovascular defence response, 
which primes the cardiovascular system for motor behaviour in response to imminent 
threat (Behbehani, 1995). Micturition (and defaecation) are recognised responses to 
extreme fright in humans and animals (Gray, 1987; Goetz et al., 1994; Schenberg et al., 
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2001). Thus it is possible that these are components of the same behavioural response 
of the whole animal to imminent threat, and the dorsal PAG may initiate descending 
activity in the micturition circuitry required to initiate a void in the absence of an efferent 
drive from distension of the bladder. The dorsal PAG could also play a role in the 
coordination of volitional voiding for scent marking in animals and pre-emptive bladder 
emptying in humans.  
 
The dorsal PAG was extremely sensitive to the effects of bicuculline. In some cases, 
lowering the cannula containing the bicuculline solution into the dorsal PAG was enough 
to evoke a full bladder, cardiovascular and respiratory response which could not be 
intensified by microinjection of 1 pmol of bicuculline. Since microinjection of 1 pmol of 
bicuculline was always required to initiate a response when the cannula was in the 
region of the ventrolateral PAG, it is likely that a difference in the ongoing level of 
GABAergic tone in the dorsal PAG in comparison to the ventral exists. This difference 
may, in part, explain the absence of an effect when muscimol was microinjected into the 
dorsal PAG as the level of GABA tone may have already been sufficient to inhibit any 
on-going GABAergic activity in the region. The sensitivity to changes in the levels of 
GABAergic neurotransmission in the dorsal PAG may reflect the need for rapid 
activation of the region to initiate behavioural responses in reaction to imminent threat. 
The dose of bicuculline (1 pmol) used was lower than that which others have used in 
investigating GABA function in the PAG (McMullan & Lumb, 2006; Numata et al., 2008), 
but much higher than the dose used in some experiments into the bicuculline-evoked 
defence response in the dorsal PAG (Morgan & Clayton, 2005). This suggests that 
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future investigation may warrant a lower dose of bicuculline in the dorsal PAG; however 
the dose appears to be sufficient to bring about reversible effects on the bladder and 
cardiorespiratory system in the ventrolateral PAG.  
 
3.6 SUMMARY AND CONCLUSIONS 
In summary, the present experiments have demonstrated that the functional integrity of 
synapses in the caudal, ventrolateral PAG is essential for the micturition reflex in 
response to bladder filling to take place. The use of a GABAA antagonist has shown that 
the micturition pathway that passes through the caudal ventrolateral PAG is tonically 
inhibited by GABAergic neurotransmission. Modulation of GABAergic neurotransmission 
at this level of the micturition circuitry might be the mechanism by which voiding is 
allowed or deferred, depending on the social situation. The role of the dorsal PAG in 
micturition is less clear. It is evidently not involved in the control of reflex voiding in 
response to bladder filling, but may play a role in ‘active voiding’ by activating 
descending pathways controlling micturition in the absence of an afferent input from the 
bladder. This could be important for controlling volitional voiding (or scent marking in 
animals) and the bladder emptying associated with the defence response integrated and 
initiated in the dorsal PAG. 
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3.7 Key Findings 
3.7.1 Microinjection of GABAA agonist (muscimol) into the PAG 
1. Reduced the frequency of the micturition reflex only when applied in the caudal 
ventrolateral region, suggesting that synapses involved in the control of reflex 
micturition are present in this region. 
2. Did not affect reflex micturition when applied in the dorsal and rostral PAG, 
suggesting that these regions are not involved in the micturition reflex, at least in 
the urethane anaesthetised rat.  
3. Did not affect the cardiovascular and respiratory parameters recorded. 
 
3.7.2 Microinjection of GABAA antagonist into the ventral PAG 
1. Increased the frequency of reflex micturition, suggesting that GABA tonically 
inhibits micturition in this region, since removing its effects facilitated micturition. 
2. Caused a pressor effect, tachycardia and tachypnoea alongside the effects on 
micturition. However, we evoked a depressor effect when the bladder was not 
distended, suggesting that the degree of afferent input to the PAG determines 
the effect on the blood pressure.  
 
3.7.3 Microinjection of GABAA antagonist into the dorsal PAG 
1. Increased the frequency of micturition evoked by continuous cystometry, despite 
the fact that microinjection of muscimol in the same region evoked no changes. 
This suggests that though the dorsal PAG may not be involved in the control of 
reflex micturition, it may play a role in volitional voiding or voiding that is 
associated with extreme fright.  
2. Evoked intense sympatho-activation, characterised by a pressor effect, 
tachycardia, tachypnoea, exophthalmos, pupillary dilatation, and vibrissae 
twitching. 
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CHAPTER 4: THE EFFECT OF MONOPOLAR ELECTRICAL STIMULATION OF 
THE PERIAQUEDUCTAL GREY ON REFLEX MICTURITION IN THE URETHANE 
ANAESTHETISED MALE RAT  
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4.1 INTRODUCTION 
The experiments reported in Chapter 3 showed that the micturition reflex pathway 
synapses in a restricted area within the caudal ventrolateral periaqueductal grey (PAG) 
and that transmission through this region is normally tonically inhibited by a GABAergic 
influence (Stone et al., 2011, Chapter 3). Interestingly, in the conscious rat, during 
periods of intravesicular distension the extracellular concentration of GABA in the caudal 
ventrolateral PAG is reduced (Kitta et al., 2008), implying that this GABAergic inhibition 
might be transiently lifted to permit micturition to take place. This critical synapse in the 
ventrolateral PAG presents a target to modulate or modify transmission through the 
micturition reflex pathway. 
 
Electrical stimulation has been used for decades by Physiologists as a tool to activate 
neuronal pathways, typically by delivering single shocks or short trains of pulses. More 
recently longer or even continuous trains of pulses have been used in the clinical setting 
to modulate or normalise pathophysiological activity underlying certain disease states. 
The technique of deep brain stimulation (DBS) is currently used clinically for the 
treatment of a number of disorders, including Parkinson’s disease and intractable pain 
(for reviews see Perlmutter and Mink, 2006, Kringelbach et al. 2007, Deniau et al. 2010). 
It is an attractive therapeutic option where pharmacotherapy has failed because 
stimulation can be applied directly to the area of interest, and the effects are of rapid 
onset and are reversible.  
 
79 
 
It is possible some forms of urge incontinence may be due to a lack of inhibitory control 
of the micturition circuitry. Therefore DBS could be a valuable therapeutic tool if it could 
be used to manipulate the activity of the voiding circuitry. 
 
4.2 AIMS AND HYPOTHESIS 
We hypothesised that electrical stimulation of the PAG could be used to manipulate the 
activity of the micturition reflex circuitry in the urethane-anaesthetised rat. Previous 
studies have shown contrasting effects of electrical stimulation of the midbrain on 
micturition in the rat, cat and dog (Nishizawa et al., 1987; Kruse et al., 1990; Matsuura et 
al., 2000; Liu et al., 2004; Ito et al., 2006; Numata et al., 2008). The objective of the 
present experiments was to investigate the effects of monopolar electrical stimulation of 
the caudal PAG with varying pulse parameters, on voiding evoked by continuous 
cystometry in the urethane-anaesthetised rat. The excitatory amino acid D,L-
homocysteic acid (DLH), a non-specific agonist of glutamate receptors, was 
microinjected at sites where the effects of electrical stimulation on micturition were 
investigated to determine whether the electrical stimulation primarily activated axons of 
passage or cell bodies. The results have provided an important insight into the potential 
for using electrical stimulation of the midbrain (or DBS) for the treatment of drug-
refractory urinary disturbances in the future.  
80 
 
4.3 METHODS 
39 male Sprague Dawley rats (201 – 341 g, Charles River, Kent, UK) were 
anaesthetised with urethane (IP, 1.4 g kg-1) and prepared for cystometry and monitoring 
of vital signs as described in the general methods (Chapter 2, Section 2.2). A dorsal 
craniotomy allowed access to the midbrain with two types of electrode (Fig. 4.1). 
Experiments 1 – 13 were conducted using the two-channel electrode design. This was 
modified to the one-channel design for experiments 13 – 39. 
 
4.3.1 Electrode design 
Both electrodes were used to apply monopolar electrical stimulation at midbrain sites. 
The differential electrode connected — via a wire soldered to a crocodile clip — to the 
open wound on the head from the craniotomy to the positive pole of the stimulator (SD9, 
Grass Telefactor, W. Warwick, RI, USA). The preparation was earthed via a wire — 
connected to the abdominal wall by a crocodile clip — which fed into a common ground 
with the headstage used to record the EMG activity of the external urethral sphincter.  
 
4.3.1.1 Electrode 1 
Electrode 1 (Fig. 4.1 A) was pulled from two tubes of borosilicate glass capillary tubing 
(1.5 mm OD, 1.17 mm ID, Harvard Apparatus, Kent, UK), fused together with heat-
shrink tubing and Araldite® at either end (Fig. 4.2 A). The centre point of the fused tubes 
was heated in an open flame, twisted — to maintain the dual structure and ensure the 
tips remained together (Fig.4.2 B) — and pulled to approximately 250 µm tip diameter 
(Fig. 4.2 C). When snapped apart, this created two dual, heat-pulled glass pipettes for 
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future use. The overall electrode tip was approximately 500 x 250 µm. To allow 
connection to polyethylene tubing (1.67 mm ID, 2.42 mm OD, Portex Tubing, SIMS 
Portex Ltd, Kent, UK) and to the stimulator, both barrels were gently heated (distal to the 
Araldite/heat shrink tubing support) in an open flame and bent through 90º (as in Fig. 4.1 
A). One channel (250 µm) was filled with Wood’s metal and was connected — via wire 
soldered into the Wood’s metal — to the negative pole of an electrical stimulator (SD9, 
Grass Telefactor, W. Warwick, RI, USA). The other channel (250 µm) contained 0.2 M 
D,L-homocysteic acid (DLH, pH 7.4, Sigma Aldrich, Gillingham, UK) with pontamine sky 
blue dye (PSB, 2% W/V. Searle Diagnostics, High Wycombe, UK) and was connected 
via heat pulled polyethylene tubing (1.67 mm ID, 2.42 mm OD, Portex Tubing, SIMS 
Portex Ltd, Kent, UK) to a microsyringe for application of discrete volumes of DLH.  
 
4.3.1.2 Electrode 2 
Electrode 2 (Fig. 4.1 B) was designed following concerns that DLH might leak dorsally 
up the channel between the two glass tubes. It was pulled from one tube of borosilicate 
glass capillary tubing (1.5 mm OD, 1.17 mm ID, Harvard Apparatus, Kent, UK) using a 
Narishige weighted electrode puller (Narishige, London, UK). The tip of the electrode 
was broken off after pulling so that the diameter was approximately 250 µm. 
Polyethylene tubing (1.67 mm ID, 2.42 mm OD, Portex Tubing, SIMS Portex Ltd, Kent, 
UK) was attached to the distal end of the barrel and was heat pulled (without twisting) so 
that it could be push-fitted to a microsyringe for application of DLH (Fig. 4.1 B). The 
external junction at which the polyethylene tubing met the glass tubing was sealed with 
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Araldite® to prevent leakage of the DLH solution to be contained within (Fig. 4.1 B). A 
heated 26 G needle tip was used to puncture a hole in the polyethylene tubing distal to 
its junction with the glass tubing, and a fine tungsten wire, insulated except for the tip 
(50 µm bare, 100 µm coated, AM Systems INC, USA) was fed down into the electrode 
until it reached the tip (Fig. 4.1 B). The wire was secured and sealed with Araldite® at its 
external junction with the polyethylene tubing (Fig. 4.1 B). The distal end of the tungsten 
wire was stripped of its insulation and connected, via a wire soldered to a crocodile clip, 
to the stimulator (SD9, Grass Telefactor, W. Warwick, RI, USA).  
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Figure 4.1. Diagram of the two types of electrodes used to apply electrical 
stimulation and D,L-homocysteic acid (DLH, 50 nl, 0.2 M) in the midbrain. A, 
electrode 1 was heat-pulled from two tubes of borosilicate glass. One channel (250 µm) 
contained Wood’s metal for electrical stimulation and DLH was contained in a separate 
glass channel (250 µm). B, electrode 2 was designed following concerns that DLH may 
leak dorsally between the two channels. It consisted of one tube of heat-pulled 
borosilicate glass (250 µm), containing a fine tungsten wire (insulated except for the tip, 
50 µm bare, 100µm coated) for electrical stimulation. DLH filled the electrode around the 
wire and was injected following recovery from electrical stimulation using a microsyringe 
via polyethylene tubing.
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Figure 4.2. Instructions for manual heat-pulling of double barrelled electrode 1 
from two borosilicate glass capillary tubes. A, two tubes are sealed together using 
heat-shrink tubing, which is secured with Araldite® glue for stability. B, The centre of the 
tubes was heated in an open flame, and they were gently twisted when the glass 
reached melting point. C, the ends of the tubing were pulled apart whilst still gently 
twisting. Once snapped apart in the middle, this could be used to produce two dual 
lumen electrodes.  
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4.3.2 Electrical stimulation 
The electrode was advanced into the brain at a 10º angle to a site within the caudal 
midbrain. Thereafter the electrode was advanced through the brain in 0.5 – 1 mm steps. 
At each step electrical stimulation was applied using square wave pulses of 60 Hz, 0.5 
ms and with an amplitude of between 0.5 and 2.5 V. Stimulus parameters were based 
on preliminary experiments and those reported to be effective in the literature (Noto et 
al., 1989, 1991; Liu et al., 2004). For voltage threshold mapping experiments the 
frequency and duration of pulses (60 Hz, 0.5 ms, 60 s) were kept constant. Recovery of 
micturition reflexes and the cardiovascular and respiratory parameters recorded was 
allowed before repeated stimulations were applied, and no less than 10 minutes elapsed 
between stimulations. 
 
4.3.2.1 Continuous cystometry 
Stimulation was started following a minimum of 3 control contractions, at the onset of a 
void signified by a sharp increase in the intravesicular pressure, and lasted for 60 s. At 
each stimulation site the minimum voltage required to inhibit urine output during 
continuous infusion of saline into the bladder (6 ml h-1) for the duration of the 60 s 
stimulation period was sought. A similar protocol was used to determine the optimum 
frequency and pulse duration. The effect of stimulation between voids and longer 
periods of stimulation (> 60 s) were investigated at some of these sites (n = 13 and n = 
12 respectively). 
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4.3.2.2 Discontinuous cystometry 
The effect of electrical stimulation on the threshold volume for initiation of a void was 
investigated during discontinuous cystometry. The bladder was emptied manually via a 
syringe connected to the infusion tubing through a 3-way tap and was then was filled 
with saline (0.1 − 0.2 ml min-1) until a void was initiated whereupon the infusion was 
stopped. The voided volume was collected in a beaker placed under the rat, and this 
was measured by collection in a 1 ml syringe. The manual drop counter was used to 
record the number of drops expelled. The residual intravesicular volume was recorded 
as the volume of fluid that was removed from the bladder following the void using a 1 ml 
syringe connected to the infusion tubing via a 3-way tap. The discontinuous cystometry 
protocol was repeated a minimum of three times at any one stimulation site to ensure 
reproducibility. The protocol was then repeated while electrical stimulation was applied 
to the midbrain (60 Hz, 0.5 ms, amplitude set at threshold voltage for complete inhibition 
of urine output during continuous cystometry) and the same parameters were recorded. 
The pre-stimulation control value (i.e. stimulator off) was compared to the ‘stimulator on’ 
condition. 
 
4.3.3 Microinjection of D,L-homocysteic acid (DLH) 
In 20 experiments, D,L-homocysteic acid DLH (50 nl, 0.2 M, in saline vehicle, pH 7.4, 
containing 2% PSB dye. Sigma-Aldrich, Gillingham, UK) was microinjected at sites 
where the effect of electrical stimulation in the midbrain on micturition had been 
investigated, during continuous cystometry. The microinjections were applied during the 
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inter-void period, and the 50nl volumes were injected slowly over 30 s using a 1 µl 
Hamilton syringe (Hamilton Bonaduz AG, Switzerland). The effect of microinjection of 
DLH on the micturition reflex and the cardiovascular and respiratory parameters 
recorded was measured.  
 
Experiments were terminated with an overdose of pentobarbital, followed by cervical 
dislocation. Brains were removed and fixed in 10% formol saline for at least 48 hours 
before they were sectioned to determine the location of electrode placement. Stimulation 
sites were identifiable following sectioning as blue spots from the pontamine sky blue 
dye added to the DLH (for details see Chapter 2: General methods, Sections 2.4 and 
2.5).  
 
4.3.4 Analysis 
All data have been reported as mean ± SEM, and analysed with a Student’s paired t test 
unless otherwise stated (for further details see Chapter 2: General methods, Section 
2.6). 
 
4.3.4.1 Electrical stimulation 
An ‘inhibitory effect’ where electrical stimulation was applied at the onset of a void was 
defined as the complete prevention of drop output during the 60 s period of stimulation 
that was started at the onset of a void as judged by the sharp increase in intravesicular 
pressure normally associated with voiding. A facilitatory effect was defined as an 
increase in the drop output during stimulation that was more than double that of the 
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control mean (derived from 3 control contractions), and was also accompanied by a 
doubling (or greater) of the duration of bursting activity associated with urine output in 
comparison to the mean of 3 control contractions. All responses falling between these 
two definitions are described as ‘no effect’.  
 
4.3.4.2 DLH 
Due to the inherent variability in the interval between voids in any one rat, the short 
duration of action of DLH, and the difficulty in identifying when a response started, an 
‘effect’ was defined as any inter-void interval between the first 5 contractions following 
microinjection of DLH that lay more than 3 standard deviations away from any of the 5 
control inter-void intervals immediately prior to the injection starting. Any inter-void 
intervals that were less than 3 standard deviations away from any of the control inter-
void intervals were deemed ‘no effect’. 
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4.4 RESULTS  
4.4.1 Effect of electrical stimulation on reflex micturition when 
applied at the onset of a void 
 
An initial series of experiments were carried out to determine whether electrical 
stimulation in the periaqueductal grey (PAG) could influence the cycles of filling and 
voiding induced by continuous infusion of saline into the bladder. These preliminary 
experiments revealed that at many sites in the PAG and surrounding tegmentum it was 
possible to suppress urine output completely during stimulation. When the train of 
pulses was initiated within 5 s of an imminent void, signalled by a sharp rise in bladder 
pressure, the void was aborted (Fig. 4.3). Urine output was suppressed completely but 
voiding resumed once the stimulation ceased. Based on the preliminary data, in 
subsequent experiments we chose to use a “standard” 60 s stimulus train of 0.5 ms 
pulses at 60 Hz and up to 2.5 V intensity to identify effective stimulation sites. 
 
Although electrical stimulation at many midbrain sites was able to inhibit voiding 
completely, the suppression of urine output was accompanied by two distinct patterns of 
change in bladder pressure and activity in the external urethral sphincter (EUS). In the 
first type of response (Type 1, n = 53) the sharp rise in intravesicular pressure was 
aborted once the electrical stimulation started and the pressure dropped rapidly back 
towards the baseline, resulting in a significant reduction in the amplitude of the pressure 
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rise and duration of contraction (Fig. 4.4, from 22.3 ± 0.6 to 8.4 ± 0.9 mmHg, P < 0.0001, 
and from 34.6 ± 1.3 to 15.2 ± 1.2 s, P < 0.0001 respectively). No bursting activity 
developed in the EMG of the EUS but tonic activity was maintained throughout the 
stimulation period. No urine escaped from the penis for the duration of the stimulus, 
despite intravesicular pressure and bladder volume rising further as the infusion of 
saline into the bladder continued (Fig. 4.3 A). On other occasions (Type 2 responses, n 
= 13), electrical stimulation still reduced the amplitude of the pressure rise normally 
associated with a void from 23.3 ± 0.7 to 15.8 ± 2.3 mmHg (Fig. 4.4, P = 0.001), but the 
duration of contraction was increased from 36.4 ± 5.3 to 71.2 ± 5.6 s (Fig. 4.4, P < 
0.0001). In these cases, despite the contraction being maintained for the duration of the 
stimulation period, no urine was expelled and in all cases bursting activity in the EUS 
normally associated with drop output failed to develop (Fig. 4.3).  
 
At a small minority of sites (4/70 effective sites) in 3 rats, electrical stimulation in the 
midbrain produced facilitatory effects on the micturition reflex (Fig. 4.5, grey filled stars). 
These responses were characterised by an increase in the number of urine drops 
produced (Fig. 4.6 A, +9.9 ± 1.4 drops void-1), an increase in the duration of contraction 
(Fig. 4.6 B from 37.3 ± 3.8 to 85.5 ±17.6 s) and an increase in the duration of the 
bursting activity in the EUS that is associated with urine output (Fig. 4.6 C, from 4.1 ± 
0.8 to 32.5 ± 9.8 s). However, there was no obvious change in the amplitude of the 
pressure rise associated with each contraction (Fig. 4.6 D, 26.5 ± 0.5 v. 26.9 ± 2.1 
mmHg). 
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Figure 4.3. Electrical stimulation of the midbrain suppressed cyclical voiding 
responses evoked by continuous infusion of saline (6 ml h-1) into the bladder. A: 
Type 1 pattern of response was associated with a reduction in the amplitude of the 
pressure rise and duration of voiding alongside inhibition of drop output during electrical 
stimulation at midbrain sites. B: Type 2 pattern of response was associated with 
inhibition of voiding during electrical stimulation and a reduction in the amplitude of the 
pressure rise, but an increase in the duration of contraction. Thick black line in between 
vertical broken lines indicates stimulation period. 
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Figure 4.4. Electrical stimulation of the midbrain inhibited urine output and this 
suppression was accompanied by two distinct patterns of change in bladder 
pressure during stimulation: quantification. In the first type of response, ‘type 1’ (left 
hand side, n = 53) the duration and amplitude of the pressure rise normally associated 
with a contraction was significantly reduced. In ‘type 2’ responses (right hand side, n = 
13), the duration of contraction was significantly increased during stimulation, along with 
a significant reduction in the amplitude of the contraction. ***P < 0.0001, **P = 0.001. 
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Figure 4.5. Location of sites where electrical stimulation was applied in the 
midbrain. Plotted onto outlines of the midbrain taken from the Atlas of Paxinos 
and Watson (1986). Filled circles: sites at which electrical stimulation inhibited 
micturition. Diameter of circles inversely proportional to the minimum stimulus intensity 
needed to inhibit micturition at that site. Grey stars represent centre of sites at which 
electrical stimulation facilitated micturition. Open circles: no effect of electrical 
stimulation. Numbers below section outlines represent mm caudal to Bregma. 
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Figure 4.6. Electrical stimulation facilitated micturition when applied at the onset 
of a void signalled by a sharp increase in intravesicular pressure at 4 midbrain 
sites. This facilitation was characterised by A, an increase in the number of drops 
associated with a void in comparison to the control period, B, an increase in the duration 
of the contraction, C, an increase in the duration of EMG bursts followed by EMG 
silence, and D, no obvious change in the amplitude of the pressure rise associated with 
voiding.
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4.4.2 Effect of stimulation between voids on reflex micturition 
 
At 13 sites where application of electrical stimulation at the onset of a void could inhibit 
micturition, stimulation was applied during the filling phase between contractions. There 
was no change in the inter-void interval following stimulation and there was no change in 
the volume of the post-stimulation void in comparison to the mean of the three pre-
stimulation control contractions (Fig. 4.7, and Table 4.1). However there was an 
increase in mean arterial blood pressure (MABP, +21.4 ± 7.4 mmHg), heart rate (+22.6 
± 5.3 beats min-1) and respiratory rate (+76.2 ± 39.2 breaths min-1), table 4.2.  
 
 
 
Figure 4.7. Effect of stimulation between voids at a site where stimulation applied 
at the onset of a void was able to inhibit urine output for the duration of the 
stimulus. Abbreviations: EUS; external urethral sphincter, EMG; electromyograph. 
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Table 4.1. Effect of stimulation between voids at inhibitory sites in the midbrain. 
 Control STIM P = 
Number of drops 
per void 
7.2               
± 0.7 
7.6               
± 1.7 
0.9 
Inter-void interval 
(s) 
113.6            
± 18.5 
163.0           
± 25.0 
0.4 
Mean ± SEM, Student’s paired t test, n = 13.  
 
 
 
Table 4.2. Effect of electrical stimulation of the midbrain between voids on 
cardiorespiratory parameters. 
 
 Control STIM P = 
MABP           
(mmHg) 
105.8           
± 2.3 
127.2       
±7.5 
0.01 
Heart Rate 
(BPM) 
434.3 
± 12.1 
456.9 
± 11.6 
0.001 
Respiratory Rate 
(Br.PM) 
170.0 
± 5.4 
246.2 
±40.8 
0.11 
Abbreviations: mean arterial blood pressure (MABP, mmHg), heart rate (beats min-1 
(BPM)) and respiratory rate (breaths min-1 (Br.PM). Mean ± SEM, Student’s paired t test, 
n = 13.
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4.4.3 Effect of longer periods of stimulation on reflex micturition 
 
At 12 sites where stimulation using standard parameters (0.5 ms, 60 Hz, 0.5 – 2.5 V) 
could inhibit urine output for at least 60 s, the effects of longer periods of stimulation 
were investigated. Stimulation was started at the onset of a void (as judged by a sudden 
increase in the bladder pressure) and was continued until drop output returned (Fig. 
4.8). Stimulation increased the inter-void interval by up to 438 s (Fig. 4.8, range +49.3 s 
to +438.0 s, n = 12). At two of these sites urine output was not accompanied by a 
transient increase in bladder pressure and bursting in the EMG of the EUS (as in Fig. 
4.8 A), but was accompanied by a sustained, high bladder pressure and tonic EMG 
activity (Fig. 4.8 B), however there was still a significant increase in the inter-void interval 
during application of the stimulus (Fig. 4.8 C). This suppression was accompanied by a 
pressor effect (+29.3 ± 3.2 mmHg, range +10.3 to +45.6 mmHg), tachycardia (+36.4 ± 
7.0 beats min-1, range +5.0 to +73.0 beats min-1) and tachypnoea (+47.6 ± 7.8 breaths 
min-1, range +19.0 to +98.0 breaths min-1). 
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Figure 4.8. Effect of longer periods of electrical stimulation in the midbrain on 
reflex micturition. A: In 10 cases, the coordinated relationship between the bladder and 
EUS was maintained, but the inter-void interval was increased. B: In 2 cases, the 
intravesicular pressure reached a sustained level and urine output was not associated 
with bursting activity in the EUS. C: Long periods of electrical stimulation (> 60 s) 
significantly increased the inter-void interval. Stimulation period (STIM) was compared to 
control period with stimulation turned off.; Abbreviations: EUS; external urethral 
sphincter, stim; stimulation. **P < 0.001 
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4.4.4 Localisation of effective stimulation sites  
 
4.4.4.1 Inhibitory sites 
A threshold mapping protocol was adopted to determine whether there was any 
localisation of the effect of electrical stimulation in the midbrain. Once an inhibitory site 
had been identified, the minimum intensity at which urine drop output was inhibited for 
the duration of the 60 s period of stimulation was determined. The maximum intensity 
applied was 2.5 V and the frequency and pulse duration was kept constant (60 Hz, 0.5 
ms) throughout these experiments. The effect of stimulation at 113 midbrain sites in 34 
rats was tested (Fig. 4.5). At 66 sites, urine output was completely inhibited for the 
duration of the stimulation period (Fig. 4.5, black filled circles). Inhibitory sites that 
required the lowest voltage for complete inhibition of drop output (0.5 – 1.5 V) were 
primarily located within and close to the PAG at the caudal levels (Fig. 4.5, P -8.0 and P 
-8.8 mm) though some were located in the underlying tegmentum at all levels of the 
PAG studied.  
 
4.4.4.2 ‘No effect’ sites 
At 43 sites, urine output could not be prevented for the duration of the stimulation period, 
even with the amplitude set at 2.5 V (Fig. 4.5, open circles). There was no significant 
change in the number of drops per void or the amplitude of contractions at these sites 
(Fig. 4.9 A and B: 6.6 ± 0.3 v. 7.7 ± 0.8 drops void-1, P > 0.05, 23.1 ± 0.5 v. 22.2 ± 0.7 
mmHg, P > 0.05). There was however, an overall increase in the duration of bladder 
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contraction during the stimulation period (Fig. 4.9 C: +11.0 ± 4.0 s, P < 0.01). These 
ineffective sites were located mainly within the PAG at rostral levels (Fig. 4.5, P -5.6 
mm) and in the tegmentum ventral to the PAG at caudal levels (Fig. 4.5, P -8.0 and P -
8.8 mm).  
 
4.4.4.3 Facilitatory sites 
As described earlier, at 4 sites in 3 rats, electrical stimulation in the midbrain produced 
facilitatory effects on the micturition reflex (Fig. 4.5 grey filled stars). Three of the 
facilitatory sites were clustered in the ventral midbrain within the region of the motor 
nucleus of the trigeminal nerve (Fig. 4.5, P -8.8 mm grey stars). During stimulation at 
these three sites, rhythmic movement of the lower jaw was noted and the ipsilateral 
vibrissae vibrated. The remaining facilitatory site was located on the boundary of the 
caudal ventrolateral PAG near to the mesencephalic trigeminal nucleus as outlined in 
the atlas of Paxinos and Watson (1986), ME5 (Fig. 4.5, P-8.8 mm, grey star). 
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Figure 4.9. Electrical stimulation did not inhibit reflex micturition at 43 midbrain 
sites. A, Drop output could not be prevented for the 60 s duration of the stimulation 
period with pulse amplitudes ≤ 2.5 V. B, At these sites there was no change in the 
amplitude of the pressure rise normally associated with a void, however there was, C, a 
significant increase in the duration of contraction. **P<0.001.  
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4.4.5 Determining the optimal stimulus parameters  
At 12 midbrain sites in 6 rats, the effects of electrical stimulation whilst varying either the 
frequency or duration of pulses at a constant amplitude was investigated to determine 
whether a) there was any difference in the effect on the micturition reflex, and b) 
whether changing the pulse parameters either increased or decreased the intensity of 
the associated cardiovascular and respiratory changes. 
 
4.4.5.1 Effect of changing the frequency of pulses on reflex 
micturition 
Increasing the frequency of square wave electrical pulses (of constant pulse duration; 
0.5 ms) reduced the number of drops per void (Fig. 4.10 A). At frequencies of 40 Hz and 
above, drop output could be completely suppressed at times. Trains of stimulation with a 
frequency of less than 40 Hz did not completely prevent drop output for the duration of 
the 60 s stimulation at any time (Fig. 4.10 A).  
 
The amplitude of the pressure rise normally associated with urine output was reduced 
by the greatest percentage when stimulation was applied at 80 Hz and above (Fig. 4.10 
B). There was no relationship between the ‘type’ of response (i.e. ‘type 1’, shorter 
duration of contraction during stimulation and ‘type 2’, longer duration of contraction 
during stimulation) and the frequency of pulses (Fig. 4.10 C), with individual rats 
showing a mixture of these responses (Fig. 4.11). 
 
103 
 
 
Figure 4.10. Effect of changing the frequency of electrical pulses applied at 
midbrain sites on reflex micturition (59 stimulations at 8 different sites in the 
midbrain). Data represented as % change in A; number of drops, B; duration of 
contraction and C; amplitude of the pressure rise normally associated with drop output. 
Grey spots show raw data for each stimulation. Horizontal black lines: Data average for 
each frequency. Nb. groups without any repeats have no average.
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Figure 4.11. Effect of changing the frequency of electrical pulses applied at one 
site in the midbrain on the micturition reflex evoked by continuous infusion of 
saline into the bladder (6 ml h-1). A, Typical ‘type 1’ response. The duration of 
contraction and the amplitude of the intravesicular pressure rise associated with a 
contraction were both reduced and urine output was completely inhibited. B, When the 
frequency of stimulation was reduced to 30 Hz, the duration of contraction was 
increased. There was no change in the amplitude of the pressure rise associated with a 
void and though there was a reduction in the number of drops expelled, output was not 
completely inhibited as it was at 60 Hz. Abbreviations: EUS; external urethral sphincter, 
stim: stimulation. 
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4.4.5.2 Effect of changing the duration of pulses on reflex micturition 
Increasing the duration of square wave electrical pulses applied at 7 sites in 7 rats in the 
midbrain with a constant pulse frequency (60 Hz), reduced the number of drops per void 
(Fig. 4.12 A, Fig. 4.13 A, B, C). At pulse durations of 0.5 ms and above, drop output 
could be completely suppressed at times (Fig. 4.12 A). Pulses of less than 0.5 ms did 
not completely prevent drop output at any time. Increasing the pulse duration increased 
the % reduction in the amplitude of the intravesicular pressure rise normally associated 
with a void (Fig. 4.12 B). There was no causal relationship between the pulse duration 
and the ‘type’ of response (i.e. ‘type 1’, a reduction in the duration of contraction during 
stimulation, or ‘type 2’ an increase in the duration of contraction during stimulation, Fig. 
4.12 C). 
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Figure 4.12. Effect of changing the duration of electrical pulses applied at 
midbrain sites on reflex micturition (41 stimulations at 7 different sites in the 
midbrain). Data represented as % change in A; number of drops, B; duration of 
contraction and C; amplitude of the pressure rise normally associated with drop output. 
Grey spots show raw data for each stimulation. Horizontal black lines: Data average for 
each frequency. Nb. groups with no repeats have no average. 
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Figure 4.13. Effect of changing the duration of electrical pulses applied at one site 
in the midbrain on the micturition reflex evoked by continuous infusion of saline 
into the bladder (6 ml h-1). Sample traces are all from the same stimulation site. A: 
Response typical of ‘type 1’ effect, duration and amplitude of contraction were reduced 
and voiding was aborted. B: When pulse duration was reduced to 0.4 ms, the duration of 
contraction was increased. There was no change in the amplitude of the pressure rise 
and there was a reduction in the number of drops expelled with as part of the ‘void’. C: 
When pulse duration was reduced further to 0.3 ms, electrical stimulation evoked no 
obvious change in the duration or amplitude of contraction, and there was no reduction 
in the number of drops void-1. Abbreviations: EUS; external urethral sphincter, stim: 
stimulation.
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4.4.6 Effect of electrical stimulation of the midbrain on the 
cardiovascular and respiratory system 
Electrical stimulation at midbrain sites also evoked cardiovascular and respiratory 
changes, typically a pressor response, tachycardia and tachypnoea. These responses 
were intensified when the duration of the square-wave pulses was increased (Fig. 4.14 
A, B, C). The effects of increasing the frequency of pulses on the mean arterial blood 
pressure (MABP) and heart rate reached a maximal at 60 Hz. Increasing the frequency 
above this level did not further intensify the effects (Fig. 4.15 A, B, C). Analysis of the 
cardiovascular and respiratory effects at 10 sites which lay in and around the PAG 
showed that pressor effects could be evoked at sites where micturition was not 
suppressed by the highest intensity stimulation (+33.2 ± 4.4 mmHg, 2.5 V, 0.5 ms, 60 
Hz). 
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Figure 4.14. Effect of changing the duration of square wave pulses applied in the 
midbrain on the cardiorespiratory parameters recorded. A: Mean arterial blood 
pressure, B; heart rate, and C; respiratory rate. Grey spots show raw data for each 
stimulation. Horizontal black lines: Data average for each frequency. Nb. groups with 
only one repeat have not been averaged. Abbreviations: MABP: mean arterial blood 
pressure, HR: heart rate BPM: beats min-1, RR: respiratory rate, Br.PM: breaths min-1. 
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Figure 4.15. Effect of changing the frequency of square wave pulses applied in the 
midbrain on the cardiorespiratory parameters recorded. A: Mean arterial blood 
pressure, B; heart rate, and C; respiratory rate. Grey spots show raw data for each 
stimulation. Horizontal black lines: Data average for each frequency. Nb. groups with 
only one repeat have not been averaged. Abbreviations: MABP: mean arterial blood 
pressure, HR: heart rate BPM: beats min-1, RR: respiratory rate, Br.PM: breaths min-1.
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4.4.7 Effect of electrical stimulation on the volume threshold for reflex 
micturition using discontinuous cystometry 
In order to investigate whether the threshold intravesicular volume for evoking a 
coordinated void changed during stimulation a different protocol was used. At 10 sites in 
5 rats, once an inhibitory site (i.e. a site where 60 s stimulation ≤ 2.5 V, 60 Hz, 0.5 ms 
could inhibit drop output) had been identified using electrical stimulation in the midbrain 
during continuous cystometry, the infusion into the bladder was stopped and the bladder 
was emptied manually by withdrawal of fluid via the injection port. Saline was then 
infused into the bladder (0.1 – 0.2 ml min-1) until a void occurred. The latency to drop 
output was increased when stimulation was applied in the midbrain (Fig. 4.16 Ai, ii). The 
intravesicular volume at which a void was triggered was increased from 0.5 ± 0.1 ml to 
0.8 ± 0.4 ml when the stimulation was applied (Fig. 4.16 B, P<0.001, n = 10). At 8 sites, 
the bladder entered a state where urine output recommenced during the stimulation 
period but was not in association with bursting activity in the EUS. At this point, the 
stimulation was stopped and coordinated voiding returned within 5.4 ± 3.7 s (range 1 – 
20 s). At the remaining 2 sites, coordinated voiding activity (with EUS EMG bursting) 
remained during stimulation, but the void was delayed in comparison to the control. 
There was a large degree of inter-rat variability in cystometric capacity (i.e. the total 
volume that each bladder held before drops of fluid were expelled from the penis, range 
0.5 – 1.5 ml with stimulation on). However in every case, the threshold volume for urine 
output was increased during stimulation (Fig.4. 16 B). 
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There was no difference in bladder compliance — i.e. the pressure-volume relationship 
— on or off stimulation (Fig. 4.16 C). 
 
The intravesicular infusion of saline during discontinuous cystometry without electrical 
stimulation did not produce any changes in the MABP in comparison to the pre-infusion 
control period (Fig. 4.17 A, 86.8 ± 2.6 v. 87.1 ± 2.8 mmHg, n = 10, P > 0.05). However 
there was a significant increase in the MABP during stimulation in comparison to both 
pre-stimulation controls (Fig. 4.17 A, +31.0 ± 2.8 mmHg, P < 0.0001). There was no 
correlation between the MABP and the latency to drop output (Fig. 4.17 B).  
113 
 
 
 
Figure 4.16. Alteration of the threshold volume for micturition during electrical 
stimulation of the midbrain at 10 sites in 5 rats. A, i, Control: Saline was infused into 
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an empty bladder (0.1 – 0.2 ml min-1). The latency from the start of the infusion to first 
drop output was measured with the stimulator turned OFF, and the threshold volume for 
urine output could be calculated from this latency and the flow rate. A, ii, Stim: This 
protocol was repeated while stimulation was applied (≤ 2.5 V, 60 Hz, 0.5 ms). B: At 
every site there was an increase in the intravesicular volume at which a void occurred in 
the ‘stimulator on’ condition compared to the control ‘stimulator off’ condition. C: There 
was no change in the pressure-volume relationship (i.e. compliance) when the bladder 
was filled from empty during stimulation of the midbrain in comparison to the control 
‘stimulation off; condition. 
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Figure 4.17. Comparison of effect of intravesicular distension and electrical 
stimulation at midbrain sites on blood pressure. A, intravesicular infusion of saline 
alone (“infusion ON, stimulator OFF”) did not affect the resting mean arterial blood 
pressure (MABP, “infusion OFF, stimulation OFF”). There was however, a significant 
increase in the MABP when electrical stimulation (≤ 2.5 V, 60 Hz, 0.5 ms) was applied at 
midbrain sites during infusion of saline into the bladder (“infusion ON, stimulation ON”, n 
= 10). B, there was no relationship between the mean arterial blood pressure and the 
latency to urine drop output, suggesting that the delayed drop output during electrical 
stimulation was not due to the pressor effect evoked by electrical stimulation. ***P < 
0.0001.
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4.4.8 Effect of microinjection of D,L-homocysteic acid (DLH) into the 
midbrain on reflex micturition 
In 20 experiments, DLH (50 nl, 0.2 M, pH 7.4 containing pontamine sky blue dye) was 
microinjected at sites where the effect of electrical stimulation on micturition during 
continuous cystometry had been investigated. At the majority of sites (n = 50), 
microinjection of DLH evoked an increase in the inter-void interval from 104.4 ± 4.1 to 
236.0 ± 9.8 s, (Fig. 4.18 B, C I, P < 0.0001). At 28 of these sites, electrical stimulation 
had been shown to inhibit voiding. Conversely, at 3 sites where microinjection of DLH 
produced inhibitory effects, electrical stimulation facilitated micturition (Fig. 4.19, 
compare with Fig. 4.5). At 4 sites, microinjection of DLH produced a facilitatory effect on 
the micturition reflex, with the inter-void interval being reduced from 183.2 ± 30.6 to 98.9 
± 13.3 s (Fig. 4.18 A, C ii).  
 
Fig. 4.19 shows the location of injection sites. Inhibitory effects on micturition were seen 
following injections made in the midbrain, including in the periaqueductal grey and the 
underlying tegmentum. Facilitatory sites were predominantly clustered in the caudal end 
of the PAG in the lateral portion (Fig. 4.19, P -8.0 mm, grey stars, n = 3), an area at 
which electrical stimulation inhibited micturition, usually with low voltages (refer to Fig. 
4.5). One facilitatory site was located more rostrally and ventral to the PAG (Fig. 4.19, P 
-6.72 mm, n = 1). At the remaining sites, microinjection of DLH had no effect on the 
micturition reflex (Fig. 4.19, open circles, n = 30). 
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Figure 4.18. Effect of microinjection of D,L-homocysteic acid (DLH, 50 nl, 0.2 M) 
into the midbrain on micturition evoked by continuous intravesicular filling (6 ml 
h-1) . A: Sample trace shows facilitatory effect of microinjection of DLH into the midbrain 
during continuous cystometry (n = 4). B, Sample trace showing the inhibitory effects of 
microinjection of DLH into other areas of the midbrain. C, i: At 50 sites, microinjection of 
DLH increased the inter-void interval, and ii) at four sites, the inter-void interval was 
reduced following microinjection of DLH. **P < 0.001.
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Figure 4.19. Location of sites at which 50 nl 0.2 M D,L-Homocysteic acid (DLH) 
with pontamine sky blue was microinjected into the midbrain. Plotted onto outlines 
of the midbrain taken from the Atlas of Paxinos and Watson (1986). Filled black circles 
represent the centre of sites where microinjection increased the inter-void interval during 
cystometry. Open circles represent the centre of microinjection sites where DLH had no 
effect on the inter-void interval. Grey filled stars represent the centre of sites at which 
microinjection of DLH reduced the inter-void interval between contractions during 
continuous cystometry.
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4.5 DISCUSSION 
In the present study electrical stimulation over an extensive area of the midbrain 
inhibited voiding evoked by continuous infusion of saline into the bladder. This finding is 
in line with previous studies in the rat, cat and dog which also showed that the 
micturition reflex could be modulated by electrical stimulation of the midbrain (Nishizawa 
et al., 1987; Kruse et al., 1990; Fukuda & Koga, 1991; Matsuura et al., 2000; Liu et al., 
2004; Ito et al., 2006; Numata et al., 2008) .  
 
In most cases, when applied at the onset of a void, electrical stimulation aborted the 
coordinated contraction of the bladder and bursting activity in the EUS normally 
associated with a void, and bladder pressure returned to baseline levels until stimulation 
was stopped. This was termed a ‘type 1’ response. Occasionally, electrical stimulation 
increased the duration of contraction whilst still preventing drop output, coordinated 
bursting in the EMG of the EUS and reducing the amplitude of the pressure rise that 
would normally be associated with drop output. This was termed a ‘type 2’ response. 
Noto and colleagues (1989) describe similar effects of electrical stimulation in the 
midbrain to the ‘type 1’ response shown in the present experiments, but did not report 
evoking ‘type 2’ responses. Since Noto and colleagues applied much shorter trains of 
stimulation, (between 0.3 and 3 s, compared to our 60 s train of stimulus pulses) it is 
unsurprising that they did not see sustained effects on the bladder and EUS (Noto et al., 
1989). 
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Interestingly, when electrical stimulation was applied during the interval in between 
voids, it had no effect on bladder pressure or on the level of on-going tonic activity in the 
EUS, despite the same stimulation inhibiting micturition when applied at the onset of a 
void. Moreover, the first void after cessation of stimulation was neither inhibited nor 
delayed, suggesting that the electrical stimulation disrupts the circuitry that coordinates 
voiding only when that circuitry is already activated by the afferent drive from a 
distended bladder, and not when that coordinating circuitry is inactive during the inter-
void period. In contrast, Noto et al. (1989) found that stimulation in between voids 
produced a small drop in intravesicular pressure. However this was using an 
isovolumetric system, with the intravesicular pressure held supra-threshold for activation 
of the micturition circuitry, thus the afferent input from the distended bladder to the PAG 
would have been consistently high. This ‘inter-void stimulation’ condition would be 
represented in our model as stimulation at the onset of a void, where the intravesicular 
volume was sufficient to trigger a void, and afferent input to the PAG was at its highest, 
rather than an inter-void stimulation in our preparation when afferent input would have 
been at its lowest. Since it has been suggested that the efferent output of the PAG is 
dependent on the afferent input (Behbehani, 1995), this is an important clarification to 
make, and perhaps a criticism of the isovolumetric cystometry technique for 
investigation of the role of the midbrain in micturition.  
 
It is unlikely that the inhibitory effects of electrical stimulation of the midbrain on 
micturition were simply due to activation of the inhibitory sympathetic drive to the 
bladder causing detrusor relaxation for two reasons (Skehan et al., 1993; Khadra et al., 
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1995; Smith et al., 2011). Firstly, although there were clear signs of systemic sympatho-
activation (including a pressor effect and tachycardia) when electrical stimulation 
inhibited micturition at the onset of a void, these sympathetically-mediated effects were 
also present when stimulation was applied during the inter-void period and evoked no 
changes in the micturition reflex. This suggests that the effects of electrical stimulation 
on micturition and the cardiovascular and respiratory systems are not evoked by a 
shared mechanism. Secondly, electrical stimulation of the midbrain during discontinuous 
cystometry evoked no change in the compliance of the bladder when the stimulation 
was applied. If the effects on micturition of electrical stimulation were due to activation of 
the inhibitory sympathetic pathway, then one would expect the bladder to become more 
relaxed and compliant when the stimulation was applied, and therefore should 
accommodate greater volumes of fluid at lower intravesicular pressures. In fact, there 
was no change in the compliance of the bladder during electrical stimulation of the 
midbrain, suggesting that the inhibitory effects on micturition were via a different 
mechanism. 
 
Existing evidence suggests that application of electrical stimulation to the region in and 
around the PAG can have both inhibitory and excitatory effects on the bladder and EUS 
(Nishizawa et al., 1987; Noto et al., 1989; Kruse et al., 1990; Noto et al., 1991; Ito et al., 
2006). In the present experiments, electrical stimulation facilitated micturition when 
applied at one site in the PAG, and three sites within the region of the motor nucleus of 
the trigeminal nerve. Similarly, microinjection of the excitatory amino acid, DLH 
facilitated micturition when applied at a limited number of sites in the caudal 
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ventrolateral PAG. The localisation of the sites at which DLH facilitated micturition in the 
caudal ventrolateral PAG is unsurprising, since synapses in this region are known to 
play a role in the micturition reflex circuitry (Stone et al., 2011) and Chapter 3). 
Microinjection of DLH is thought to initially depolarise neurons (Curtis et al., 1959, 1960), 
thus it is possible that DLH increased the frequency of micturition either by a) directly 
activating excitatory neurons in the micturition circuitry in this region, b) by lowering the 
threshold for excitation of efferent outputs of the micturition circuitry which would allow 
micturition to be evoked by a lower level of afferent input from the bladder or c) via a 
depolarisation block of inhibitory neurons in the micturition circuitry. The location of the 
sites in the ventral midbrain at which electrical stimulation facilitated micturition is more 
surprising, since this region is not reported in the literature to be involved in the midbrain 
control of micturition. It is possible that this region may contain neurons involved in the 
afferent or indeed efferent pathways of the micturition reflex circuitry and that electrical 
stimulation activated these projections, or alternatively there may have been a spread of 
electrical current dorsally via a low resistance route up the electrode track. Further 
experiments, such as ortho- and anterograde neuronal tracing from the region, 
electrophysiological recording during periods of intravesicular distension, or use of a 
bipolar stimulating electrode to focus the area of influence of the applied current would 
be required for conclusions on the importance of the area in the control of micturition to 
be drawn and to reduce the likelihood of the current spreading to dorsal regions.  
 
At the majority of midbrain sites, electrical stimulation and microinjection of DLH evoked 
inhibitory effects on reflex micturition as a result of intravesicular filling. These 
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functionally inhibitory effects seem counter-intuitive, since electrical stimulation and DLH 
both activate neurons (Curtis et al., 1959, 1960; Kringelbach et al., 2010). However 
these experiments are not the first reports suggesting electrical stimulation can evoke an 
inhibitory effect on micturition (Nishizawa et al., 1987; Kruse et al., 1990; Fukuda & 
Koga, 1991; Matsuura et al., 2000; Liu et al., 2004; Ito et al., 2006; Numata et al., 2008).  
 
It is thought that DLH primarily activates the cell body of a neuron, due to the relative 
absence of glutamate receptors on the axonal membrane in comparison to the somatic. 
Thus DLH has been used in the past as a tool to identify whether the effects of electrical 
stimulation are evoked by somatic or axonal activation (Shaikh et al., 1987; al Maskati & 
Zbrozyna, 1989; Zhang et al., 1997), and this was the purpose of microinjection in the 
present experiments. Therefore the widespread locations in the midbrain at which DLH 
evoked inhibitory effects on micturition was unexpected, since we have shown that 
critical synapses involved in controlling the micturition reflex circuitry are located in a 
discrete region of the caudal ventrolateral PAG (Chapter 3, Stone et al., 2011). 
However, recent evidence has suggested the existence of some subtypes of glutamate 
receptors on myelinated axons (Ouardouz et al., 2009a; Ouardouz et al., 2009b), 
therefore the effects of DLH on micturition in the present experiments may not have 
solely been via activation of the cell body. Nonetheless, it is still a possibility that DLH 
activated inhibitory interneuron pools (Reichling & Basbaum, 1990) via projections which 
course to the PAG, thus increasing their inhibitory tone over the micturition circuitry as it 
passes through the PAG. It must also be considered that these widespread effects might 
have been due to diffusion of the DLH back up the cannula track to the PAG, though 
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there was not a greater delay to the onset of effects as the cannula was advanced 
ventrally. Furthermore, inhibitory effects on micturition were evoked by microinjection of 
DLH laterally, as well as ventral to the PAG. Using the present experimental protocol, we 
cannot be sure that DLH did not evoke some effects on micturition via glial cell 
activation, since these cells have been shown to possess glutamate receptors 
(Teichberg, 1991; Steinhauser & Gallo, 1996; Bergles et al., 2010; Parpura et al., 2012). 
Future experiments should use an alternative method to deduce the mechanism of 
action of electrical stimulation of the midbrain on micturition, such as recording the 
electrophysiological activity at other levels of the micturition reflex circuitry: in the 
pontine micturition centre, or in the region of Onuf’s nucleus in the sacral spinal cord 
during electrical stimulation of the midbrain. 
 
There are a number of theories suggesting how activation of neurons by electrical 
stimulation might produce inhibitory effects. Electrical stimulation can activate afferent or 
efferent axons at the site of stimulation (Nowak & Bullier, 1998), probably in both ortho- 
and antidromic directions (Perlmutter & Mink, 2006; Kringelbach et al., 2007; Deniau et 
al., 2010). Therefore the inhibitory effects on micturition that were evoked in the present 
experiments might have been via a central effect on the descending micturition circuitry, 
by a peripheral effect on the bladder and sensory afferent transmission, or a 
combination of the two. However, since neither the compliance of the bladder nor the 
subjective responses to intravesicular filling in human participants were changed during 
stimulation — despite a significant increase in the maximal cystometric capacity during 
electrical stimulation of the midbrain using a similar cystometry protocol in human 
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patients (Green et al., 2012) — it is unlikely that the inhibitory effects on micturition were 
due to a decrease in the sensory responsiveness of the bladder during electrical 
stimulation of the midbrain. 
 
It is possible that electrical stimulation of the midbrain evoked inhibitory effects on the 
micturition reflex by causing release of the inhibitory neurotransmitter GABA. GABA is 
known to tonically inhibit the micturition reflex at the level of the caudal ventrolateral 
PAG (Chapter 3, Stone et al., 2011). A range of evidence gathered from in vitro, in vivo 
and clinical settings has shown that high frequency electrical stimulation selectively 
causes GABA release (Moser et al., 2003; Li et al., 2004; Ogura et al., 2004; Li et al., 
2006; Mantovani et al., 2006; Hiller et al., 2007). Interestingly, it has also been 
suggested that in the thalamus, high frequency electrical stimulation can produce similar 
behavioural effects as microinjection of the GABA agonist muscimol (Pahapill et al., 
1999). In support of this, we found that microinjection of muscimol into the caudal 
ventrolateral PAG evoked inhibitory effects on micturition, seen as a reduction in the 
frequency or complete inhibition of voids evoked by a continuous intravesicular infusion 
of saline (Chapter 3, Stone et al., 2011). However the profile of the micturition 
contractions (i.e. the amplitude and duration) was unchanged following microinjection of 
muscimol, whereas electrical stimulation completely aborted drop output and reduced 
the amplitude of the contraction. This might suggest that the two inhibitory responses 
are not evoked by the same mechanisms. However it is possible that the responses 
evoked by electrical stimulation could be ‘stronger’ versions of the inhibitory effects 
evoked by microinjection of muscimol, since electrical stimulation might cause the 
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release of more GABA than was introduced by unilateral microinjection of the GABA 
agonist. The inhibitory effects of electrical stimulation were evoked over a much wider 
area of the midbrain than those evoked by microinjection of muscimol, which were 
clustered in the caudal ventrolateral PAG. However, since the effects of muscimol were 
specifically via agonism at GABAA receptors, whilst electrical stimulation could 
potentially activate any cell bodies or axons from a number of nuclei passing into the 
PAG, and cause the release of GABA either from the interneuron pool (Reichling & 
Basbaum, 1990), it might be expected that electrical stimulation should have a greater 
area of influence. Further experiments that simultaneously apply electrical stimulation 
alongside a GABA antagonist, or analysis of the perfusate from microdialysis in the 
caudal ventrolateral PAG during electrical stimulation could elucidate whether the 
electrical stimulation of the midbrain in the current preparation causes release of GABA 
in the region of the PAG. 
 
Often overlooked glial cells might also be involved in producing the functional inhibition 
of the micturition reflex that is evoked by electrical stimulation of the midbrain. High 
frequency stimulation causes depolarization of glial cells and release of adenosine 
(Kang et al., 1998; Bekar et al., 2008; Tawfik et al., 2010). The action of adenosine via 
A1 receptors is to inhibit synaptic transmission by activation of post-synaptic potassium 
channels, and action on pre-synaptic calcium channels prevents neurotransmitter 
release (Trussell & Jackson, 1985; MacDonald et al., 1986; Dunwiddie & Masino, 2001; 
Vedam-Mai et al., 2012). It has also been shown that the inhibitory effect of electrical 
stimulation was absent in the A1 deficient mouse and also following application of an A1 
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receptor antagonist (Bekar et al., 2008). It is impossible to assess the contribution that 
glial cell activation during high frequency stimulation had under the present experimental 
conditions, though it would be interesting to apply an A1 antagonist within the PAG 
during electrical stimulation to find out whether adenosine plays a role in the inhibitory 
effects on micturition in this region in the urethane anaesthetised rat. 
 
It must also be considered that activation of neurons by repeated pulses of electrical 
stimuli might have caused a block of depolarisation thus an overall inhibition of the 
neuronal activity. Beurrier and colleagues (2001) found that high frequency stimulation 
of the subthalamic nucleus in vitro produced a brief inhibition of voltage-gated currents 
in these neurons (Beurrier et al., 2001). These findings however, have not been 
repeatable through in vivo experiments which have shown that in the same area of the 
brain, high frequency stimulation reduces but does not block neuronal activity (Tai et al., 
2003; Meissner et al., 2005). Also, other research has shown that the neuronal activity in 
the target nucleus is increased during high frequency stimulation (Hashimoto et al., 
2003; Maurice et al., 2003), not reduced as one might expect if the stimulated neurons 
were inhibited. In the present experiments, if depolarisation blockade were responsible 
for the functional inhibition of the micturition reflex, then one would hypothesise that 
when pulse trains were applied at low frequencies, the stimulation should either activate 
or facilitate the reflex by activation of neurons, and at high frequencies, neuronal activity 
would inhibit micturition due to depolarisation blockade. In fact, changing the frequency 
of the pulses applied at a number of midbrain sites did not reverse the inhibitory effect 
on micturition. Moreover, application of low frequency electrical stimulation during the 
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inter-void period never evoked voiding at sites where application of electrical stimulation 
at the onset of a void had inhibited micturition. 
 
A more recent theory explaining the functionally inhibitory effects of electrical stimulation 
is ‘neurophysiological jamming’. High frequency electrical stimulation can cause 
activated neurons to become ‘time locked’ into a state where they fire at a similar rate to 
the stimulus that is being applied (Garcia et al., 2003; Hashimoto et al., 2003; Maurice et 
al., 2003; Li et al., 2007; Hammond et al., 2008; Deniau et al., 2010). Similarly to 
findings in the thalamus (Garcia et al., 2003; Hashimoto et al., 2003; Maurice et al., 
2003; Li et al., 2007; Hammond et al., 2008), electrical stimulation in the midbrain may 
entrain neurons projecting through the micturition circuitry at the same frequency as the 
applied stimulus, which could cause the network activity reaching the peripheral voiding 
machinery from the spinal outflows to be ‘jammed’ into this frequency, preventing the 
physiological neuronal activity that would normally coordinate a void. This hypothesis 
would explain why electrical stimulation in the midbrain only had an inhibitory effect on 
micturition evoked by continuous cystometry when applied at the onset of a void, and 
not during the inter-void interval when the network that coordinates voiding was inactive. 
The neurophysiological jamming theory could also explain why electrical stimulation 
produced inhibitory effects when applied over such a large area of the midbrain. Tracing 
experiments have shown that inputs to Barrington’s nucleus (the PMC) course not only 
though the PAG, but as lateral as the medial lemniscus and more ventral than the 
brachium conjunctivum (Blok & Holstege, 1994). Stimulation in the region of any of 
these afferent, efferent or descending frontal projections into the micturition circuitry 
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would have the same net effect: to drive the whole micturition circuitry at the prescribed 
frequency and prevent the translation of physiological network activity in to a 
coordinated void. To determine whether neuronal ‘jamming’ is the mechanism by which 
electrical stimulation inhibits micturition when applied at midbrain sites, one could record 
the electrophysiological activity in different levels of the micturition circuitry during 
electrical stimulation of the midbrain and PAG, including in the PMC, the sacral spinal 
cord and in both pelvic efferents and afferents to determine whether stimulation drives 
the micturition circuitry at the prescribed frequency.  
 
If neurophysiological jamming is the mechanism by which normal neuronal network 
activity is prevented from coordinating a void then theoretically one should achieve the 
same inhibitory effects on micturition when stimulation is applied at any level of the 
micturition circuitry, not specifically within the midbrain. Indeed, electrical stimulation 
(known as sacral nerve modulation, SNM) is already used to treat urge incontinence and 
non-obstructive urinary retention in around 26,000 patients (Van Kerrebroeck & 
Marcelissen, 2011). This stimulation is applied via an electrode implanted at the level of 
the sacral roots (Tanagho et al., 1989), and is reported to improve urinary disturbance 
by up to 70% (Monga et al., 2012). Similarly to electrical stimulation of the brain used in 
the clinic, the mechanism of action of SNM is unclear. Though there are indications that 
the neural stimulation works via a spinal mechanism, much evidence points to afferent 
effects of SNM on structures in the brain (Dasgupta et al., 2005; Blok et al., 2006). Thus 
stimulation of neurons involved in the micturition circuitry at the level of the midbrain (as 
in the present experiments) or the sacral cord may evoke effects on micturition via a 
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similar mechanism. In which case, if electrical stimulation of the midbrain were to be 
considered in the future for human patients who demonstrate urinary disturbances that 
are refractory to pharmacotherapy, then the attendant risk of surgery associated with 
implanting stimulating electrodes in to the brain could be reduced by targeting the 
micturition circuitry peripherally rather than centrally. Investigation into the effects of 
applying electrical stimulation at the level of the sacral cord on reflex micturition in the 
urethane anaesthetised rat would allow comparison to the effects of electrical 
stimulation of the midbrain on reflex micturition. Furthermore, recording the neuronal 
activity at different levels of the micturition circuitry during SNM in the rat, including in 
pelvic afferents and efferents, at the level of Onuf’s nucleus and centrally in the PAG 
and PMC would deduce more about the mechanism of action of SNM and whether the 
effects are evoked by a central or peripheral mechanism.  
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4.6 SUMMARY AND CONCLUSIONS 
In summary, the present experiments have shown that stimulation of the midbrain both 
electrically and chemically predominantly inhibits micturition evoked by continuous 
infusion of saline into the bladder. The mechanism of action of this functional inhibition is 
unclear. Inhibitory effects on micturition were evoked by both electrical stimulation and 
DLH over a wide area of the midbrain, despite the critical synaptic relays in the 
micturition circuitry being situated in the caudal ventrolateral PAG (Chapter 3, Stone et 
al., 2011). This may be due to electrical stimulation readily activating axons of passage, 
which could have been afferent or efferent inputs in to spinal relays controlling the 
bladder and EUS. The widespread action of DLH in the midbrain is more surprising, 
since it is generally thought to activate cell bodies rather than axons of passage, and 
synapses in the micturition circuitry have not been identified in the caudal midbrain 
ventral and lateral to the PAG. Further experiments are required to understand the 
mechanism of action and to deduce how electrical stimulation, which is thought to 
activate neurons, can evoke an inhibitory effect on micturition. Nevertheless, these 
findings have important implications and demonstrate the potential of using localised 
electrical stimulation of the midbrain as a tool for treating urinary incontinence involving 
uncontrolled bladder emptying in patients that have proven refractory to the currently 
available therapies.  
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4.7 CHAPTER 4: KEY FINDINGS 
4.7.1 Electrical stimulation of the midbrain (60 Hz, 0.5 ms, 0.5 – 2.5 V) 
1. When applied at the onset of a void signalled by a sharp rise in intravesicular 
pressure, inhibited voiding. 
2. Did not evoke effects on the micturition reflex when applied during the inter-void 
period, however did evoke the same sympatho-activation of the cardiovascular 
and respiratory systems, suggesting that the inhibitory effects on micturition are 
not due to activation of the inhibitory sympathetic drive to the detrusor. 
3. Stimulation was effective at sites ventral and lateral to the PAG, some distance 
away from the synapses involved in reflex micturition that we identified in chapter 
3. This suggests that we may be activating axons of passage, which could be 
from afferent or efferent neurons in the micturition circuitry. 
4. Stimulation was inhibitory at the majority of sites in the midbrain, except at 4 sites 
(1 in the PAG and 3 close to the motor nucleus of the trigeminal nerve). Since 
electrical stimulation primarily activates neurons, the predominantly inhibitory 
effects seem counter intuitive. Further experiments would be required to deduce 
the mechanism of action, which might be via release of inhibitory 
neurotransmitters, activation of glial cells or neurophysiological jamming. 
 
4.7.2 Chemical stimulation of the midbrain with D,L-homocysteic acid 
(DLH) 
1. Microinjection evoked inhibitory effects on micturition at the majority of midbrain 
sites, seen as an increase in the inter-void interval. Since DLH depolarises 
neurons, this might be via activation of inhibitory pathways controlling the 
micturition circuitry. 
2. At 3 sites in the caudal ventrolateral PAG, DLH facilitated micturition (reduced the 
inter-void interval). This may have been via synaptic activation of excitatory 
projections from the PAG.  
3. The widespread inhibitory action of DLH in the midbrain on micturition was 
unexpected, since it is thought to primarily activate cell bodies as opposed to 
axons, and synapses in this area of the brain have been identified in a localised 
area of the PAG, some distance from the centre of effective sites. This may be 
due to spread of the drug, or activation of more recently identified axonal 
glutamate receptors and glial cells.
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CHAPTER 5: THE ROLE OF DOPAMINERGIC NEUROTRANSMISSION IN THE 
PERIAQUEDUCTAL GREY IN THE CONTROL OF MICTURITION IN BOTH THE 
CONSCIOUS AND THE URETHANE ANAESTHETISED MALE RAT 
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5.1 INTRODUCTION  
We have shown in Chapter 3 that the micturition reflex pathway synapses in the caudal 
ventrolateral periaqueductal grey (PAG), and that these synapses are subject to on-
going GABAergic inhibition (Stone et al., 2011, Chapter 3). In the conscious rat, the 
extracellular concentration of GABA in the caudal ventrolateral PAG is reduced during 
periods of intravesicular distension (Kitta et al., 2008), suggesting that this inhibitory 
GABA tone is withdrawn to allow micturition to occur. Kitta and colleagues (2008) also 
showed that the extracellular concentration of dopamine in the same region of the PAG 
is increased during periods of intravesicular distension, and local application of D1 
receptor antagonist, SCH23390 by microdialysis increased the amplitude of the 
intravesicular pressure rise associated with voiding. This suggests that dopaminergic 
neurotransmission in the ventrolateral PAG may play a role in the central control of the 
micturition circuitry. 
 
Interestingly, a population of dopaminergic cells has been identified in a discrete region 
of the caudal ventrolateral PAG (Saper & Petito, 1982; Flores et al., 2004; Lu et al., 
2006), raising the possibility that these dopamine cells could be the source of the 
increase in levels of dopamine in the ventrolateral PAG during intravesicular distension 
in the conscious rat (Kitta et al., 2008). 
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Furthermore, in animal models of Parkinson’s disease that have used selective 
neurotoxins to lesion dopaminergic cells of the nigro-striatal pathway, the lesions have 
been shown to extend as far as the PAG (Shaw et al., 2010), and urinary disturbances 
as a result of this lesioning have been reported (Soler et al., 2011). Thus it is possible 
that lesioning the population of dopaminergic cells in the caudal ventrolateral PAG could 
lead to urinary disturbances. 
 
6-hydroxydopamine (6-OHDA) is a neurotoxin that selectively lesions dopaminergic cells 
and is used to produce animal models that demonstrate some of the key features of 
Parkinson’s disease (for reviews see Blandini et al., 2008; Duty & Jenner, 2011 and 
Blandini & Armentero, 2012). The chemical structure of 6-OHDA is very similar to that of 
dopamine (Fig. 5.1), so the neurotoxin is readily taken up into dopaminergic cells by 
dopamine transporters (Duty & Jenner, 2011). Indeed, the structure is also similar to 
noradrenaline, but specificity for dopaminergic terminals can be improved by systemic 
pre-treatment with the noradrenaline re-uptake inhibitor, desipramine (Luthman et al., 
1989; Duty & Jenner, 2011). Once inside the cell, 6-OHDA is oxidised (Heikkila & 
Cohen, 1972; Salonen et al., 1996), causing the release of toxic free radicals that 
ultimately lead to cell death (Blum et al., 2001). 6-OHDA is also taken up by 
mitochondria where it impairs the electron transport chain via inhibition of complex I 
(Glinka et al., 1997; Duty & Jenner, 2011). 
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Figure 5.1. Diagram showing chemical structure of the neurotransmitter dopamine 
and the neurotoxin 6-hydroxydopamine (6-OHDA). Due to its structural similarities 
with dopamine (left), 6-OHDA (right) is readily taken up by the dopamine transporter into 
dopaminergic cells. Once inside the cell, 6-OHDA oxidises and ultimately causes cell 
death.  
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5.2 AIMS AND HYPOTHESIS 
We hypothesised that the increase in extracellular dopamine in the ventrolateral PAG 
associated with periods of intravesicular distension (Kitta et al., 2008) originates from the 
population of dopaminergic cells located in the caudal ventrolateral PAG (Saper & 
Petito, 1982; Flores et al., 2004; Lu et al., 2006), and that dopaminergic 
neurotransmission in this region could play a role in the control of the micturition 
circuitry. Therefore loss of these dopaminergic cells could lead to urinary disturbances. 
We used bilateral localised microinjections of the neurotoxin 6-OHDA to selectively 
lesion dopaminergic cells in the caudal ventrolateral PAG of male rats. The effects of 
this lesion on micturition were investigated by recording the 24 h urine output in the 
conscious rat, and by carrying out continuous cystometry in the urethane-anaesthetised 
rat. The effectiveness of the lesion was assessed by tyrosine hydroxylase 
immunohistochemistry of the PAG, following which the number of tyrosine hydroxylase 
— an enzyme involved in the production of dopamine — containing cells were counted.
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5.3 METHODS 
Male Sprague Dawley rats (n = 20, 220 – 377 g, Charles River, Kent. UK) were 
randomly assigned to the 6-OHDA and sham (saline) lesioning groups for chronic 
experiments. Acute experiments investigating the effects of microinjection of a dopamine 
agonist and antagonist were carried out on 8 urethane-anaesthetised rats (198 – 244 g, 
Charles River, Kent UK) that had not been subjected to any pre-treatment.  
 
5.3.1 24 h urine output in the conscious, unrestrained rat 
Each rat was placed into a metabolism cage (Nalgene, Harvard Apparatus, UK) to 
monitor urine output over 24 h before surgery, and then again 14 days after lesioning 
surgery. Rats were placed into the cages during the early part of the light cycle between 
8 am and 10 am and were removed 24.5 h later. Recordings of urine output were started 
after a 30 min acclimatisation period in the metabolism cage. An automatic drop counter 
(AD Instruments, Oxford, UK), which was connected to a Powerlab acquisition system 
(AD Instruments, Oxford, UK) was positioned below the urine chute to record (in 
LabChart v 4.2.3, AD Instruments, Oxford, UK) each time a drop fell from the 
metabolism cage (Fig. 5.2). This data was collected continuously for the 24 h period and 
allowed measurement of the total voided volume, the inter-void interval, the number of 
drops per void and comparison of voiding activity during the light and dark periods. The 
protocol was identical for the second exposure to the metabolism cage carried out 14 
days after lesioning surgery. 
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Figure 5.2. Diagram of Nalgene metabolism cage. Rats were placed into the cage 
with food and water available ad libitum for 24 h. During this time, urine output was 
monitored. The infra-red drop counter streamed data to the LabChart programme 
continuously for the 24 h and recorded when a drop fell from the collection chute into the 
urine collection tube. Faeces fell directly down into the central collection tube, whereas 
urine trickled down the side and into the chute, then into the collection tube. The plastic 
shield prevented urine falling directly into the faeces tube. A shield below the water 
bottle prevented water drops from entering the metabolism cage (not shown in diagram). 
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5.3.2 6-OHDA lesions of the periaqueductal grey  
These recovery procedures were carried out in the Biomedical Services Unit at the 
University of Birmingham and a sterile surgical technique was employed to reduce the 
chance of post-surgical infections. 30 minutes after intra-peritoneal injections of 
desipramine (25 mg kg-1) and pargyline (30 mg kg-1 both from Sigma-Aldrich, Gillingham, 
UK) were made to protect noradrenergic and serotonergic terminals, a combination of 
medetomidine and ketamine in dH2O (0.04 mM, Tocris, Bristol, UK and 80 mM Pfizer, 
UK, respectively) was administered via an intraperitoneal injection in volumes of 3ml kg-1 
to induce general anaesthesia. Depth of anaesthesia was deemed sufficient when the 
pedal and corneal reflexes were absent. Rats were placed on to an electric heating 
blanket and mounted prone in a Kopf stereotaxic frame. A rectal temperature-sensing 
probe was inserted to monitor core body temperature and a heating lamp was used to 
warm the rat when core body temperature fell below 37.0º.  
 
The dorsal surface of the skull was exposed by incision with a scalpel, and a portable, 
wireless drill (Draper Tools, Hampshire, UK) with a dental burr was used to create a 
limited dorsal craniotomy (4 x 4 mm). A sterile 26 G needle was used to perforate the 
dura and allowed insertion of a stainless steel cannula (500 µm diameter), at an 
inclination of 10º from vertical and under stereotaxic guidance, into the ventral 
periaqueductal grey (PAG). The cannula was left in place for 5 min before administration 
of drug or sham solution. Microinjections of 6-hydroxydopamine (6-OHDA, 1 µl, 5 mg ml-
1, with ascorbic acid for stabilisation, Sigma-Aldrich, Gillingham, UK) or saline (0.9%) 
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were administered over a 5 min period, and the cannula was left in place for a further 5 
min before being withdrawn. This process was then repeated on the contralateral side of 
the PAG. The analgesic, buprenorphine (0.03 mg kg-1) was administered 
subcutaneously at this point to afford analgesia during the initial phase of recovery. The 
cranial wound was closed using vicryl absorbable suture (Ethicon, Johnson and 
Johnson Medical Limited, West Lothian, UK) and 5 ml of glucosaline was administered 
subcutaneously to replace fluids lost under anaesthesia.  
 
Anaesthesia was reversed with atipamezole (0.5 mg in 0.15 ml, Pfizer, UK) and rats 
were placed onto a heated table for approximately 1 h while the effects of the 
anaesthetic were reversed. Recovery for the first 24 h was in individual cages before 
being returned to shared cages for the remainder of the 14 day recovery period.  
 
5.3.3 Acute cystometry 
Either one or two days after the second 24 h exposure to the metabolism cage (either 15 
or 16 days after cranial surgery and microinjection of 6-OHDA or saline − sham − into 
the PAG), an acute terminal experiment was carried out under urethane anaesthesia. 
Rats (n = 15, 291 − 466 g) were terminally anaesthetised (IP urethane, 1.4 g kg-1), and 
prepared for cystometry and monitoring of vital signs as described in the Chapter 2: 
General methods, Section 2.2 (excluding the craniotomy and electrode placement). 
Once the preparation was completed a 30 min stabilisation period was allowed. Saline 
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was then continuously infused into the bladder (6 ml h-1) for at least 2 h and the resulting 
effect on the intravesicular pressure and EMG of the EUS were recorded. 
5.3.4 Preparation of tissues for immunohistochemistry 
At the termination of the experiment, the brain tissue was fixed by perfusion of a 
paraformaldehyde solution via the vascular system. The abdominal aorta was dissected 
from the surrounding tissue below the origin of the renal blood supply, and the flow in 
the aorta was temporarily halted with a clip. The distal end of the dissected aorta was 
tied with a tight ligature, and a loose ligature was placed around the middle of the 
dissected portion to secure the cannula once in place. A polyethylene cannula (1.67 mm 
ID, 2.42 mm OD, heat pulled at the tip, Portex tubing, SIMS Portex Ltd, Kent, UK) 
attached to a 50 ml syringe containing heparinised saline (10 units ml-1, Multiparin, CP 
Pharmaeuticals Ltd., Wrexham, UK) was advanced into the aorta in a retrograde fashion 
and was secured in place with the aforementioned ligature around the vessel and the 
tubing. The temporary clip was removed, the right and left jugular veins were severed. 
Heparinised saline (10 units ml-1, 100 ml Multiparin, CP Pharmaceuticals Ltd., Wrexham, 
UK) was washed through the circulatory system — entering via the aorta and exiting via 
the jugular veins — to clear blood from the vascular system. The rats were then 
perfused with 200 ml of 4% paraformaldehyde in 0.1 M phosphate buffer (PFA, pH 7.4, 
see appendix B for recipe), again via the abdominal aorta. The brain was removed and 
post fixed in PFA for 2 h before being stored in 30% sucrose in 0.1 M phosphate buffer 
to afford cryoprotection. 
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5.3.5 Immunohistochemistry  
Tyrosine hydroxylase (TH) immunohistochemistry was carried out on 30 serial sections, 
each 40 µm thick that extended 1200 µm rostrally from the caudalmost PAG, from 
approximately 9.0 mm caudal to Bregma, to -7.8 mm caudal to Bregma. Sections were 
incubated for 1h in block solution containing normal horse serum (NHS, Vector Labs, 
Peterborough, UK) to limit non-specific binding, hydrogen peroxide (H2O2, Sigma-
Aldrich, Gillingham, UK) to reduce endogenous peroxidase activity and phosphate 
buffered saline (PBS, 0.1 M, pH 7.4, see appendix C for recipe), containing Triton-X-100 
(0.01%, Fluka Biochemika, Sigma-Aldrich Gillingham, UK) to increase the permeability 
of cell membranes. Following this, sections were incubated for 2 days in 0.01% primary 
TH antibody (Mouse anti-tyrosine hydroxylase, Alexa Flour Conjugated monoclonal 
antibody, Millipore, Watford, UK) made up in solution containing PBS, Triton-X-100 
(0.01%) and NHS (1.5%), at 5 ºC and were gently agitated using an orbital shaker (IKA-
Vibrax-VXR-17, IKA Laboratories, Staufen, Germany). After three washes with PBS, 
sections were transferred into a secondary antibody solution containing biotinylated anti-
mouse IgG (0.2%, Biotinylated anti-mouse IgG (H&L), affinity purified, made in horse, 
Vector Laboratories, Peterborough, UK) and NHS (2.5%) in PBS. Sections were again 
washed 3 times in PBS and then transferred into avidin-biotin complex (ABC, Vector 
Laboratories, Peterborough, UK) solution for 1 h to label the biotinylated secondary 
antibody. Reaction products were developed using di-aminobenzoate (DAB, Sigma-
Aldrich, Gillingham, UK) and H2O2, and development was monitored for a visual colour 
change and quenched after approximately 60 s by flooding vials with ice-cold PBS. 
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Sections were then washed 3 times in PBS before being mounted on to gelatinised 
slides and allowed to dry overnight. Following dehydration with ascending 
concentrations of alcohol slides were cover slipped with Histomount (National 
Diagnostics, Hull, UK) and viewed under a light microscope (Olympus BH2, Olympus, 
Southend-on-Sea, UK). TH positive cells from each section were mapped onto outline 
drawings of the PAG with the use of the drawing tube attachment on the microscope. 
Large (> 30 µm) cells were marked as circles and small cells (≤ 30 µm) crosses. From 
these pictures, large and small cells were counted to assess the effectiveness of 
lesions. 
 
5.3.6 Acute microinjection of dopamine agonists and antagonists 
In 8 urethane anaesthetised (1.4 g kg-1) and previously untreated rats, (198 − 244 g, 
Charles River, Kent, UK) the acute effects of microinjection of the non-selective 
dopamine agonist apomorphine (94.0 mM, containing ascorbic acid to reduce oxidation, 
RBI, Sigma-Aldrich, Gillingham, UK) and the D1 receptor antagonist, SCH23390 (5.0 
mM, Tocris Bioscience, Bristol, UK) on reflex micturition were investigated. Rats were 
anaesthetised and prepared for cystometry and monitoring of vital signs as described in 
Chapter 2: General methods, Section 2.2. Microinjections (50 nl) were administered at 
0.5 − 1.0 mm intervals in the caudal midbrain and PAG and the effects on the micturition 
reflex evoked by continuous infusion of saline into the bladder (6 ml h-1) were recorded. 
The doses of apomorphine and SCH23390 administered in the present experiments 
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were within the range of those reported in the literature in the PAG and other brain 
regions (Melo et al., 2009; Meyer et al., 2009; Dang et al., 2010; Chen et al., 2011). 
These experiments were terminated by overdose of pentobarbitone via the intravenous 
catheter, and cervical dislocation. The brains were removed and stored in 10% formol 
saline before processing for histological analysis (See Chapter 2: General methods, 
Sections 2.4 and 2.5 for details). 
 
5.3.7 Analysis 
All means are represented ± SEM. Unless otherwise stated, paired data have been 
compared with a Student’s paired t test. For details of statistical testing see Chapter 2: 
General methods, Section 2.6. Analysis of data from the metabolism cage, urethane-
anaesthetised cystometry and TH immunohistochemistry was carried out blind to reduce 
experimenter bias. The TH cell population was counted manually from maps of the 40 
µm sections made using a drawing arm attached to a light microscope (Olympus BH2, 
Olympus, Southend-on-Sea, UK). Occasionally, one large TH+ cell spanned two 40 µm 
sections, as seen by the presence at identical positions in two neighbouring sections. 
These cells were only counted once. 
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5.4 RESULTS 
5.4.1 Chronic experiments: 6-OHDA lesioning of the PAG 
In the 24 h following reversal of anaesthesia and cranial surgery, 5 rats (2 from the 6-
OHDA group, and 3 from sham group) lost weight and demonstrated signs of illness 
(hunched posture, porphyrin staining around the eyes, piloerection, absence of 
grooming behaviour). These rats were euthanased with an IP injection of pentobarbitone 
and data from the pre-surgery exposure to the metabolism cage for these rats were 
discarded.  
 
5.4.1.1 Effect on 24 h urine output 
5.4.1.1.1 24 h voiding pattern in the conscious rat 
The 24 h pattern of urine output was measured in 15 rats (of which 8 went on to receive 
6-OHDA injections into the PAG and the other 7 went on to receive injections of the 
saline vehicle). Recording of drop output failed for 3 rats (2 from 6-OHDA lesion group 
and 1 from sham lesioned group). Therefore these subjects were not included in the 
drop pattern analysis since paired observations could not be made. Urine collection also 
failed in one of these subjects from the 6-OHDA group, so this rat was also excluded 
from the urine volume analysis. Therefore the number of rats used for analysis of 24 h 
urine volume was 7 from the 6-OHDA group, and 7 from the sham lesioned group. 
Analysis of the pattern of urine output was carried out on data from 6 rats from the 6-
OHDA group and 6 rats from the sham lesioned group. 
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There was no difference in the volume or pattern of urine output between the groups 
before surgery, therefore the data have been pooled. The rats voided 20.2 ± 2.0 times (n 
= 12), producing 2.7 ± 0.4 ml 100g-1 of urine in the 24 h (n = 14). The volume of urine 
produced has been reported as a function of the rat weight in order to account for any 
weight gain upon the second exposure 14 days after the lesioning surgery. 
  
There was a diurnal pattern in urine output, with a significantly greater number of voids 
occurring during the dark period (7 pm to 7 am, 12.7 ± 1.1 voids) in comparison to the 
light period (7 am to 7 pm, 7.5 ± 1.0 voids, P < 0.0001, Student’s paired t test, n = 12, 
Fig. 5.3 A). Consequently, the inter-void interval was shorter in the dark period (63.8 ± 
6.8 min) in comparison to the light period (110.6 ± 15.3 min, Fig. 5.3 B, P < 0.01, n = 
12).  
 
Interestingly, voids made during the dark period were smaller than during the light period 
(Fig. 5.3 C, 10.4 ± 1.4 v. 14.5 ± 2.1 drops void-1 respectively, P < 0.05, n = 12), so that 
the total number of urine drops counted during the dark and light periods was similar 
(Fig. 5.3 D, 106.0 ± 7.5 v. 92.4 ± 10.6 drops 24 h-1 respectively, P = 0.13, n = 12). 
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Figure 5.3. 24 h Urine output in the conscious unrestrained rat over 24 h period in 
metabolism cage before any treatment (n = 12). Lights on condition (7 am to 7 pm) 
compared to dark period (7 pm to 7 am). Data shown: A, total number of voids in 24 h, 
light v dark, B, inter-void interval, C, number of drops per void , D, total number of urine 
drops expelled in 24 h *** P < 0.001, * P < 0.05, Student’s paired t test. 
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5.4.1.1.2 Voiding diaries in the 6-OHDA and sham lesioned rat  
There appeared to be an increase in 24 h urine output in both the 6-OHDA lesioned and 
the sham lesioned groups upon their post-recovery exposure to the metabolism cage. 
This difference persisted even after the data had been corrected for the animals’ weight 
gain over the 14 day period since the first 24 h collection was made, (Fig. 5.4 A). 
However, the difference did not reach significance. Interestingly, close examination of 
individual data sets revealed that of the 14 rats used, 4 (2 from the 6-OHDA lesioned 
group and 2 from the sham lesioned group) showed excessive urine production 
following surgery ( > 100% increase in urine production). 24 h urine output increased by 
up to 298.4% (mean 246.9 ± 25.7%, min 185.8%), compared to a 2.9 ± 12.7% increase 
(range -48.4 to 63.2%) in the other 10 rats, Fig. 5.4 B. 
 
There was no difference in the total number of voids during the 24 h that 6-OHDA 
lesioned rats were exposed to the metabolism cage following recovery from surgery in 
comparison to their pre-surgery exposure (Fig. 5.5, 17.8 ± 2.1 v. 21.5 ± 4.5 voids, P = 
0.5). The diurnal pattern of voiding remained post-surgery, with a significantly greater 
number of voids during the dark period in comparison to the light (Fig. 5.5, 14.5 ± 3.6 
compared to 7.0 ± 1.1 voids, P < 0.05). Similarly, in the sham lesioned group, there was 
no difference in the total number of voids during the 24 h that subjects were exposed to 
the metabolism cage following recovery from surgery (Fig. 5.5, 19.3 ± 4.2 compared to 
26.9 ± 3.2 voids, P = 0.24). The diurnal pattern in urine output was also maintained in 
the sham lesioned group (Fig. 5.5, 9.6 ± 1.2 v. 17.3 ± 2.7, P < 0.05).
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Figure 5.4. Volume of urine produced during 24 h exposure to the metabolism 
cage. A, Mean volume of urine produced in 24 h exposure to metabolism cage for the 
sham (n = 7) lesioned and 6-OHDA (n = 7) lesioned groups before and after lesioning 
surgery. B, Individual data sets showing 24 h urine output before and after injections of 
saline or 6-OHDA into the PAG. 
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Figure 5.5. Number of voids in 24 h exposure to the metabolism cage during the 
light (yellow, 7 am to 7 pm) and dark (blue, 7 pm to 7 am) period in rats receiving 
microinjections of saline (sham n = 6) or 6-OHDA (n = 6) into the PAG. Asterisks 
indicate significant difference between dark and light periods for each group Student’s 
paired t test, *P < 0.05). 
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5.4.1.2 Effect of 6-OHDA lesioning on micturition reflex evoked by 
intravesicular filling in the urethane anaesthetised rat 
One or two days after the second 24 h urine collection period (15 or 16 days after 
lesioning), every rat (sham lesioned n = 7, 6-OHDA lesioned n = 8) entered in to a 
terminal experiment using the same preparation and experimental protocol described 
previously in detail in the general methods (Chapter 2, Section 2.2). In both 6-OHDA 
and sham lesioned rats infusion of saline into the bladder (6 ml h-1) elicited periodic 
increases in intravesicular pressure that were associated with development of bursting 
activity in EMG recorded from the EUS and the expulsion of drops of fluid from the 
urethral meatus. This reflex failed to develop within 2 h of the intravesicular infusion 
starting in one rat from the 6-OHDA group (12.5%), and two from the sham lesioned 
group (28.6%). There was no significant difference between any of the parameters of 
voiding measured during continuous cystometry in the sham and 6-OHDA lesioned 
groups (Table 5.1).  
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Table 5.1. Comparison of parameters of voiding induced by continuous infusion 
of saline into the bladder (6 ml h-1) of urethane anaesthetised rats treated with 6-
OHDA or sham microinjection into the midbrain 
 6-OHDA 
treated 
Sham 
treated 
P = 
Reflex developed (n) 7/8 5/7 n/a 
Frequency of contractions 
(contractions min-1) 
0.5                ± 
0.1 
0.5               
± 0.1 
0.7 
Amplitude of contraction (mmHg) 21.4              ± 
1.7 
21.6             
± 1.8 
0.9 
Baseline bladder pressure 
(mmHg) 
8.8                ± 
0.5 
10.2              
± 1.9 
0.5 
Duration of contraction (s) 31.0               ± 
2.0 
27.0              
± 2.0 
0.24 
Number of drops per void 5.9                ± 
1.0 
5.8               
± 1.2 
0.95 
 
Values shown as mean ± SEM. P values from Student’s unpaired t tests.  
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5.4.1.3 Effect of 6-OHDA lesioning on tyrosine hydroxylase 
containing cell numbers in the caudal of the PAG 
In sham lesioned rats, cells immunostained for tyrosine hydroxylase (TH) were present 
throughout the PAG. Two brains were spoilt during storage before 
immunohistochemistry, one from the 6-OHDA lesioned group and one from the sham 
saline group. Therefore the numbers are 7 and 6 respectively. At the most caudal levels 
of the PAG (P -8.8 mm), TH+ cells were clustered almost exclusively in the ventrolateral 
portion. At more rostral levels TH+ cells were spread more diffusely throughout the 
ventral PAG and ventral to the aqueduct in the dorsal raphe nucleus (though rarely 
dorsal to the central aqueduct), Fig. 5.6.  
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Figure 5.6. Map taken from camera lucida drawings of TH+ cell population in the 
caudal PAG of a rat that received bilateral microinjections of saline vehicle 
(sham). Cells are mapped on to three representative levels of the caudal PAG. Green 
spots represent small TH+ cells (≤ 30µm) and purple stars represent large TH+ cells (> 
30µm) Abbreviations: Aq. aqueduct, PAG: periaqueductal grey, TH: tyrosine 
hydroxylase. Numbers represent mm caudal to Bregma.
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5.4.1.3.1 TH+ cell population in sham rats. 
There was a large degree of inter-rat variability in the total number of TH containing 
(TH+) cells in the caudal 1200 µm of the PAG (range 476 – 2211 cells, mean 1254.0 ± 
260.3, Fig. 5.7 A). Two types of TH+ cells could be distinguished in the PAG, defined as 
‘small’ (diameter of cell body ≤ 30 µm) and ‘large’ (diameter of cell body > 30 µm), Fig. 
5.8. Population density of both the small and large cells was equal on both the left and 
right hand sides of the PAG in the sham group (large cells: 18.5 ± 9.1 v. 31.5 ± 8.0, P = 
0.51, small cells: 654.9 ± 131.1 v. 668.5 ± 129.1, P = 0.88). Therefore cell numbers for 
both the left and right hand sides have been combined. There were significantly more 
small cells than large cells in the caudalmost 1200 µm of the PAG studied (Fig. 5.7 B, P 
= 0.001). Large diameter TH+ cells were more numerous in the more caudal 600 µm of 
the PAG studied in comparison to the more rostral 600 µm in the sham group (Fig. 5.7 
C, Table 2). 
 
5.4.1.3.2 Effect of 6-OHDA microinjections 
Large and small TH+ cells were also present in the PAG of 6-OHDA lesioned rats, and 
followed a similar distribution to the sham lesioned group (Fig. 5.7 C, Table 5.2). 
However, there was no difference in the total number or distribution of TH+ cells when 
the 6-OHDA lesioned group was compared to the sham group (Fig. 5.7 A, Fig. 5.9, 
Table 5.2). 
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Figure 5.7. Effect of bilateral microinjection of 6-OHDA and saline (sham) into the 
caudal periaqueductal grey (PAG) on tyrosine hydroxylase containing (TH+) cell 
numbers. A, total number of TH+ cells in the caudal 1200 µm of the PAG, large and 
small TH+ cells combined for sham (n = 6) and 6-OHDA (n = 7). B, number of TH+ cells 
in the caudal 1200 µm of the PAG, showing small and large cells. C, number of TH+ 
cells in the caudal 1200 µm of the PAG, showing the number of cells in the most caudal 
portion (600 µm) separately to the most rostral 600 µm. **P ≤ 0.001, *P < 0.05. 
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Figure 5.8. Photomicrograph of tyrosine hydroxylase positive (TH+) cells in the 
caudal ventrolateral PAG. Large and small diameter cells indicated by red and blue 
arrows respectively. Aq: central aqueduct.
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Table 5.2. Effect of bilateral microinjection of 6-OHDA into the ventrolateral PAG 
on tyrosine hydroxylase positive (TH+) cells in the most caudal 1200 µm of the 
PAG. 
 6-OHDA 
treated 
Sham 
treated 
(n) 7 6 
Total TH+ cell count     (caudal 
1200 µm of PAG) 
1124.5          
± 124.7 
1373.4         
± 261.1 
Large cell count            (caudal 
600 µm) 
69.9              
± 15.9 
48.6             
± 12.7 
Large cell count               (rostral 
600 µm) 
8.0                
± 2.4 
5.6               
± 2.3 
Small cell count            (caudal 
600 µm) 
316.9             
± 48.7 
369.6           
± 73.1 
Small cell count             (rostral 
600 µm) 
742.9            
± 94.1 
841.2           
± 191.5 
 
Values shown as mean ± SEM. 6-OHDA: 6-hydroxydopamine. 
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Figure 5.9. Map taken from 
camera lucida drawings of TH+ cell population in the caudal PAG of a rat that received 
bilateral microinjections of 6-OHDA. Cells are mapped on to three representative levels 
of the caudal PAG. Green spots represent small TH+ cells (≤ 30µm) and purple stars 
represent large TH+ cells (> 30µm) Abbreviations: Aq. aqueduct, PAG: periaqueductal 
grey, TH: tyrosine hydroxylase. Numbers represent mm caudal to Bregma. 
161 
 
 
 
5.4.2 Acute experiments: Effect of dopamine agonism and 
antagonism in the midbrain of the urethane anaesthetised rat 
Infusion of saline into the bladder elicited periodic increases in bladder pressure (0.5 ± 
0.03 contractions min-1, 21.2 ± 0.3 mmHg) that were associated with an increase in the 
level of tonic EMG activity of the EUS that adopted a bursting pattern that coincided with 
urine output (6.6 ± 0.2 drops per void). 
 
5.4.2.1 Microinjection of SCH23390 into the superior colliculi, dorsal 
PAG, ventral PAG and ventral tegmentum  
Once periodic voiding had been established, microinjections of the D1 antagonist 
SCH23390 (5 mM, 50 nl) were made into the superior colliculi (n = 3), dorsal PAG (n = 
5), ventral PAG (n = 14) and ventral tegmentum (n = 7, Fig. 5.10). SCH23390 did not 
affect any of the parameters of voiding including the threshold, maximum, baseline or 
amplitude of the pressure rise (Fig. 5.11). There was also no change in the frequency, 
the number of drops per void or the duration of contractions (Fig. 5.11). The bursting 
activity in the EMG of the EUS remained synchronous with the periodic increases in 
bladder pressure and expulsion of drops from the urethral meatus.  
 
Following microinjection of SCH23390, at 2/29 sites (6.9%) one in the superior colliculus 
and the other in the ventral PAG, unusual burst activity in the EMG of the EUS 
developed within 12.3 min, which appeared to be unrelated to voiding (Fig. 5.12, sample 
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trace). EMG bursting (average frequency 0.4 and 0.7 Hz respectively) was accompanied 
by twitching of the scrotum and a very small rise in intravesicular pressure (< 5 mmHg). 
Bursting activity usually lasted around 60 s and was characterised by an initial high 
intensity high frequency activity (around 2.5 Hz) which gradually subsided and slowed 
down (slow ≈ 0.4 Hz), Fig. 5.12.  In one case, two drops of fluid were expelled from the 
urethral meatus during a burst of activity (Fig 5.12). 
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Figure 5.10. Location of 
sites where dopamine agonists and antagonists were microinjected into the superior 
colliculi, dorsal periaqueductal grey (PAG), ventral PAG and tegmentum, mapped on to 
outlines of the midbrain taken from the Atlas of Paxinos and Watson (1986). Black open 
circles represent the centre of sites at which SCH23390 was microinjected during 
continuous cystometry. Red filled circles represent the centre of sites where 
apomorphine was microinjected and had no effect on the micturition reflex evoked by 
continuous cystometry. Numbers indicate distance (mm) caudal to Bregma. 
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Figure 5.11. Effect of microinjection of SCH23390 into the superior colliculi (SC, n 
= 3), dorsal PAG (dPAG, n = 5), ventral PAG (vPAG, n = 14) and ventral tegmentum 
(Teg, n = 7) on A, threshold, B, maximum pressure, C, baseline pressure, D, amplitude 
of the pressure rise, E, number of drops per void, F, duration of contraction, G, 
frequency of contractions. Analysis: No statistical testing for small n in SC, Mann 
Whitney U test for paired observations in the dPAG, paired t test for vPAG and Teg. All 
P values where analysed > 0.05. 
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Figure 5.12. Sample trace showing atypical bursting in the EMG of the EUS 
following microinjection of SCH23390 into the PAG. A, periodic increases in bladder 
pressure are normally associated with increased activity in the EMG activity of the EUS 
and expulsion of drops from the urethral meatus. Independent bursting in EMG of the 
EUS in absence of a change in intravesicular pressure is highlighted on an increased 
timescale in B.  
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5.4.2.2 Microinjection of apomorphine into the ventral PAG 
Microinjections of the D1 agonist, apomorphine (94 mM, 50 nl) were made at 8 sites in 
the ventral PAG (Fig. 5.10 map, red circles, n = 8) during continuous cystometry. There 
was no change in any of the parameters of voiding that were measured. Analysis was 
carried out into the effects on the threshold for initiation of contraction of the detrusor, 
maximum pressure reached during contraction, the baseline bladder pressure, the 
amplitude of the pressure rise, the number of drops per void, the duration of contraction 
and the frequency of contractions (Fig. 5.13). Paired t tests showed no significant 
differences between any of the above parameters before and after administration of 
apomorphine.  
 
At 2/8 sites, following microinjection of apomorphine into the ventral PAG, bursting 
activity developed in the EMG of the EUS within 2.3 min at a mean frequency of 1.1 and 
0.8 Hz in each case. Bursting started off at a slow frequency (≈ 0.4 Hz), then became 
fast for a short period (≈ 2.5 Hz) before slowing again. This bursting lasted for a 
maximum of 1.7 min and occurred in the absence of the sharp rise in intravesicular 
pressure that was normally associated with a void.  
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Figure 5.13. Microinjection of apomorphine (APO, n = 8): Effect on parameters of 
the micturition reflex evoked by continuous infusion of saline into the bladder of 
urethane anaesthetised rats. A, threshold pressure for contraction, B, maximum 
pressure reached during contraction, C, baseline bladder pressure, D, amplitude of 
pressure rise during contraction, E, number of drops per void, F, duration of contraction, 
G, frequency of contractions. All control means analysed with Student’s paired t test to 
the APO values. All P > 0.05.
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5.5 DISCUSSION 
This study was designed to investigate the contribution of dopamine-containing cells in 
the PAG on micturition. 24 h urine output was measured before and after the 6-OHDA 
lesioning or sham procedure so that each animal could act as its own control. 
 
All rats showed a diurnal pattern in urine output, with a greater number of voids during 
the dark period, when rats are awake and active, in comparison to the light period. This 
finding is in accord with previous studies, which reported more frequent and smaller 
volume voids during the dark period compared to the light (Longhurst et al., 1992; 
Schmidt et al., 2001; Herrera & Meredith, 2010). Surprisingly, the volume of urine 
produced during the 24 h period in the present experiments was almost half of that 
reported by Schmidt and colleagues (2001). It is possible that evaporation of fluid from 
the collection tube over the 24 h period led to an underestimation of the volume of urine 
produced. However, the rats used by Schmidt and colleagues (2001) had received 5 ml 
water by gavage in an attempt to standardise the baseline hydration status before urine 
collection was started. These animals would have been severely volume loaded which 
would have contributed to their high urine volume output over the subsequent 24 h. 
 
Interestingly, in the present experiments, though the number of voids during the light, 
inactive period was lower than during the dark period, the volume of urine produced 
during this time was equal to the volume produced during the dark, active period. 
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Therefore during the light, inactive period, rats did fewer voids, but the volume of each 
void was greater than during the dark period. Usually, there is a diurnal pattern in the 
volume of urine produced, with production levels reduced in the inactive period 
compared to the active period (Mills, 1951; Schmidt et al., 2001), which was not seen in 
the present experiments. It is possible that since this was a novel environment, and the 
first time alone in a cage for these rats, their diurnal patterns may have been disrupted. 
In the future, habituation to the metabolism cage, as carried out by Schmidt and 
colleagues (2001) would determine whether this was the cause. 
 
When 24 h urine output was measured following the lesioning or sham-lesioning 
procedures, there was no difference in the volume of urine produced compared to the 
baseline pre-surgery values in either group. However, counts of tyrosine hydroxylase 
positive (TH+) cells in the periaqueductal grey (PAG) in the 6-OHDA-injected group 
were not significantly different to the sham-lesioned rats, suggesting that the lesioning 
procedure had not been effective. 
 
In sham-lesioned rats the immunohistochemistry experiments revealed densely stained 
TH immunoreactive cells bilaterally in the ventrolateral PAG and dorsal raphe nucleus, 
in accordance with previous findings (Hokfelt et al., 1976; Hasue & Shammah-Lagnado, 
2002; Flores et al., 2004). TH is an enzyme responsible for the hydroxylation of L-
tyrosine to form L-3,4-dihydroxyphenylalanine (L-DOPA) which is then converted to 
dopamine in the dopamine synthesis pathway. Synthesis of noradrenaline shares a 
common pathway with dopamine being converted to noradrenaline by dopamine β 
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hydroxylase (DBH). Thus it is important to clarify that one is identifying dopaminergic 
neurons with TH immunohistochemistry as opposed to noradrenergic neurons that 
contain DBH. Flores and colleagues (2004) used a similar immunohistochemistry 
protocol to the present experiments, and as well as immunostaining for TH, they carried 
out DBH immunohistochemistry and found that there were no cells containing DBH in 
the PAG. This suggests that the TH cells stained in their sections, and indeed in the 
present experiments are likely to be dopaminergic neurons. Two morphologically distinct 
populations of TH+ cells (large and small) in the PAG with a morphology and distribution 
similar to those found in the present study have also been described previously (Flores 
et al 2004). However in contrast to the study of Flores et al (2004) where approximately 
one third of the immunostained population comprised large cells, only 5% of cells in the 
current study were classified as large. This discrepancy may be due to difference in the 
area sampled in the two studies. In the present experiments, TH+ cells in the dorsal 
raphe nucleus have been included in the total cell counts and it is not explicitly clear 
whether these cells were counted in Flores and colleagues’ model used for estimation of 
cell numbers (Flores et al., 2004). 
 
In the present study there was a more than 4-fold range in the number of TH+ cells 
present in the caudalmost 1200µm of the PAG between individual sham-lesioned rats. 
Thus it was possible that the high degree of inter-individual variability might be masking 
an effect of 6-OHDA lesioning. Furthermore, the method employed to quantify the effect 
of the 6-OHDA lesion was a simple cell count that did not take into account the size of 
the remaining TH+ cells aside from identifying those which were less or greater than 
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30µm. Thus the possibility of cells being double-counted was not considered using a 
correction such as Abercrombie’s which takes into account the size of cells and the 
thickness of the section. However one might expect the error caused by double counting 
to be of an equal magnitude in both the 6-OHDA and sham lesioned group since neither 
were subject to Abercrombie’s correction, thus it is unlikely that this error masked any 
overall change in cell numbers. Moreover there was no correlation between the 24 h 
urine output and TH+ cell number in either the sham-lesioned or lesioned groups. 
Therefore we have to conclude that the lesioning procedure had been ineffective.  
 
The reason for the ineffectiveness of 6-OHDA in the lesioning of the DA-containing cell 
population in the PAG is not clear. It is possible that the 6-OHDA became inactive due to 
oxidation. However, a number of precautions were taken to prevent this happening. On 
arrival, the drug was dissolved in aqueous solution containing ascorbate and was stored 
at -20oC. On the day of an experiment the aliquot was stored in darkness and on ice 
until the last possible moment before filling the microinjection cannula.  
 
To carry out the lesioning procedure the rats were anaesthetised with an IP injection of 
ketamine and medetomidine. One possibility is that this anaesthetic interfered with the 
neurotoxic actions of the 6-OHDA. An interesting paper suggested that a similar 
anaesthetic mix of ketamine and xylazine protected dopaminergic cells from the 
lesioning effects of 6-OHDA (Ferro et al., 2007). Ferro and colleagues (2007) found 
significantly fewer dopaminergic cells were lesioned when 6-OHDA was administered 
into the substantia nigra pars compacta under ketamine/xylazine anaesthesia in 
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comparison to under thiopental anaesthesia. However, Ferro et al (2007) did not find 
that this anaesthetic had a 100% neuroprotective effect. Moreover, others have also 
successfully used the 6-OHDA lesioning procedure in different brain regions using the 
same general anaesthesia as used in the present experiments (Yoshimura et al., 2003; 
Soler et al., 2011). This suggests that the success of 6-OHDA lesions in our surgeries 
carried out under ketamine/medetomidine anaesthesia may have been thwarted by the 
anaesthetic but this cannot explain the complete failure of the lesioning technique. 
 
A further consideration is that the dose of 6-OHDA used in the present experiments may 
have been too low. Similar doses have been used to selectively lesion dopaminergic 
cells in the nigrostriatal pathway in animal models of Parkinson’s disease (Ungerstedt, 
1968; Sauer & Oertel, 1994; Yoshimura et al., 2003; Blandini et al., 2008; Soler et al., 
2011), but it is possible that different biophysical properties of dopaminergic cells in the 
PAG could leave them more resistant to 6-OHDA lesioning. However, an identical dose 
of 6-OHDA to that used in the present study administered into the PAG was found to 
lesion around 60% of large TH+ cells in the PAG without affecting the number of small 
cells (Flores et al 2004). In contrast, others used much higher doses of 6-OHDA in the 
PAG to achieve a similar reduction in the number of TH+ cells (Lu et al., 2006). This 
study did not specify whether the neurotoxin produced differential effects on the large 
and small cell populations. This suggests that the ineffectiveness of 6-OHDA might have 
been due to insufficient dosing. Unfortunately, due to constraints imposed on the 
conditions of the Project Licence governing this work, we were unable to carry out 
further experiments to test this hypothesis.  
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An interesting and unexpected finding in the present study was that a significant minority 
of rats in both the sham-lesioned and 6-OHDA lesioned groups developed polyuria 
following the surgical procedure. Since the only common factor was the anaesthesia, it 
is possible that in these animals polyuria was a lasting effect of the 
ketamine/medetomidine anaesthetic. It is known that administration of this anaesthetic 
produces acute diuresis via α2 activation (Cabral et al., 1997; Cabral et al., 1998). 
However there are no reports of long-lasting effects. We were unable to carry out control 
experiments to test this hypothesis due to restrictions on the Project Licence governing 
the work. To answer these questions fully, future experiments could repeatedly expose 
an age-matched control group to the metabolism cage, but without the intervening 
anaesthesia and lesioning surgery to see whether the polyuria was an effect of age. If 
there were no differences then another control group should be exposed to the 
metabolism cage, receive the anaesthetic and drugs associated with surgery for a 
similar length of time without any surgery being carried out.  
 
Since lesioning experiments were stopped before methodological issues concerning 
optimising the procedure could be resolved, we moved to a pharmacological approach 
to investigate the role of dopaminergic transmission in the PAG on reflex micturition. The 
effects of microinjection of a dopamine agonist and an antagonist in the urethane 
anaesthetised rat in an acute preparation were investigated.  
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In our anaesthetised rat preparation, microinjection of neither the D1 antagonist 
SCH23390 nor the non-selective dopamine agonist apomorphine had any affect any of 
the parameters of voiding. These findings are in contrast to previous studies in 
conscious rats in which application of SCH23390, into the ventrolateral PAG increased 
the maximal voiding pressure and reduced the inter-void interval during continuous 
cystometry (Kitta et al., 2008) and apomorphine caused an increase in the maximal 
voiding pressure following systemic administration (Uchiyama et al., 2009). The failure of 
these agonists to produce an effect in the present study was unexpected. Indeed, a 
previous study in conscious rats showed that during micturition, the levels of dopamine 
in the caudal ventrolateral PAG were increased whilst the levels of GABA decreased 
(Kitta et al., 2008), suggesting that dopamine and GABA may work in concert in the 
ventrolateral PAG to control the micturition circuitry. In striatal tissue dopamine has been 
shown to inhibit the release of GABA (Harsing & Zigmond, 1996). It is possible that a 
similar relationship may exist in the caudal ventrolateral PAG, where dopamine could 
inhibit the release of GABA, thus allowing micturition to occur as the GABAergic 
inhibition is lifted. In the present study carried out under urethane anaesthesia, the 
levels of GABA in the whole of the brain, including the PAG, are likely to be high 
(Krnjević, 1986). Therefore if dopamine acts by inhibiting GABA release, but GABA 
levels are already high, then the effects of a dopamine agonist or antagonist on GABA 
release may be silenced. It is possible that the absence of an effect in these 
experiments was due to insufficient dosing of both the agonist and the antagonist, 
despite the doses being within the ranges reported in the literature (Melo et al., 2009; 
Meyer et al., 2009; Dang et al., 2010; Chen et al., 2011). Further experiments that 
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administer a higher dose of both SCH23390 and apomorphine would resolve this 
uncertainty but might lead to more non-specific activation of other receptor subtypes.  
 
Although apomorphine was ineffective in influencing micturition, in 25% of cases it 
evoked atypical low frequency EMG bursting in the EUS in the absence of a change in 
the intravesicular pressure that would normally signify a void. Similar bursting patterns 
have been seen in investigations into the coital reflex in rats (Carro-Juarez & Rodriguez-
Manzo, 2000). Moreover, administration of apomorphine systemically, and into other 
regions of the brain is known to induce ejaculation (Pehek et al., 1988; Pehek et al., 
1989; Stafford & Coote, 2006; Yonezawa et al., 2009). The PAG has been implicated in 
the control of sexual function in females, producing lordosis, but this role in males has 
not been described (Behbehani, 1995). Marson (2004) has shown that inhibition of the 
PAG can prevent the medial preoptic area induced coital reflex in male rats (Marson, 
2004). Thus bursting activity in the EUS evoked by apomorphine may be related to 
sexual behaviour.  
 
5.6 SUMMARY AND CONCLUSIONS 
In summary, the present experiments have neither proven nor disproven the role that 
dopamine in the caudal ventrolateral PAG plays in the control of micturition. 
Optimisation of the lesioning technique is required to be able to draw any conclusions 
about whether degeneration of the dopaminergic cells in the caudal ventrolateral PAG 
might contribute to the urinary disturbances that have been reported in animal models of 
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Parkinson’s disease (Soler et al., 2011). Our experiments in the urethane anaesthetised 
rat indicate that this preparation is not an ideal experimental model for investigation of 
the role of dopamine in the midbrain in control of reflex micturition, possibly because the 
urethane anaesthetic interferes with central neurotransmission. 
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5.7 KEY FINDINGS: CHAPTER 5 
5.7.1 Chronic experiments: Lesioning of dopaminergic cells in the 
PAG with 6-OHDA 
1. 24 h urine output can be recorded in the conscious, unrestrained rat by 
placement in a metabolism cage with an infra-red drop counter recording 
passage of drops into the urine collection tube via PowerLab and LabChart 
software. Future experiments should allow a longer acclimatisation period or 
habituation in case exposure to the novel metabolism cage environment affects 
voiding patterns. 
2. Bilateral microinjection of a 5 mg ml-1 solution of 6-OHDA did not reduce the 
number of TH+ cells in the ventral 1200 µm of the PAG in comparison to the 
sham lesioned controls. This may have been due to insufficient dosing or an 
interaction between the 6-OHDA and anaesthesia used for surgery. Future 
experiments should use a higher dose and an alternative anaesthetic.  
3. There was a high degree of inter-rat variability in the number of TH+ cells in the 
caudal portion of the PAG. This should be considered when using the cell number 
to assess the extent of 6-OHDA lesioning. 
 
 
5.7.2 Acute experiments: Microinjections of dopamine agonist and 
antagonist into the PAG of the urethane anaesthetised rat 
1. Microinjection of the D1 antagonist SCH23390 and the non-specific dopamine 
agonist apomorphine into the PAG did not affect the micturition reflex in the 
urethane anaesthetised rat; despite previous research suggesting that 
dopaminergic neurotransmission in the caudal ventrolateral PAG might play a 
role in the control of micturition in the conscious rat (Kitta et al., 2008).  
2. The urethane anaesthetised rat may not be a suitable preparation to use in these 
investigations because of the increased GABA tone that produces general 
anaesthesia. 
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CHAPTER 6: GENERAL DISCUSSION 
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These studies were designed with the short-term goal of furthering understanding of the 
normal control of micturition in the rat, and with a long-term goal of identifying novel 
therapeutic targets for human diseases that affect the urine storage and emptying 
function of the bladder.  
 
6.1 KEY FINDINGS  
Microinjection of the GABA agonist, muscimol into the periaqueductal grey (PAG) 
revealed that critical synapses involved in reflex micturition are located in a restricted 
area within the caudal ventrolateral region. Furthermore, these experiments have shown 
that synaptic transmission through this region is tonically suppressed by a GABAergic 
influence since microinjection of the GABAA antagonist, bicuculline, into the same region 
of the PAG increased the frequency of voiding evoked by continuous infusion of saline 
into the bladder. The presence of on-going GABAergic tone is clearly an important factor 
for maintaining urinary continence. It is possible that disease states that lead to 
disruption of GABA levels in the PAG could cause a failure of this inhibitory mechanism 
leading either to urinary retention due to excess levels of GABA in the caudal 
ventrolateral PAG, or overactive bladder: a frequent desire to void, possibly caused by 
insufficient levels of GABAergic inhibition in the same area.  
 
The PAG receives inputs from a number of brain regions, and integrates coordinated 
behavioural and emotional responses, including anxiety, sympathetic activation of the 
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cardiovascular and respiratory systems and nociception (Behbehani, 1995) (Behbehani, 
1995). It is probable that the caudal ventrolateral PAG also acts as a site for integration 
in the control of micturition, receiving afferent signals from the distended bladder, and 
efferent projections from frontal regions (Marson, 1997) which might be involved in the 
conscious component of socialised voiding.  
 
The ubiquitous nature of GABAergic transmission within the brain makes selective 
targeting of local GABAergic circuits for therapeutic gain by pharmacological means 
almost impossible. However, the presence of a discrete population of tyrosine 
hydroxylase containing (TH+) neurons localised in the ventrolateral PAG (Saper & 
Petito, 1982; Flores et al., 2004; Lu et al., 2006) corresponding to the area where critical 
synapses in the micturition circuitry had been identified (Stone et al. 2011, Chapter 3) 
raised the possibility that dopamine might be involved in the control of micturition. 
Moreover, Kitta and colleagues (2008) found that during periods of intravesicular 
distension, the extracellular levels of dopamine in the caudal ventrolateral PAG of the 
conscious rat were raised. We hypothesised that the population of TH+ cells in the 
ventrolateral PAG might be the source of this dopamine, and designed experiments to 
investigate the effects of lesioning these cells on micturition in the rat. The results of 
these studies were inconclusive. Technical problems in optimising a procedure for 
selectively lesioning this cell group did not allow us to establish whether they are a 
critical component of the micturition reflex pathway.  
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Pharmacological manipulation of dopaminergic transmission through the PAG using 
selective agonists and antagonists did not have any effect on reflex micturition in the 
urethane-anaesthetised rat. Since others have shown that similar manipulation, both 
systemically and locally evoked dose and time dependent effects on the frequency of 
voiding in the conscious rat (Kitta et al., 2008; Uchiyama et al., 2009), it is possible that 
the urethane anaesthesia in the present experiments interfered with the actions of the 
drugs. Refinement of experimental procedures would resolve many of the technical 
problems that arose in our investigations into the role of dopaminergic 
neurotransmission in the control of micturition and would provide conclusive evidence as 
to whether the population of dopaminergic cells in the PAG are involved in controlling 
micturition.  
 
This study has however shown that powerful control of micturition can be produced by 
electrical stimulation within the PAG. These inhibitory effects were rapidly reversible, 
with voiding returning shortly after the stimulation was stopped. Electrical stimulation of 
discrete regions of the brain (‘deep brain stimulation’, DBS) has become increasingly 
popular as a clinical tool for the alleviation of symptoms of a number of disorders, 
including Parkinson’s and intractable pain (for reviews see Perlmutter and Mink, 2006, 
Kringelbach et al. 2007, Deniau et al. 2010). In cases that are refractory to other 
treatments DBS is an attractive therapeutic option because although electrode 
implantation involves invasive neurosurgery, DBS has been shown to be effective, 
highly selective, of rapid onset and rapidly reversible. Thus the side effects are limited 
(and depend on the locus of stimulation).  
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6.2 TRANSLATIONAL POTENTIAL 
Based on our findings in the rat, the translational potential of electrical stimulation in the 
PAG for controlling human continence has been explored by our clinical colleagues at 
the John Radcliffe and Churchill Hospitals in Oxford. The neurosurgical team at the John 
Radcliffe Hospital in Oxford and others use deep brain stimulation of the PAG to control 
pain in patients with chronic intractable pain (Nandi et al., 2002; Bittar et al., 2005; 
Hamani et al., 2006; Owen et al., 2006). We were therefore fortunate to have access to 
a cohort of 7 patients with electrodes already implanted into midbrain sites that 
consented to being participants in a study to investigate the effects of their DBS on 
bladder function. Six of these patients — with normal bladder function — had electrodes 
implanted into the PAG and/or ventral posterolateral nucleus of the hypothalamus (VPL) 
for the purpose of treating their chronic pain. A further patient had electrodes in the VPL 
only. A similar protocol was used to the ‘discontinuous cystometry’ experiments on rats 
(Chapter 4, Section 4.3.2.2). Maximum cystometric capacity, the volume at which 
patients could not tolerate further intravesicular filling, was increased when the PAG 
stimulator was turned on, compared to when the PAG stimulator was turned off (Fig. 
6.1). Moreover, in two patients with electrodes implanted in the VPL, deep brain 
stimulation was ineffective (Fig. 6.1) (Green et al., 2012). Importantly, the effects of DBS 
were not secondary to changes in pain. 
 
These exciting results suggest that there may be therapeutic potential for DBS of the 
midbrain for the treatment of urinary incontinence in human patients. In addition, our 
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parallel study in animals validates the use of the anaesthetised rat model in basic 
scientific research into the central control of reflex micturition. 
 
 
 
 
Figure 6.1. Effect of electrical stimulation of the midbrain of both anaesthetised 
rats and conscious humans on the maximal cystometric capacity. Figure adapted 
from collaborative work with Green et al. 2012. A, Parasagittal maps showing location of 
sites at which electrical stimulation was applied and the effects on bladder filling from 
empty were recorded in the rat (i) and human (ii). Centre of effective sites in the rat 
represented as green circles. Open circles represent ‘no effect’. In human map (A ii), 
pairs of contacts are indicated by same coloured circles. Abbreviations: AC: anterior 
commissure; PAG: periaqueductal grey; PC: posterior commissure; PVG: periventricular 
grey; RN: red nucleus; SC: superior colliculus. B i, Effect of electrical stimulation on 
discontinuous cystometry in the rat: Change in bladder volume at which urine was first 
expelled ON v. OFF stimulation when the bladder was filled from empty (n = 10; 
P<0.001, Student’s paired t test on raw data). B ii, Effect of electrical stimulation in 
human participants: PAG/PVG (unbroken lines, n = 6) and VPL (broken lines, n = 2) 
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showing an increase in maximum cystometric capacity (MCC) in participants. One 
participant (3, blue lines) had electrode placements in PAG where stimulation increased 
MCC and VPL (broken lines) where it decreased MCC. Corresponding electrode 
placements for each participant are shown by equivalent coloured circles in A ii. For 
PAG/VPL sites P = 0.028 ON v. OFF stimulation, Wilcoxon signed rank test carried out 
on raw data from human participants. 
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6.3 SUMMARY AND CONCLUSIONS 
These experiments have shown that GABAergic neurotransmission in the caudal 
ventrolateral PAG tonically inhibits the micturition reflex evoked by continuous infusion 
of saline into the bladder of the urethane anaesthetised rat. Though we have been 
unable to draw conclusions on the effects of dopaminergic neurotransmission in the 
same area of the PAG, we have shown that electrical stimulation in the PAG and also 
over a wide area of the midbrain can inhibit reflex voiding in response to intravesicular 
distension. The translational potential of these finding is great, and indeed we have been 
in the rare position of being able to collaborate with clinical colleagues to translate our 
findings from laboratory animal into preliminary trials with human participants. The future 
for therapeutic intervention using DBS to alleviate urinary disturbances is exciting. 
 
Nonetheless, there is still much scope for basic research to further understanding of the 
normal control of the micturition circuitry — particularly the pharmacology of conscious 
control of micturition and its integration with the reflexive autonomic control of the 
bladder and EUS — with a view to deducing the pathophysiology underlying the failure 
of the storage and emptying functions of the bladder and EUS that afflict so many. With 
this knowledge, novel, targeted therapies may be realised or existing therapies modified 
to improve success rates and the overall quality of life of individuals suffering from 
urinary disturbances. 
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APPENDICES 
APPENDIX A: CALCULATION OF TOTAL EMG ACTIVITY DURING THE INTER-VOID 
INTERVAL 
Nb. The sampling frequency must remain constant during and between experiments in 
order to make mathematical comparisons of the EMG activity using the following 
method.  
 
1. Sum the total rectified EMG signal over 60 s during the inter-void interval. To do 
this: 
a. Highlight relevant section in Chart 
b. Save as .txt file 
c. Copy/paste values into Excel 
d. Rectify the data by selecting any negative values (ctl+f) and replacing 
them with positive.  
e. Sum the first 6000 values to calculate the total EMG activity in 60s (6000 
because the sampling rate for these experiments was set at 100Hz, and 
want 60s period counted (100x60=6000) 
2. Divide the total rectified EMG activity achieved by summing the first 6000 values 
by 5000. This is to take account for the x5000 gain on the NeuroLog amplifiers.  
This will give the total EMG activity recorded from the EUS in mV min.  
3. Divide by 60 to convert units to seconds.  
4. (If necessary multiply by 1000 and use µV s) 
 
Example: 
EXP ID: ES86 1.1 pre musc 
 
1. Sum of EMG over 60s (6000 inter-void values) = 97.91  mV. min 
2. Divide by 5000 to take into account gain on NeuroLog amplifier = 0.0196 mV. min 
3. Divide by 60 to convert units to seconds = 0.00033 mV.s 
4. Multiply by 1000 to convert to µV. s = 0.33 µV. s  
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APPENDIX B: 0.1M PHOSPHATE BUFFER (PB) RECIPE 
1. Dissolve 3.9 g sodium dihydrogen orthophosphate in 400 ml distilled water 
2. Add 0.8 g sodium hydroxide and dissolve 
3. Make up to 500 ml with distilled water 
4. pH to 7.4 with sodium hydroxide 
 
(All solid ingredients from Fisher Scientific, Loughborough, UK) 
 
 
APPENDIX C: 0.1M PHOSPHATE BUFFERED SALINE (PBS) RECIPE 
1. Dissolve 0.195g sodium dihydrogen orthophosphate in 400ml distilled water. 
2. Add 0.535g disodium hydrogen orthophosphate and dissolve 
3. Add 4.25g sodium chloride and dissolve 
4. Make up to 500ml with distilled water 
5. pH to 7.4 with sodium hydroxide 
 
(All solid ingredients from Fisher Scientific, Loughborough, UK) 
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